data_1iou_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iou _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 80' ' ' ILE . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.579 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 15' ' ' LYS . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 10' ' ' ARG . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.425 ' OG ' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' CG2' ' A' ' 129' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' ' CE1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HA ' HD21 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' CE2' ' A' ' 28' ' ' PHE . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.463 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.421 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 46' ' ' THR . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 45' ' ' GLU . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.7 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' THR . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' HG12 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.66 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.7 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.582 ' CD ' ' C ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.572 ' N ' ' HG2' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.595 ' O ' HG11 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.66 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.552 ' HB3' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HA ' HG21 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.693 HG21 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 132' ' ' TYR . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 98' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.536 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.446 ' CE1' HG13 ' A' ' 75' ' ' ILE . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.572 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 110' ' ' TRP . 38.0 t . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.414 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.496 ' HB2' HG13 ' A' ' 97' ' ' ILE . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.448 ' HA ' HG23 ' A' ' 22' ' ' VAL . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 33.0 mt-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.631 HD13 HG13 ' A' ' 6' ' ' ILE . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' ASP . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.631 HG13 HD13 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.609 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.501 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 19' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 28' ' ' PHE . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.42 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.775 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.775 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.522 ' OG1' HG13 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HD3' ' CE1' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.655 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CG ' ' OG1' ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.532 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' CH2' ' A' ' 110' ' ' TRP . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.713 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 18' ' ' GLU . 40.4 t . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.576 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 124' ' ' GLN . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.618 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.482 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.538 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.497 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.658 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.455 ' CB ' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 126' ' ' ASP . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.451 ' CE2' ' CE ' ' A' ' 40' ' ' MET . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.545 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.43 ' CG1' ' CE ' ' A' ' 40' ' ' MET . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.451 ' CE ' ' CE2' ' A' ' 28' ' ' PHE . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.833 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.642 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.59 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.516 ' CG1' ' HA ' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 79' ' ' LEU . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.833 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.536 ' O ' HG13 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.658 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD21 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.514 ' HB ' ' CG1' ' A' ' 3' ' ' ILE . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HA ' ' CG1' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' CD2' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.426 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.496 ' HG ' HD21 ' A' ' 79' ' ' LEU . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.618 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.618 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' CB ' ' A' ' 124' ' ' GLN . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.567 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.461 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.461 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 110' ' ' TRP . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.7 t . . . . . 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.412 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 97' ' ' ILE . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.587 ' HA ' HG22 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.424 ' CD1' HD12 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.612 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.917 0.389 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.609 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' HG22 ' A' ' 8' ' ' VAL . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 126' ' ' ASP . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.469 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.434 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.518 ' OG1' HG12 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.557 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' LEU . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.691 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.59 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 ' CD2' HD11 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.518 ' CD1' HG22 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.45 HD12 ' CE2' ' A' ' 132' ' ' TYR . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.558 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.524 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 96' ' ' LYS . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.498 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.667 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 43.3 t . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.672 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.519 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 . . . . . 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.963 0.411 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.564 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.675 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.444 ' CD1' HG13 ' A' ' 75' ' ' ILE . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' HD12 ' A' ' 125' ' ' LEU . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' CG1' ' HE3' ' A' ' 40' ' ' MET . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.54 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.752 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.47 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.657 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.629 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.44 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' LEU . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.554 HG21 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.764 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.564 ' CB ' ' HA ' ' A' ' 3' ' ' ILE . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.524 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 6' ' ' ILE . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.574 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 97' ' ' ILE . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.556 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 37.9 t . . . . . 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.558 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.631 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.62 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.461 ' HB2' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 129' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 28' ' ' PHE . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.485 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.424 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.404 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.774 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.518 ' OG1' HG13 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 79' ' ' LEU . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.774 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' CG ' ' A' ' 94' ' ' LEU . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.487 HD12 ' CD1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.528 ' CD2' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 69' ' ' TYR . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.469 ' CD1' ' CD2' ' A' ' 132' ' ' TYR . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.553 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.553 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.487 ' CD1' HD12 ' A' ' 75' ' ' ILE . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 105' ' ' HIS . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.549 ' CE2' ' O ' ' A' ' 107' ' ' LYS . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.5 t . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.431 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 20' ' ' SER . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 22' ' ' VAL . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.406 ' N ' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.863 0.363 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 79' ' ' LEU . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.678 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.606 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.729 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB1' ' N ' ' A' ' 49' ' ' SER . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.607 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.435 ' OG ' HG22 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' TYR . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.43 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG13 ' CE2' ' A' ' 28' ' ' PHE . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.491 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.42 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.734 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' HB1' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.462 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.587 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.734 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' PHE . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.634 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.42 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.486 HD22 ' CD2' ' A' ' 132' ' ' TYR . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.55 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.535 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.607 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.601 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.601 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 110' ' ' TRP . 17.6 t . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.89 0.376 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.525 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.49 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.567 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.486 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.621 HD13 HG13 ' A' ' 6' ' ' ILE . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HG13 ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 8' ' ' VAL . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 28' ' ' PHE . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.445 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.407 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.834 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.537 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.502 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.637 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.571 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.834 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HB2' ' CG ' ' A' ' 94' ' ' LEU . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.64 ' HB ' ' HE1' ' A' ' 9' ' ' PHE . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.646 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.443 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.622 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' CG ' ' A' ' 132' ' ' TYR . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 98' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' LYS . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.71 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.71 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.1 t . . . . . 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 129' ' ' ILE . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HA ' HG21 ' A' ' 22' ' ' VAL . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 121.029 0.442 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.681 ' HB ' HG13 ' A' ' 129' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.672 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' CD1' HG13 ' A' ' 75' ' ' ILE . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 126' ' ' ASP . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 33' ' ' ARG . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 28' ' ' PHE . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.477 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.421 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.563 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' LEU . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.592 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.554 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' HA3' HD12 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.672 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 67' ' ' HIS . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.683 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD1' HG22 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' ' CD2' ' A' ' 67' ' ' HIS . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.499 HD12 HD22 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.633 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.633 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 96' ' ' LYS . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' ILE . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.633 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.583 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.681 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.487 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.51 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.555 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.644 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HA ' ' CE2' ' A' ' 28' ' ' PHE . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 25' ' ' LEU . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 28' ' ' PHE . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.463 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.585 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' LEU . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.706 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.498 ' CG1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.504 ' CD2' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.694 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 3' ' ' ILE . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CG ' HG23 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.443 HG23 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.613 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.437 HD13 ' CZ2' ' A' ' 110' ' ' TRP . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.845 0.355 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 4.1 mm-40 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.741 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 2.3 pt20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.952 0.406 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.504 ' CD1' HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.661 HD13 ' HB ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' CB ' ' HG3' ' A' ' 10' ' ' ARG . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 129' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HA ' HD23 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.574 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.743 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.528 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.743 HG21 ' HB ' ' A' ' 47' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HB3' ' HG ' ' A' ' 94' ' ' LEU . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.432 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.714 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.668 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' HB3' HG22 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 94' ' ' LEU . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 132' ' ' TYR . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.588 HG13 ' HB3' ' A' ' 125' ' ' LEU . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.55 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.549 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' TRP . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 9.6 t . . . . . 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 120.915 0.388 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.588 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.661 ' HB ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' TYR . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 28' ' ' PHE . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.451 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 28' ' ' PHE . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.532 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 78' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.617 ' CG1' HG12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.47 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HG2' ' CD1' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.617 HG12 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 81' ' ' THR . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA3' HG13 ' A' ' 59' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.471 ' HB2' HD13 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 57' ' ' GLN . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.488 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PHE . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.585 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.514 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.623 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.623 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 110' ' ' TRP . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB1' ' CD2' ' A' ' 105' ' ' HIS . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.616 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 3.3 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.417 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 129' ' ' ILE . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.419 ' N ' HG23 ' A' ' 129' ' ' ILE . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 3' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG13 ' A' ' 129' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.692 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB3' ' OH ' ' A' ' 5' ' ' TYR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.673 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.512 ' OG1' HG13 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.4 m-70 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.509 HG13 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' O ' ' O ' ' A' ' 9' ' ' PHE . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' HIS . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.595 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.554 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.688 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' CD2' ' A' ' 132' ' ' TYR . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.609 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HA ' ' CD1' ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.558 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.497 ' H ' ' HE3' ' A' ' 110' ' ' TRP . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.2 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.914 0.388 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.609 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.611 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.582 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.655 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.582 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.682 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.621 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 49' ' ' SER . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 126' ' ' ASP . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HB2' HD12 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.47 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.426 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.579 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.505 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.544 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.566 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 29.0 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.588 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.645 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.599 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.519 HG21 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.588 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.535 ' OH ' ' CG ' ' A' ' 132' ' ' TYR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 132' ' ' TYR . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' THR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 125' ' ' LEU . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.587 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.579 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 110' ' ' TRP . 19.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.682 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.535 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.552 HD12 HG13 ' A' ' 6' ' ' ILE . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.602 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' CB ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' CB ' ' HG3' ' A' ' 10' ' ' ARG . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HG3' ' CD1' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.451 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 ' OG1' HG13 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.692 HG23 ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' ' HG2' ' A' ' 56' ' ' ARG . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.537 HG22 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.44 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.44 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CD2' ' OH ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.637 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' LYS . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 110' ' ' TRP . 9.5 t . . . . . 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.932 0.396 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HA ' HG23 ' A' ' 22' ' ' VAL . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.645 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.519 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 6.9 mt-30 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.633 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.611 ' NE ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' PHE . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 28' ' ' PHE . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.465 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.749 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.483 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.749 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.569 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 51' ' ' THR . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.605 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.498 HD23 HD22 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.656 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.53 ' HB ' ' CG1' ' A' ' 3' ' ' ILE . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.404 ' CG2' ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.457 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 88' ' ' ARG . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.468 HD13 ' CG ' ' A' ' 132' ' ' TYR . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.579 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 105' ' ' HIS . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.711 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.49 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.711 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.557 ' HB ' ' NE ' ' A' ' 10' ' ' ARG . 2.3 t . . . . . 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.571 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.641 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.629 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CG ' HD13 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.456 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.734 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.555 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 78' ' ' VAL . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' HG22 ' A' ' 129' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 28' ' ' PHE . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.553 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' O ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.78 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.78 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.514 ' OG1' HG12 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.529 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.726 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 47' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.607 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.726 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.547 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.538 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CE1' HD21 ' A' ' 19' ' ' LEU . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.578 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 12.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.491 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.547 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 1.5 pp0? . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.967 0.413 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.585 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 8' ' ' VAL . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' CG2' HG22 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' TYR . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.462 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.745 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.619 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.576 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.745 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' ' CD2' ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.468 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.653 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CG ' ' OG1' ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.456 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 91' ' ' TYR . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.588 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CD2' HG11 ' A' ' 87' ' ' VAL . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.613 HD21 HG13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' CD2' ' CD1' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.613 HG13 HD21 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' HA ' ' CD1' ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.468 ' CE1' HG13 ' A' ' 75' ' ' ILE . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.599 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.542 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.656 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.656 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HG21 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.476 ' CG2' ' CB ' ' A' ' 110' ' ' TRP . 2.0 t . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' HG ' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.496 ' CD2' ' CZ ' ' A' ' 132' ' ' TYR . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.585 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 44.3 mt-30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.53 HD11 HG13 ' A' ' 6' ' ' ILE . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.675 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.508 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.727 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 126' ' ' ASP . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.431 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 44' ' ' ALA . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.488 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.52 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.585 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' HG13 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.559 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.624 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' HIS . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.658 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.504 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CD1' HG22 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CD1' HD21 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CB ' ' CD2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.653 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 19' ' ' LEU . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.443 HD13 ' CZ2' ' A' ' 110' ' ' TRP . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.586 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.604 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.653 ' HB2' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.526 ' HA ' HG23 ' A' ' 22' ' ' VAL . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.675 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.427 ' HB3' HG23 ' A' ' 3' ' ' ILE . 2.4 pp0? . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.915 0.388 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ASP . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.615 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.439 ' OG ' HG21 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 4' ' ' TYR . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.493 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.401 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.575 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 46' ' ' THR . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.766 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.551 ' OG1' HG12 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 24.7 mm100 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.516 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.428 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' LEU . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.766 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.458 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.711 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.667 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' A' ' 132' ' ' TYR . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.693 HG13 ' HB2' ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 19' ' ' LEU . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 102' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.368 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -149.82 123.22 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 80' ' ' ILE . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.579 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 15' ' ' LYS . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 10' ' ' ARG . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.759 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' CG2' ' A' ' 129' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' ' CE1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HA ' HD21 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' CE2' ' A' ' 28' ' ' PHE . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.463 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 46' ' ' THR . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 45' ' ' GLU . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.7 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' THR . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' HG12 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.66 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.585 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.7 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.582 ' CD ' ' C ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.572 ' N ' ' HG2' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' O ' HG11 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.66 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.552 ' HB3' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HA ' HG21 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.693 HG21 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 132' ' ' TYR . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 98' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.536 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.446 ' CE1' HG13 ' A' ' 75' ' ' ILE . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.572 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 110' ' ' TRP . 38.0 t 70.94 -62.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 17' ' ' LEU . 1.5 p 66.68 -1.59 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.072 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 113' ' ' VAL . 5.5 pt-20 -164.6 109.4 0.95 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 m -130.39 171.74 12.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.636 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' LYS . 1.9 m120 -115.29 72.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.5 p-10 -54.23 -16.9 2.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.895 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.87 -13.45 42.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.051 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.04 27.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.44 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 117' ' ' ASN . 4.9 tptt -117.08 138.18 51.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.522 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mtp 67.21 60.78 0.49 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.846 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.14 -27.94 16.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.414 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.448 ' HA ' HG23 ' A' ' 22' ' ' VAL . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 33.0 mt-30 -33.27 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 132' ' ' TYR . 7.2 m-20 -73.2 162.63 73.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.206 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.57 -26.45 36.98 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 137' ' ' GLN . 2.0 m -150.55 -55.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' SER . 0.0 OUTLIER 82.67 -17.03 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.604 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 59.16 34.81 23.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.94 31.73 20.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.094 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.91 96.49 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.13 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.631 HD13 HG13 ' A' ' 6' ' ' ILE . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' ASP . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.631 HG13 HD13 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.609 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.501 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 19' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 28' ' ' PHE . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.775 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.775 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.522 ' OG1' HG13 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HD3' ' CE1' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.655 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CG ' ' OG1' ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.532 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.475 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' CH2' ' A' ' 110' ' ' TRP . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.713 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 18' ' ' GLU . 40.4 t -35.7 -32.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.466 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 11.3 p 40.74 27.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 113' ' ' VAL . 7.3 pt-20 -172.02 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.468 ' HB ' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.3 164.77 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -156.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.3 -17.36 19.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.15 -53.89 51.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 111.374 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.44 -28.29 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 168.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.56 ' O ' HD23 ' A' ' 125' ' ' LEU . 3.4 ttt -177.32 72.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.326 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.47 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.028 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.576 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 124' ' ' GLN . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.618 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.482 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.538 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -39.31 -22.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -92.13 167.98 13.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 0.0 110.764 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 28.2 Cg_endo -61.15 -34.43 89.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.444 2.096 . . . . 0.0 111.963 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -176.63 77.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.651 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 4.3 mm-40 -47.92 -23.14 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.678 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' GLN . . . 86.48 78.59 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.057 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.26 42.37 9.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -165.95 102.47 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.658 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.455 ' CB ' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 126' ' ' ASP . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.451 ' CE2' ' CE ' ' A' ' 40' ' ' MET . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.545 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' CG1' ' CE ' ' A' ' 40' ' ' MET . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.451 ' CE ' ' CE2' ' A' ' 28' ' ' PHE . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.833 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.642 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.59 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.516 ' CG1' ' HA ' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 79' ' ' LEU . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.833 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.536 ' O ' HG13 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.658 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 HD21 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.514 ' HB ' ' CG1' ' A' ' 3' ' ' ILE . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HA ' ' CG1' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' CD2' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.426 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.496 ' HG ' HD21 ' A' ' 79' ' ' LEU . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.618 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.618 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.57 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.567 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.461 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.461 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 110' ' ' TRP . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.7 t -65.95 133.92 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.3 t -97.81 16.48 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -177.67 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 4.9 t -53.64 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.76 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 177.73 -68.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.043 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.31 -33.55 59.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.384 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' MET . . . -60.85 -41.76 96.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -23.97 33.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.501 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 32.56 5.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.57 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -77.14 81.4 3.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.413 . . . . 0.0 110.73 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -27.07 3.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.728 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.412 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 97' ' ' ILE . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.587 ' HA ' HG22 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.424 ' CD1' HD12 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.612 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 59.18 0.58 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.519 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.8 OUTLIER -176.3 175.59 0.64 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -51.81 -25.63 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.115 1.877 . . . . 0.0 111.69 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.6 m -177.11 -65.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 81.06 -22.82 0.25 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.817 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 63.27 30.88 15.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.183 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.2 t0 57.97 31.61 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.156 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.815 0.34 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.91 129.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.609 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 114' ' ' THR . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.888 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 126' ' ' ASP . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.434 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.518 ' OG1' HG12 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.557 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' LEU . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.691 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.59 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 ' CD2' HD11 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.518 ' CD1' HG22 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.45 HD12 ' CE2' ' A' ' 132' ' ' TYR . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.558 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.524 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.498 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.667 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 43.3 t 69.63 -64.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.428 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.2 p 74.99 -8.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.666 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.91 103.79 1.71 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.413 ' CG2' ' CD ' ' A' ' 121' ' ' LYS . 1.7 m -124.54 170.19 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 112.558 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.61 86.59 2.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.526 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 4.5 m-20 -50.93 -15.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.313 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.91 92.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.94 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mp -153.39 47.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.357 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.413 ' CD ' ' CG2' ' A' ' 116' ' ' THR . 0.3 OUTLIER -82.91 -19.85 36.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.167 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.509 ' HE3' ' CG1' ' A' ' 97' ' ' ILE . 1.9 mtp -162.26 78.56 0.51 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 111.795 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -24.4 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.672 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.519 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 13.82 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER 169.75 171.76 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.606 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 59.7 Cg_endo -69.69 -41.39 4.4 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.483 2.122 . . . . 0.0 111.982 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m -166.37 72.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -47.29 -24.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.755 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 80.5 44.48 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.009 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t70 64.48 39.06 7.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.098 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? 53.81 26.72 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.31 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.675 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' CD1' HG13 ' A' ' 75' ' ' ILE . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' HD12 ' A' ' 125' ' ' LEU . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' CG1' ' HE3' ' A' ' 40' ' ' MET . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.54 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.752 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.47 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.657 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.629 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.44 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' LEU . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.554 HG21 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.764 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.564 ' CB ' ' HA ' ' A' ' 3' ' ' ILE . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.524 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 6' ' ' ILE . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.574 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 119' ' ' ALA . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.556 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 37.9 t 79.68 -63.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p 69.7 -4.15 1.49 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.6 70.78 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.092 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 t -46.82 166.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.267 0.556 . . . . 0.0 111.907 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -173.96 -55.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.02 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.69 -42.94 39.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.279 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' CB ' ' CE2' ' A' ' 101' ' ' TYR . . . -62.32 -35.01 77.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.632 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -25.85 67.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.94 23.86 12.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.63 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.14 83.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.5 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -47.03 -34.62 5.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.558 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.631 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -40.47 -18.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -93.45 167.72 13.43 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.691 0.281 . . . . 0.0 110.753 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 46.4 Cg_endo -65.96 -34.17 39.55 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m -166.42 72.4 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.09 -28.14 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.979 0.419 . . . . 0.0 110.566 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 77.14 33.37 0.43 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.14 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 60.49 31.4 20.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.11 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -156.87 -178.31 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.488 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.62 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.461 ' HB2' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 129' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 28' ' ' PHE . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.485 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.424 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.404 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.774 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.518 ' OG1' HG13 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.602 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 79' ' ' LEU . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.774 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' CG ' ' A' ' 94' ' ' LEU . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.487 HD12 ' CD1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.528 ' CD2' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 69' ' ' TYR . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' CD1' ' CD2' ' A' ' 132' ' ' TYR . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.553 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.553 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.487 ' CD1' HD12 ' A' ' 75' ' ' ILE . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 105' ' ' HIS . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.549 ' CE2' ' O ' ' A' ' 107' ' ' LYS . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.5 t 71.35 -57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.79 11.57 1.4 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.083 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.5 91.58 0.51 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.358 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 2.1 m -138.34 172.79 12.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.319 0.581 . . . . 0.0 111.947 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -164.59 98.25 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.037 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' HB2' ' CA ' ' A' ' 20' ' ' SER . 3.7 t0 -46.71 -22.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.442 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.81 -21.34 19.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.49 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.41 -2.06 8.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.816 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -153.22 171.53 18.37 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.196 0.522 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.51 ' HG3' ' HB3' ' A' ' 125' ' ' LEU . 7.1 tpt 63.02 37.51 11.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.929 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -50.53 -28.16 8.01 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.51 ' HB3' ' HG3' ' A' ' 122' ' ' MET . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 22' ' ' VAL . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.406 ' N ' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.31 57.01 0.24 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -170.82 164.44 5.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.76 -39.44 26.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.689 2.259 . . . . 0.0 112.544 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.45 -32.47 70.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 53.98 24.74 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.4 68.64 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.257 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.69 57.92 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.999 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.122 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.749 0.309 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 66.31 175.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 79' ' ' LEU . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.678 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.606 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.729 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB1' ' N ' ' A' ' 49' ' ' SER . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.607 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.435 ' OG ' HG22 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 4' ' ' TYR . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.43 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG13 ' CE2' ' A' ' 28' ' ' PHE . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.491 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.734 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' HB1' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.462 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.587 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.734 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' PHE . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.634 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.42 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.486 HD22 ' CD2' ' A' ' 132' ' ' TYR . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.55 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.535 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.571 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.607 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.601 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.601 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 110' ' ' TRP . 17.6 t 76.14 -62.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.427 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . 2.5 p 63.89 6.61 2.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.42 56.24 0.7 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 111.309 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -126.99 -173.06 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 111.101 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 167.92 -165.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.895 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.5 -16.21 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.3 -53.19 60.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 101' ' ' TYR . 3.2 tp -47.43 -30.05 3.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.023 0.44 . . . . 0.0 110.394 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt 58.29 168.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.264 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.571 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 0.7 OUTLIER -179.56 88.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -46.68 -27.33 1.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.031 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.525 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.49 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.567 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.486 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 1.7 mm100 -46.43 -12.92 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 23.6 t0 89.62 39.71 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 122.881 0.472 . . . . 0.0 112.192 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 134' ' ' ASP . 75.0 Cg_endo -81.17 -32.33 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.392 2.061 . . . . 0.0 111.825 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -143.89 17.25 1.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.161 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 52.45 36.74 20.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.606 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.41 81.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.452 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.06 60.38 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.129 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.76 130.49 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.621 HD13 HG13 ' A' ' 6' ' ' ILE . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HG13 ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 121' ' ' LYS . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 28' ' ' PHE . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.445 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.407 ' CG2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.834 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.537 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.502 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.637 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.571 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.834 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HB2' ' CG ' ' A' ' 94' ' ' LEU . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.64 ' HB ' ' HE1' ' A' ' 9' ' ' PHE . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.646 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.443 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.622 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' CG ' ' A' ' 132' ' ' TYR . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 98' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' LYS . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.71 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.71 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.1 t 71.25 -62.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.409 ' CA ' ' HG ' ' A' ' 17' ' ' LEU . 1.8 p 64.57 6.39 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.66 96.11 0.64 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.751 0.31 . . . . 0.0 111.167 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -144.84 -169.55 3.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.915 0.388 . . . . 0.0 111.29 -179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.27 -165.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.882 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.84 -15.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.778 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.66 -53.31 53.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD11 ' CE1' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -56.69 -22.14 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 11.1 ttpt -46.78 108.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.009 0.433 . . . . 0.0 111.286 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.46 ' HE2' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -88.56 143.73 26.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.141 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -23.25 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 129' ' ' ILE . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HA ' HG21 ' A' ' 22' ' ' VAL . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -38.46 -31.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -72.1 166.85 37.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.803 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 9.3 Cg_endo -51.61 -25.05 18.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.53 2.153 . . . . 0.0 112.078 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.83 -59.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.631 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.39 6.98 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.373 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.779 0.323 . . . . 0.0 111.396 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t0 62.8 31.75 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.078 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 71.31 153.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.333 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.681 ' HB ' HG13 ' A' ' 129' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.672 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 116' ' ' THR . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' CD1' HG13 ' A' ' 75' ' ' ILE . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 126' ' ' ASP . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 33' ' ' ARG . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 28' ' ' PHE . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.477 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.421 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.563 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.683 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' LEU . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.592 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.554 HG13 ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' HA3' HD12 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.672 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 67' ' ' HIS . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.683 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD1' HG22 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' ' CD2' ' A' ' 67' ' ' HIS . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.499 HD12 HD22 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.633 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.633 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' ILE . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.612 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.633 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER 65.15 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.88 19.85 5.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.19 57.82 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 2.9 t -54.85 -170.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.883 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' LEU . 48.6 p-10 -118.06 48.49 1.39 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.46 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.3 p30 -50.08 -22.5 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.78 30.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 117' ' ' ASN . 15.0 tp -76.43 -40.41 50.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.676 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 0.5 OUTLIER 63.51 15.42 8.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.514 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.427 ' HB3' ' CD2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER 53.48 99.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 110.937 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -48.76 -27.19 2.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.583 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.441 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.681 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.487 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.51 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.6 OUTLIER -42.98 -28.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 166.19 63.04 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.86 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.483 2.122 . . . . 0.0 112.192 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 m -168.2 27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 46.25 30.83 1.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.877 0.37 . . . . 0.0 110.931 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 50.92 80.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.26 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.74 63.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.092 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.76 0.314 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.77 179.8 8.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 81' ' ' THR . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.555 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.644 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HA ' ' CE2' ' A' ' 28' ' ' PHE . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 25' ' ' LEU . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 28' ' ' PHE . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.463 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.585 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' LEU . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.706 HG22 ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 91' ' ' TYR . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.498 ' CG1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.504 ' CD2' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.694 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 3' ' ' ILE . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CG ' HG23 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.443 HG23 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.613 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.437 HD13 ' CZ2' ' A' ' 110' ' ' TRP . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t 73.59 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -87.29 24.54 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.12 76.09 0.27 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.247 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.435 ' CB ' HD11 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -135.43 -178.74 5.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.62 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.638 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.66 -16.89 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.139 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.14 -31.66 55.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.41 7.43 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.06 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -56.49 -168.45 0.0 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.482 ' HE1' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -144.89 137.22 26.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.73 -23.56 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 4.1 mm-40 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.741 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 2.3 pt20 -44.97 -28.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.05 147.91 46.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.004 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.83 -26.29 15.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.534 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.66 -25.09 16.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.07 23.62 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.29 38.41 29.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.277 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 t70 62.13 32.36 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.067 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.885 0.374 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 64.96 158.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.212 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' CD1' HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.661 HD13 ' HB ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' CB ' ' HG3' ' A' ' 10' ' ' ARG . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 129' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HA ' HD23 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.574 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.743 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.528 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' LEU . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.743 HG21 ' HB ' ' A' ' 47' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HB3' ' HG ' ' A' ' 94' ' ' LEU . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.432 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.714 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.668 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' HB3' HG22 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 94' ' ' LEU . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 132' ' ' TYR . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.651 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.55 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.549 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' TRP . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 9.6 t -64.39 142.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -100.79 17.99 20.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.428 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 177.92 112.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 117' ' ' ASN . 54.0 m -157.25 162.15 39.22 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 116' ' ' THR . 0.5 OUTLIER -156.99 136.45 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.495 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.414 ' HB2' ' CA ' ' A' ' 20' ' ' SER . 8.1 t0 -60.87 -19.12 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.4 -20.62 56.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.81 -46.44 8.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 -165.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 111.534 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.651 ' HE1' ' HA ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER 82.92 33.34 0.07 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.264 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -51.81 -24.36 5.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.376 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.588 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.661 ' HB ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.459 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.46 ' C ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -69.6 53.17 0.11 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 1.4 p30 37.86 49.16 1.6 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 54.1 Cg_endo -88.12 -39.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.462 2.108 . . . . 0.0 112.34 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.71 26.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 53.34 29.52 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.2 49.53 12.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.745 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t0 59.32 59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.069 179.861 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -154.36 126.34 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.695 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' N ' ' A' ' 49' ' ' SER . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' TYR . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 28' ' ' PHE . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.451 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 28' ' ' PHE . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.532 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 78' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.617 ' CG1' HG12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.47 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HG2' ' CD1' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.617 HG12 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 81' ' ' THR . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA3' HG13 ' A' ' 59' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.471 ' HB2' HD13 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 57' ' ' GLN . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.488 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PHE . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.514 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.623 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.623 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 110' ' ' TRP . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB1' ' CD2' ' A' ' 105' ' ' HIS . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.616 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 3.3 t -68.9 140.07 19.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -101.01 16.15 26.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.804 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -163.51 86.72 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.9 t -57.54 -160.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 178.13 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.362 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 122' ' ' MET . 21.1 m-20 -60.62 -31.43 70.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 20' ' ' SER . . . -47.04 -42.29 18.16 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.101 0.477 . . . . 0.0 110.479 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -16.4 14.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.98 68.54 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 111.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.557 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 10.5 ttt -156.92 66.23 0.52 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.038 0.446 . . . . 0.0 111.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -18.37 35.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.594 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.417 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 129' ' ' ILE . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.419 ' N ' HG23 ' A' ' 129' ' ' ILE . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -49.84 -9.4 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -93.19 168.5 12.04 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 110.973 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.13 -29.08 18.06 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.705 2.27 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.0 m -165.38 71.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.435 ' OE1' ' CE1' ' A' ' 132' ' ' TYR . 1.8 mp0 -42.71 -30.75 0.4 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.484 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 137' ' ' GLN . . . 82.6 40.1 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.114 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t0 60.42 40.36 17.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.155 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.834 0.35 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 61.87 -178.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG13 ' A' ' 129' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.692 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB3' ' OH ' ' A' ' 5' ' ' TYR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.673 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.512 ' OG1' HG13 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.4 m-70 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.509 HG13 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' O ' ' O ' ' A' ' 9' ' ' PHE . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' HIS . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.595 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.554 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.688 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' CD2' ' A' ' 132' ' ' TYR . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.609 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HA ' ' CD1' ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.558 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.497 ' H ' ' HE3' ' A' ' 110' ' ' TRP . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.2 t -66.42 122.49 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -93.23 22.05 5.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.198 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -172.59 85.93 0.07 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.686 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.02 -169.51 2.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.4 p30 170.8 -170.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -53.55 -21.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 111.182 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.9 -49.03 72.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.28 8.12 25.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 20' ' ' SER . 3.8 ttpm? -54.38 161.2 1.45 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.86 0.362 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.422 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -123.08 135.67 54.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.982 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.81 -21.49 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.432 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.609 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.611 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.582 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.655 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.582 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -42.01 -30.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -76.39 169.87 18.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.486 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -53.11 -23.74 23.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 111.94 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 m -175.21 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 77.83 -8.44 1.67 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.248 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 62.01 32.36 17.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.783 0.325 . . . . 0.0 111.162 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.01 42.98 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.056 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.38 66.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.682 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.621 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 49' ' ' SER . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 126' ' ' ASP . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HB2' HD12 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.434 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.47 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.426 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.579 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.505 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.544 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' CG1' ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.566 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 29.0 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.588 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.645 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.599 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.519 HG21 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.588 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' OH ' ' CG ' ' A' ' 132' ' ' TYR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 132' ' ' TYR . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' THR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.694 ' O ' ' HE1' ' A' ' 122' ' ' MET . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.587 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.579 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 110' ' ' TRP . 19.7 t 77.09 -71.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 p 63.41 5.19 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.917 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -160.25 58.14 0.35 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.201 0.524 . . . . 0.0 109.996 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.444 HG22 ' CA ' ' A' ' 19' ' ' LEU . 1.2 t -81.96 -161.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.82 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' CG2' ' A' ' 116' ' ' THR . 10.9 p30 -140.48 65.97 1.39 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.3 p30 -49.78 -21.44 1.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.736 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -30.7 44.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.942 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.84 -38.48 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 5.4 mtpt 58.96 159.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.17 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.694 ' HE1' ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -86.85 117.13 25.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -49.17 -28.07 4.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.682 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.535 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.03 57.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t0 66.6 60.12 0.96 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.915 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.33 -45.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.584 2.189 . . . . 0.0 112.024 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 m -153.08 13.49 0.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 48.17 51.66 14.46 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 52.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.778 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.63 40.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.674 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.19 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.723 0.297 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.25 169.93 21.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.552 HD12 HG13 ' A' ' 6' ' ' ILE . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.602 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' CB ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' CB ' ' HG3' ' A' ' 10' ' ' ARG . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HG3' ' CD1' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.451 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 ' OG1' HG13 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.692 HG23 ' HB ' ' A' ' 47' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' ' HG2' ' A' ' 56' ' ' ARG . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.537 HG22 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.44 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.44 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CD2' ' OH ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.637 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 110' ' ' TRP . 9.5 t 75.52 -62.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p 73.21 -11.51 0.89 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.852 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.41 23.16 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.458 ' HA ' HD22 ' A' ' 19' ' ' LEU . 6.1 t 41.82 -167.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.279 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.47 ' ND2' ' CE1' ' A' ' 105' ' ' HIS . 0.7 OUTLIER 173.93 -40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.017 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD2' ' CD2' ' A' ' 101' ' ' TYR . 16.5 m-20 -76.85 -29.3 55.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.694 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' SER . . . -52.93 -51.27 61.9 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -22.34 61.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.399 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -149.81 103.72 3.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.498 ' HG2' ' CD2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -168.41 58.29 0.06 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 178.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -50.99 -23.83 3.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HA ' HG23 ' A' ' 22' ' ' VAL . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.517 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.645 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.519 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 6.9 mt-30 -36.74 -31.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.63 167.0 40.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 0.0 111.094 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.5 -31.19 22.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m -166.67 72.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.658 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -44.49 -27.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.819 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 79.3 92.11 0.06 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.62 52.95 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.085 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.865 0.364 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -173.65 150.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 81' ' ' THR . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.633 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.611 ' NE ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' PHE . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 28' ' ' PHE . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.465 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.427 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CD2' HD13 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.749 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.483 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.749 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.569 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 51' ' ' THR . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.605 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD23 HD22 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.656 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.53 ' HB ' ' CG1' ' A' ' 3' ' ' ILE . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.404 ' CG2' ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.457 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 88' ' ' ARG . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.468 HD13 ' CG ' ' A' ' 132' ' ' TYR . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.579 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' CG ' ' CE ' ' A' ' 122' ' ' MET . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 105' ' ' HIS . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.711 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.49 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.711 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.557 ' HB ' ' NE ' ' A' ' 10' ' ' ARG . 2.3 t -92.81 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 p -107.3 14.52 25.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.334 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -164.41 145.45 8.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.909 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.2 t -124.0 -179.18 4.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.0 111.767 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -175.14 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -76.86 -40.72 46.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.091 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.59 76.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -27.5 13.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.32 48.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.019 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.497 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -97.01 80.52 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -50.75 -26.32 5.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.571 ' HB3' HG13 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.641 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.629 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CG ' HD13 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 0.8 OUTLIER -41.81 -32.93 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 27.9 t70 168.64 63.0 0.01 OUTLIER Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.99 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.56 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -175.01 31.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 47.03 28.03 0.83 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.961 0.41 . . . . 0.0 110.848 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.64 78.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.368 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.05 54.79 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.111 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 60.86 -176.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.734 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.555 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 78' ' ' VAL . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' HG22 ' A' ' 129' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.485 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 28' ' ' PHE . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.553 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' O ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.78 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.78 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.514 ' OG1' HG12 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.529 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.726 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 47' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' ' CD1' ' A' ' 91' ' ' TYR . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.607 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.726 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.547 ' OH ' ' HB3' ' A' ' 132' ' ' TYR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.538 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CE1' HD21 ' A' ' 19' ' ' LEU . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.578 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.437 ' CG1' ' OG1' ' A' ' 116' ' ' THR . 12.6 t 76.9 -51.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.417 ' HA ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 65.82 7.73 4.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.374 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.4 81.62 0.26 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.437 ' OG1' ' CG1' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -143.1 178.35 7.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.379 0.609 . . . . 0.0 111.777 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -168.58 150.06 4.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.711 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -56.55 -19.47 15.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.032 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.86 61.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.978 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -48.86 64.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.97 108.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.792 0.329 . . . . 0.0 111.53 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.57 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 6.0 tpt -175.82 31.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -24.82 5.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.734 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.547 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 1.5 pp0? -51.67 -20.59 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.68 155.04 37.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.198 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.67 -26.59 23.11 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.816 2.344 . . . . 0.0 112.262 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -21.38 26.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.228 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 132' ' ' TYR . 31.9 mt-30 60.33 32.91 20.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 110.552 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 59.28 73.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.177 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.07 52.34 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.154 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -144.51 169.06 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.585 ' HB ' HG13 ' A' ' 129' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.689 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 8' ' ' VAL . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' CG2' HG22 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' TYR . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.462 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.745 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.619 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.576 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.745 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' ' CD2' ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.468 HG13 ' CE1' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 67' ' ' HIS . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.653 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CG ' ' OG1' ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 91' ' ' TYR . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.588 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CD2' HG11 ' A' ' 87' ' ' VAL . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 HD21 HG13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' CD2' ' CD1' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.613 HG13 HD21 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' HA ' ' CD1' ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.494 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.468 ' CE1' HG13 ' A' ' 75' ' ' ILE . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.599 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.542 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.656 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.656 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HG21 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.476 ' CG2' ' CB ' ' A' ' 110' ' ' TRP . 2.0 t -73.07 130.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.5 p -95.27 19.61 10.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.579 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.76 110.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.991 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 86.9 m -159.71 166.53 30.34 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -157.57 140.33 14.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.403 ' N ' ' HA ' ' A' ' 20' ' ' SER . 10.0 p-10 -48.86 -27.3 2.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.77 -26.14 13.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.67 -57.3 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -160.16 -171.75 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.204 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.522 ' HE2' ' CG2' ' A' ' 97' ' ' ILE . 2.9 tpt 95.85 29.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.672 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -26.47 11.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.496 ' CD2' ' CZ ' ' A' ' 132' ' ' TYR . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.585 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 44.3 mt-30 -36.75 -30.67 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.64 163.04 68.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.9 -29.13 88.74 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.104 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -95.94 -81.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 175.06 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.148 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.59 76.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.548 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t0 56.51 57.27 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.017 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.072 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' CG ' ' CB ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.973 0.416 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -157.31 153.52 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.53 HD11 HG13 ' A' ' 6' ' ' ILE . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.675 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.508 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.727 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 126' ' ' ASP . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.431 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 44' ' ' ALA . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.488 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.52 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.585 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' HG13 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.559 HG13 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.624 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' HIS . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.658 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.504 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.417 ' CB ' ' CG ' ' A' ' 1' ' ' MET . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CD1' HG22 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CD1' HD21 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' CB ' ' CD2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.653 HG13 ' HB2' ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.54 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 19' ' ' LEU . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.443 HD13 ' CZ2' ' A' ' 110' ' ' TRP . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.586 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.604 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER 57.09 108.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -77.18 4.41 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.932 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.71 129.16 0.8 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.01 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.1 m -133.06 169.87 16.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.175 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -111.59 68.46 0.67 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.813 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 p30 -45.75 -22.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.718 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.41 -31.2 67.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.42 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.11 53.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.783 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.86 31.24 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.54 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -178.13 48.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.2 -31.86 1.66 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.653 ' HB2' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.526 ' HA ' HG23 ' A' ' 22' ' ' VAL . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.675 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.427 ' HB3' HG23 ' A' ' 3' ' ' ILE . 2.4 pp0? -70.7 56.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 74.0 57.65 0.3 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.157 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' LYS . 90.4 Cg_endo -82.57 -45.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.127 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.25 28.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 53.72 24.92 4.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 110.811 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.34 43.07 23.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.409 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.09 32.17 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.117 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.776 0.322 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' CD ' ' HB2' ' A' ' 134' ' ' ASP . 10.9 mmp_? 68.99 -172.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ASP . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.615 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' NH1' ' CG2' ' A' ' 114' ' ' THR . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.439 ' OG ' HG21 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 4' ' ' TYR . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' PHE . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 25' ' ' LEU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.493 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.401 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.575 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 46' ' ' THR . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 45' ' ' GLU . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.766 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.551 ' OG1' HG12 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 24.7 mm100 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.428 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' LEU . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.766 ' CG2' ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.458 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.711 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' HD12 ' A' ' 3' ' ' ILE . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.667 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' A' ' 132' ' ' TYR . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 97' ' ' ILE . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.693 HG13 ' HB2' ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CE2' HD22 ' A' ' 19' ' ' LEU . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 102' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.478 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.31 113.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.403 ' CG2' ' NH1' ' A' ' 10' ' ' ARG . 62.1 p -96.39 26.99 3.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.2 56.2 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.173 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.69 168.73 11.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.597 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.8 t-20 177.95 -161.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.443 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -57.46 -15.32 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.031 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.7 16.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.951 0.405 . . . . 0.0 110.86 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.28 -32.12 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.729 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.38 -62.38 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.381 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.586 ' HE1' HG12 ' A' ' 97' ' ' ILE . 7.5 ttt 73.4 72.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.281 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -43.64 -31.17 0.71 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.693 ' HB2' HG13 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.468 ' C ' ' HD3' ' A' ' 135' ' ' PRO . 1.7 pp0? -68.31 51.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 14.5 m-20 39.52 48.2 1.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 49.5 Cg_endo -88.05 -39.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.444 2.096 . . . . 0.0 112.512 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.86 22.15 0.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 56.09 31.49 18.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.0 110.342 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 47.39 46.42 17.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.465 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.81 58.44 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.069 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.977 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.772 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 18' ' ' GLU . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.759 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.772 HD22 ' OH ' ' A' ' 101' ' ' TYR . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.589 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 6' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD22 ' HA ' ' A' ' 33' ' ' ARG . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 32' ' ' GLU . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.853 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.635 ' OG1' HG11 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 71' ' ' ARG . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 51' ' ' THR . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.467 HG21 ' CE1' ' A' ' 67' ' ' HIS . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.091 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 78' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.885 ' CD1' HD22 ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.672 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 68' ' ' VAL . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.091 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.964 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.964 ' CD1' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.779 ' HA ' HG22 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.73 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.779 HG22 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 79' ' ' LEU . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 125' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.772 ' OH ' HD22 ' A' ' 19' ' ' LEU . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 99' ' ' ASP . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG21 ' OH ' ' A' ' 101' ' ' TYR . 38.0 t . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.0 HD12 HD11 ' A' ' 97' ' ' ILE . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 129' ' ' ILE . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.977 ' HA ' HG22 ' A' ' 3' ' ' ILE . 33.0 mt-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.063 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.421 ' HB3' ' HE3' ' A' ' 40' ' ' MET . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG13 ' CA ' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.752 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 9' ' ' PHE . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.964 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.748 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.146 HD12 ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 33' ' ' ARG . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.702 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.867 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.454 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.799 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.774 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.799 ' OG1' HG11 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.66 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 78' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.788 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.657 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 68' ' ' VAL . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.724 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.664 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.94 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.94 ' CD1' HG21 ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.629 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.866 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.598 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.889 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 1.146 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 98' ' ' LEU . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HB2' ' CG ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.74 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 101' ' ' TYR . 40.4 t . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.964 ' N ' HD23 ' A' ' 125' ' ' LEU . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.767 ' HB3' HD21 ' A' ' 93' ' ' LEU . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.785 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.866 ' CE2' HD23 ' A' ' 93' ' ' LEU . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 1.063 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HB3' ' NE2' ' A' ' 133' ' ' GLN . 56.6 mtm-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 6' ' ' ILE . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 93' ' ' LEU . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.905 ' HB3' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.81 ' C ' HD23 ' A' ' 25' ' ' LEU . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.81 HD23 ' C ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HB2' ' HG3' ' A' ' 33' ' ' ARG . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.744 ' HE3' HG12 ' A' ' 36' ' ' VAL . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.858 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.783 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.061 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.783 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.832 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 51' ' ' THR . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.638 ' N ' HG12 ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.601 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.724 HD11 ' HE2' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.488 ' CE1' HG21 ' A' ' 65' ' ' ILE . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.061 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' OE1' HD13 ' A' ' 102' ' ' LEU . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.54 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.565 ' O ' HG12 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 68' ' ' VAL . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.698 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 85' ' ' TYR . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HE2' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' CG ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 6' ' ' ILE . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD23 ' CG ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.675 HG21 HD22 ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HG3' ' CB ' ' A' ' 124' ' ' GLN . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.474 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' HB3' ' HD3' ' A' ' 10' ' ' ARG . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.7 t . . . . . 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.642 HD21 ' OG ' ' A' ' 20' ' ' SER . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.662 ' HA ' HG21 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 2' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.917 0.389 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.923 HD11 HG13 ' A' ' 6' ' ' ILE . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.923 HG13 HD11 ' A' ' 3' ' ' ILE . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 75' ' ' ILE . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.83 ' OG ' HD21 ' A' ' 125' ' ' LEU . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.745 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.483 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CG ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.884 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.835 ' OG1' HG11 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 68' ' ' VAL . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.638 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.504 ' NE2' HG21 ' A' ' 65' ' ' ILE . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.96 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.765 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.021 HG13 HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 47' ' ' VAL . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.638 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.76 ' CG ' HG21 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 79' ' ' LEU . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 79' ' ' LEU . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD11 ' O ' ' A' ' 69' ' ' TYR . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 96' ' ' LYS . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.88 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.767 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.767 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 110' ' ' TRP . 43.3 t . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.83 HD21 ' OG ' ' A' ' 20' ' ' SER . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 . . . . . 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.963 0.411 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.732 HD11 HG13 ' A' ' 6' ' ' ILE . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 3' ' ' ILE . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.739 HD21 ' HE3' ' A' ' 40' ' ' MET . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.89 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.698 ' HG2' HD13 ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.739 ' HE3' HD21 ' A' ' 25' ' ' LEU . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.826 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.67 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.698 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 61' ' ' GLU . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.762 ' CE1' HG22 ' A' ' 87' ' ' VAL . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.942 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.718 ' OH ' HG12 ' A' ' 87' ' ' VAL . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 98' ' ' LEU . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.942 ' CG2' HG22 ' A' ' 68' ' ' VAL . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.835 HD11 ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.788 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.036 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.036 ' CD1' HG21 ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.762 HG22 ' CE1' ' A' ' 67' ' ' HIS . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 125' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.742 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.801 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.801 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG22 ' HB3' ' A' ' 110' ' ' TRP . 37.9 t . . . . . 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.517 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' CD2' HD12 ' A' ' 93' ' ' LEU . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.766 HD11 HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.907 HD11 HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.946 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 101' ' ' TYR . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.481 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.709 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HD2' HG21 ' A' ' 36' ' ' VAL . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.532 ' CE ' HG12 ' A' ' 36' ' ' VAL . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.823 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.879 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.686 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.725 ' OH ' HG12 ' A' ' 87' ' ' VAL . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 48' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 68' ' ' VAL . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.75 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.789 HG21 ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.789 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.725 HG12 ' OH ' ' A' ' 69' ' ' TYR . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 HD11 ' A' ' 6' ' ' ILE . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.989 HD11 ' CD1' ' A' ' 125' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.602 ' N ' HG23 ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.664 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.664 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 110' ' ' TRP . 24.5 t . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.447 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.989 ' CD1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.552 ' N ' HD23 ' A' ' 125' ' ' LEU . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.665 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.695 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.0 mm-40 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.863 0.363 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 133' ' ' GLN . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.84 HD11 HD21 ' A' ' 79' ' ' LEU . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.872 HG23 ' OG ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.748 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.872 ' OG ' HG23 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD2' HD13 ' A' ' 129' ' ' ILE . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 32' ' ' GLU . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' GLU . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' SER . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.497 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.887 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.85 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.85 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.987 ' OG1' HG11 ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 80' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.657 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.987 HG11 ' OG1' ' A' ' 51' ' ' THR . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 94' ' ' LEU . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 94' ' ' LEU . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.723 ' CD1' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.686 ' CD1' HG21 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.678 HD21 HD13 ' A' ' 6' ' ' ILE . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 79' ' ' LEU . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 98' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 103' ' ' VAL . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.614 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 99' ' ' ASP . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 110' ' ' TRP . 17.6 t . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.89 0.376 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.56 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.924 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 mm100 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.87 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.654 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.876 HD22 ' OH ' ' A' ' 101' ' ' TYR . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.543 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 33' ' ' ARG . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.872 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 25' ' ' LEU . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.47 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.756 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.047 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.8 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.882 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.672 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.047 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.763 ' OH ' HG12 ' A' ' 87' ' ' VAL . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.668 HG13 HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.571 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.765 HG11 HG21 ' A' ' 47' ' ' VAL . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.034 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.651 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.767 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.767 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.763 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 HD11 ' A' ' 79' ' ' LEU . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' HB2' ' A' ' 79' ' ' LEU . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 94' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' LYS . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.876 ' OH ' HD22 ' A' ' 19' ' ' LEU . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.532 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.739 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.1 t . . . . . 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 125' ' ' LEU . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 129' ' ' ILE . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.87 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 121.029 0.442 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 3' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 8' ' ' VAL . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 6' ' ' ILE . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.762 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' CG ' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.809 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.795 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.915 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.478 HG21 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.652 ' CE1' HG22 ' A' ' 87' ' ' VAL . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HD1' HD23 ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.597 ' HG3' HD23 ' A' ' 98' ' ' LEU . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.849 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 68' ' ' VAL . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 93' ' ' LEU . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG12 ' OH ' ' A' ' 69' ' ' TYR . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.859 HD22 ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.67 ' CG2' HD12 ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 96' ' ' LYS . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.938 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.899 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.411 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.899 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.588 ' C ' HG23 ' A' ' 113' ' ' VAL . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.888 HG22 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.587 HD22 HD11 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.64 ' HA ' HG21 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.468 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CD2' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.997 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.737 HG22 ' CB ' ' A' ' 133' ' ' GLN . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.823 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.685 ' CG1' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HD2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' HD2' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.882 HD21 HG13 ' A' ' 75' ' ' ILE . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 33' ' ' ARG . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 36' ' ' VAL . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.658 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.766 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.931 ' OG1' HG11 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.59 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 HG21 ' CE1' ' A' ' 67' ' ' HIS . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CE1' HG21 ' A' ' 65' ' ' ILE . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.931 HG11 ' OG1' ' A' ' 51' ' ' THR . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.823 ' CB ' HD22 ' A' ' 94' ' ' LEU . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.882 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 HG22 ' A' ' 68' ' ' VAL . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.751 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.05 HD12 HD11 ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.844 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' CE2' ' CE1' ' A' ' 105' ' ' HIS . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.421 ' CE1' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.583 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.612 ' CE3' HG23 ' A' ' 75' ' ' ILE . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.767 ' HA ' HG22 ' A' ' 75' ' ' ILE . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 112' ' ' ASP . 1.9 t . . . . . 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.845 0.355 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' CE1' ' A' ' 128' ' ' TYR . 1.1 mm100 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 125' ' ' LEU . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.847 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.541 ' CE1' ' NE2' ' A' ' 124' ' ' GLN . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.823 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.737 ' CB ' HG22 ' A' ' 3' ' ' ILE . 2.3 pt20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.952 0.406 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.858 HD11 HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.947 HD11 HD21 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 18' ' ' GLU . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.896 ' N ' HD13 ' A' ' 17' ' ' LEU . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD21 HG13 ' A' ' 75' ' ' ILE . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.579 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 6' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' CG ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.63 ' HD2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.889 ' CG ' HD13 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.634 ' CE ' HG12 ' A' ' 36' ' ' VAL . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.824 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 1.016 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.741 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.892 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.754 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 78' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' HG12 ' A' ' 87' ' ' VAL . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' CG ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.792 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 68' ' ' VAL . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.947 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.98 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.98 ' CD1' HG21 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.657 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 79' ' ' LEU . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 94' ' ' LEU . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 125' ' ' LEU . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.922 ' HA ' HD12 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 99' ' ' ASP . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' ASP . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 75' ' ' ILE . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 110' ' ' TRP . 9.6 t . . . . . 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 120.915 0.388 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 6' ' ' ILE . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.796 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.844 HG23 ' CB ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' CB ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 19' ' ' LEU . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' C ' HD23 ' A' ' 17' ' ' LEU . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.844 ' CB ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' ILE . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 33' ' ' ARG . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.763 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' HG12 ' A' ' 36' ' ' VAL . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.819 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.953 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.625 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.818 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.956 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.841 ' HB2' HD12 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.848 ' CD1' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' THR . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' O ' HG12 ' A' ' 8' ' ' VAL . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.88 HG22 HG22 ' A' ' 68' ' ' VAL . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.956 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.589 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.589 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.848 HD13 ' CD1' ' A' ' 69' ' ' TYR . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.798 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.616 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.628 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 110' ' ' TRP . 3.3 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.836 ' N ' HD23 ' A' ' 125' ' ' LEU . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.859 ' CD2' HD23 ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.796 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.85 HG22 ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 3' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 32' ' ' GLU . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.518 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 21' ' ' GLU . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.876 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.923 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.856 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.705 ' OG1' HG11 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 37.5 m80 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 78' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.842 ' CG ' HD22 ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 8' ' ' VAL . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 68' ' ' VAL . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD23 HD11 ' A' ' 6' ' ' ILE . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.918 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.95 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.95 ' CD1' HG21 ' A' ' 81' ' ' THR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.693 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.74 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 79' ' ' LEU . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 8' ' ' VAL . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.927 ' HA ' HD12 ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.572 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' ASP . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.443 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.2 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.914 0.388 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.58 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.649 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.85 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 3' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.892 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' H ' HD22 ' A' ' 17' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.7 HD22 ' OH ' ' A' ' 101' ' ' TYR . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 33' ' ' ARG . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.838 ' CG ' HD13 ' A' ' 25' ' ' LEU . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 4.1 tp-100 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.55 ' HE3' HG12 ' A' ' 36' ' ' VAL . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.77 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.77 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.937 ' OG1' HG11 ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.769 HE22 ' HB2' ' A' ' 50' ' ' ARG . 88.4 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.709 HG21 ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.828 ' HB2' HD12 ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.973 ' CG2' HG22 ' A' ' 78' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.65 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.973 HG22 ' CG2' ' A' ' 68' ' ' VAL . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.616 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' CD1' ' A' ' 79' ' ' LEU . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.684 HD21 HD13 ' A' ' 6' ' ' ILE . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD12 HD11 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 125' ' ' LEU . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.911 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.587 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.911 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' OH ' ' A' ' 101' ' ' TYR . 19.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.892 HD11 ' CA ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.607 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.2 tm0? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.904 HG22 HD13 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 20' ' ' SER . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.846 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 18' ' ' GLU . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.787 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 10' ' ' ARG . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.628 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.822 HD23 ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.822 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.869 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.794 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.936 ' OG1' HG11 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.804 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 78' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.779 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 68' ' ' VAL . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.842 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.842 ' CD1' HG21 ' A' ' 81' ' ' THR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.863 ' HG ' HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HG ' HD12 ' A' ' 79' ' ' LEU . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' LYS . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.418 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.637 ' CB ' HG22 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.637 HG22 ' CB ' ' A' ' 110' ' ' TRP . 9.5 t . . . . . 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.932 0.396 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 HG22 ' A' ' 6' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 125' ' ' LEU . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 93' ' ' LEU . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.669 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CD2' HD23 ' A' ' 93' ' ' LEU . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.927 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.9 mt-30 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.956 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.753 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.815 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 10' ' ' ARG . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CZ ' ' A' ' 10' ' ' ARG . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.802 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.913 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.49 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG12 ' A' ' 36' ' ' VAL . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.78 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.912 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.801 ' OG1' HG11 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' THR . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 78' ' ' VAL . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.711 ' OH ' HG22 ' A' ' 87' ' ' VAL . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.683 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.683 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.711 HG22 ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 88' ' ' ARG . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.546 HG22 ' HE3' ' A' ' 96' ' ' LYS . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.599 HD22 HD23 ' A' ' 79' ' ' LEU . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' OH ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.848 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.508 ' HB2' ' CG ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.73 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 110' ' ' TRP . 2.3 t . . . . . 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.81 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.634 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' CG ' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.956 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 6' ' ' ILE . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.942 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.82 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' CD2' HD23 ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.81 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.722 ' HE3' HD21 ' A' ' 25' ' ' LEU . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.817 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.847 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.767 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.926 ' OG1' HG11 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' ASN . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.98 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 68' ' ' VAL . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.052 HD11 HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.651 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.052 HD22 HD11 ' A' ' 79' ' ' LEU . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.98 HD13 ' CD1' ' A' ' 69' ' ' TYR . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 125' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CE1' HD21 ' A' ' 19' ' ' LEU . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.883 HD12 ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 106' ' ' PRO . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.557 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 12.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.976 HD12 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.946 ' N ' HD23 ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.5 pp0? . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.967 0.413 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 3' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.878 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.833 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.812 HD22 ' OH ' ' A' ' 101' ' ' TYR . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' HE3' ' A' ' 40' ' ' MET . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.675 ' HE3' HD11 ' A' ' 25' ' ' LEU . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB1' ' CE2' ' A' ' 9' ' ' PHE . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.966 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.871 ' OG1' HG11 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 87' ' ' VAL . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.966 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.83 ' CD1' HD22 ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CG ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.621 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB1' ' A' ' 70' ' ' ALA . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.851 HG22 ' CG2' ' A' ' 68' ' ' VAL . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.015 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.015 ' CD1' HG21 ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 67' ' ' HIS . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 94' ' ' LEU . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 HD11 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.03 HD11 HD22 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 71' ' ' ARG . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.556 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.669 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CZ2' HD23 ' A' ' 102' ' ' LEU . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 110' ' ' TRP . 2.0 t . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.922 HD12 HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 129' ' ' ILE . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.533 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.533 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 1.036 ' HA ' HG22 ' A' ' 3' ' ' ILE . 31.4 mt-30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 133' ' ' GLN . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.95 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.554 ' OG ' HG23 ' A' ' 8' ' ' VAL . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.768 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 36' ' ' VAL . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD22 ' A' ' 25' ' ' LEU . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 40' ' ' MET . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.596 ' CE ' HD21 ' A' ' 25' ' ' LEU . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HE2' ' A' ' 5' ' ' TYR . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.5 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG11 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 78' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.674 ' CG ' HD22 ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 68' ' ' VAL . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.727 HD21 HD22 ' A' ' 93' ' ' LEU . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.616 ' HA ' HD23 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 79' ' ' LEU . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.947 HD11 HD12 ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 102' ' ' LEU . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.493 ' CD1' HD11 ' A' ' 75' ' ' ILE . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.586 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.621 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.621 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 113' ' ' VAL . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 6.8 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.95 HD11 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.69 ' N ' HD23 ' A' ' 125' ' ' LEU . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.681 HG12 HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.931 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.4 pp0? . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.9 mmp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.915 0.388 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.793 HG13 HD11 ' A' ' 3' ' ' ILE . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.888 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 113' ' ' VAL . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.603 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.906 HD13 ' HG2' ' A' ' 33' ' ' ARG . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.906 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.908 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.895 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.543 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.988 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.844 ' OG1' HG11 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 70.3 mm-40 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.592 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.74 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.988 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.704 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 68' ' ' VAL . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.991 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.652 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.013 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.013 ' CD1' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.74 HG22 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.677 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.677 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 HD11 ' A' ' 79' ' ' LEU . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 79' ' ' LEU . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 103' ' ' VAL . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' CE2' HD21 ' A' ' 19' ' ' LEU . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 98' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.419 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.368 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.69 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.716 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.79 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' CA ' ' HB2' ' A' ' 84' ' ' GLN . 24.3 ttm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -149.82 123.22 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.977 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.772 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 18' ' ' GLU . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.759 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.772 HD22 ' OH ' ' A' ' 101' ' ' TYR . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.785 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 118' ' ' ASP . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 6' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD22 ' HA ' ' A' ' 33' ' ' ARG . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 32' ' ' GLU . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.853 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.635 ' OG1' HG11 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 71' ' ' ARG . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 51' ' ' THR . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.467 HG21 ' CE1' ' A' ' 67' ' ' HIS . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.091 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 78' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.885 ' CD1' HD22 ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.672 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 68' ' ' VAL . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.091 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.964 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HB2' ' CA ' ' A' ' 1' ' ' MET . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.964 ' CD1' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.779 ' HA ' HG22 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.73 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.779 HG22 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 79' ' ' LEU . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 125' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.772 ' OH ' HD22 ' A' ' 19' ' ' LEU . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 99' ' ' ASP . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 115' ' ' GLU . 38.0 t 70.94 -62.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.461 ' CA ' HD11 ' A' ' 17' ' ' LEU . 1.5 p 66.68 -1.59 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.072 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.764 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.5 pt-20 -164.6 109.4 0.95 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 117' ' ' ASN . 4.5 m -130.39 171.74 12.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.636 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.544 ' H ' HG22 ' A' ' 116' ' ' THR . 1.9 m120 -115.29 72.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.785 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.5 p-10 -54.23 -16.9 2.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.895 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.87 -13.45 42.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.051 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.04 27.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.44 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 117' ' ' ASN . 4.9 tptt -117.08 138.18 51.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mtp 67.21 60.78 0.49 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.846 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.14 -27.94 16.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.0 HD12 HD11 ' A' ' 97' ' ' ILE . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 129' ' ' ILE . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.977 ' HA ' HG22 ' A' ' 3' ' ' ILE . 33.0 mt-30 -33.27 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 132' ' ' TYR . 7.2 m-20 -73.2 162.63 73.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.206 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.57 -26.45 36.98 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 137' ' ' GLN . 2.0 m -150.55 -55.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' SER . 0.0 OUTLIER 82.67 -17.03 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.604 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 59.16 34.81 23.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.94 31.73 20.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.094 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.91 96.49 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.13 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.063 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' HB3' ' HE3' ' A' ' 40' ' ' MET . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG13 ' CA ' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.752 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 9' ' ' PHE . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.964 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.748 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.146 HD12 ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 33' ' ' ARG . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.702 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.867 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.454 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.799 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.774 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.799 ' OG1' HG11 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.66 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 78' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.788 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.657 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 68' ' ' VAL . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.724 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.664 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.94 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.94 ' CD1' HG21 ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.629 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.866 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.598 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.889 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.685 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 1.146 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 98' ' ' LEU . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HB2' ' CG ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.74 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 101' ' ' TYR . 40.4 t -35.7 -32.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.633 ' C ' HD11 ' A' ' 17' ' ' LEU . 11.3 p 40.74 27.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.486 ' HG2' HG12 ' A' ' 113' ' ' VAL . 7.3 pt-20 -172.02 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.439 ' HB ' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.3 164.77 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -156.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.3 -17.36 19.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.15 -53.89 51.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 111.374 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.44 -28.29 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 168.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.924 ' HB3' HD22 ' A' ' 125' ' ' LEU . 3.4 ttt -177.32 72.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.326 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -39.47 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.028 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.964 ' N ' HD23 ' A' ' 125' ' ' LEU . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.767 ' HB3' HD21 ' A' ' 93' ' ' LEU . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.785 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.866 ' CE2' HD23 ' A' ' 93' ' ' LEU . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 1.063 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -39.31 -22.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -92.13 167.98 13.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 0.0 110.764 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 28.2 Cg_endo -61.15 -34.43 89.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.444 2.096 . . . . 0.0 111.963 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -176.63 77.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.651 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 4.3 mm-40 -47.92 -23.14 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.678 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 86.48 78.59 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.057 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.26 42.37 9.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HB3' ' NE2' ' A' ' 133' ' ' GLN . 56.6 mtm-85 -165.95 102.47 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.254 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 6' ' ' ILE . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 93' ' ' LEU . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.905 ' HB3' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.81 ' C ' HD23 ' A' ' 25' ' ' LEU . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.81 HD23 ' C ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HB2' ' HG3' ' A' ' 33' ' ' ARG . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.744 ' HE3' HG12 ' A' ' 36' ' ' VAL . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.858 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.783 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.061 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.783 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.832 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 51' ' ' THR . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.638 ' N ' HG12 ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.724 HD11 ' HE2' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.488 ' CE1' HG21 ' A' ' 65' ' ' ILE . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.061 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' OE1' HD13 ' A' ' 102' ' ' LEU . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.54 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.565 ' O ' HG12 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 68' ' ' VAL . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.698 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 85' ' ' TYR . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HE2' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' CG ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 6' ' ' ILE . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD23 ' CG ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.675 HG21 HD22 ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.474 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' HB3' ' HD3' ' A' ' 10' ' ' ARG . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 115' ' ' GLU . 2.7 t -65.95 133.92 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.3 t -97.81 16.48 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.687 ' H ' HG12 ' A' ' 113' ' ' VAL . 13.1 pt-20 -177.67 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 119' ' ' ALA . 4.9 t -53.64 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.76 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 177.73 -68.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.043 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.31 -33.55 59.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.384 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -60.85 -41.76 96.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.79 -23.97 33.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.501 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 32.56 5.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.583 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -77.14 81.4 3.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.413 . . . . 0.0 110.73 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -27.07 3.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.728 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.642 HD21 ' OG ' ' A' ' 20' ' ' SER . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.662 ' HA ' HG21 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -73.38 59.18 0.58 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.525 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.8 OUTLIER -176.3 175.59 0.64 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -51.81 -25.63 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.115 1.877 . . . . 0.0 111.69 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.6 m -177.11 -65.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 81.06 -22.82 0.25 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.817 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 63.27 30.88 15.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.183 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.2 t0 57.97 31.61 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.156 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' CB ' ' HB2' ' A' ' 84' ' ' GLN . 1.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.815 0.34 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.91 129.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.923 HD11 HG13 ' A' ' 6' ' ' ILE . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.923 HG13 HD11 ' A' ' 3' ' ' ILE . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 75' ' ' ILE . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.921 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.745 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.483 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CG ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.884 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.835 ' OG1' HG11 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 68' ' ' VAL . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.638 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.504 ' NE2' HG21 ' A' ' 65' ' ' ILE . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.96 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.765 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.021 HG13 HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 47' ' ' VAL . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.638 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 1' ' ' MET . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.76 ' CG ' HG21 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 79' ' ' LEU . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 79' ' ' LEU . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD11 ' O ' ' A' ' 69' ' ' TYR . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.88 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.767 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.767 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.835 HG12 ' H ' ' A' ' 115' ' ' GLU . 43.3 t 69.63 -64.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.553 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.2 p 74.99 -8.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.666 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.835 ' H ' HG12 ' A' ' 113' ' ' VAL . 3.9 pt-20 -158.91 103.79 1.71 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 17' ' ' LEU . 1.7 m -124.54 170.19 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 112.558 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' H ' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -120.61 86.59 2.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.526 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.921 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 4.5 m-20 -50.93 -15.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.313 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 120' ' ' LEU . . . -64.4 -43.91 92.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.94 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 119' ' ' ALA . 1.9 mp -153.39 47.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.357 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HG2' HG21 ' A' ' 116' ' ' THR . 0.3 OUTLIER -82.91 -19.85 36.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.167 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.625 ' HE1' ' CG1' ' A' ' 97' ' ' ILE . 1.9 mtp -162.26 78.56 0.51 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 111.795 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -24.4 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.83 HD21 ' OG ' ' A' ' 20' ' ' SER . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 13.82 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.9 OUTLIER 169.75 171.76 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.606 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 59.7 Cg_endo -69.69 -41.39 4.4 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.483 2.122 . . . . 0.0 111.982 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m -166.37 72.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 4.6 mm-40 -47.29 -24.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.755 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 80.5 44.48 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.009 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t70 64.48 39.06 7.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.098 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? 53.81 26.72 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.31 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.732 HD11 HG13 ' A' ' 6' ' ' ILE . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 3' ' ' ILE . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.739 HD21 ' HE3' ' A' ' 40' ' ' MET . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.89 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.698 ' HG2' HD13 ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.739 ' HE3' HD21 ' A' ' 25' ' ' LEU . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.826 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.67 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.698 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 61' ' ' GLU . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.762 ' CE1' HG22 ' A' ' 87' ' ' VAL . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.942 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.718 ' OH ' HG12 ' A' ' 87' ' ' VAL . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 98' ' ' LEU . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.942 ' CG2' HG22 ' A' ' 68' ' ' VAL . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.835 HD11 ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.788 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.036 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.036 ' CD1' HG21 ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.762 HG22 ' CE1' ' A' ' 67' ' ' HIS . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 125' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.645 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.742 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.801 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 118' ' ' ASP . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.801 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 115' ' ' GLU . 37.9 t 79.68 -63.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.4 p 69.7 -4.15 1.49 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.1 pt-20 -163.6 70.78 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.593 ' CG2' HD12 ' A' ' 120' ' ' LEU . 1.6 t -46.82 166.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.267 0.556 . . . . 0.0 111.907 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -173.96 -55.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.02 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 5.0 m-20 -76.69 -42.94 39.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.279 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . . . -62.32 -35.01 77.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.632 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.4 -25.85 67.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.94 23.86 12.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.645 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.14 83.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.5 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -47.03 -34.62 5.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.517 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' CD2' HD12 ' A' ' 93' ' ' LEU . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -40.47 -18.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -93.45 167.72 13.43 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.691 0.281 . . . . 0.0 110.753 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 46.4 Cg_endo -65.96 -34.17 39.55 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m -166.42 72.4 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -44.09 -28.14 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.979 0.419 . . . . 0.0 110.566 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 77.14 33.37 0.43 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.14 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 60.49 31.4 20.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.11 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -156.87 -178.31 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.766 HD11 HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.907 HD11 HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.946 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.671 HH11 HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 101' ' ' TYR . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.481 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.709 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HD2' HG21 ' A' ' 36' ' ' VAL . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.532 ' CE ' HG12 ' A' ' 36' ' ' VAL . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.823 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.879 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.686 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.725 ' OH ' HG12 ' A' ' 87' ' ' VAL . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 48' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 68' ' ' VAL . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.75 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.789 HG21 ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.789 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.725 HG12 ' OH ' ' A' ' 69' ' ' TYR . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 HD11 ' A' ' 6' ' ' ILE . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.989 HD11 ' CD1' ' A' ' 125' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.602 ' N ' HG23 ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.664 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.664 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG11 ' OG1' ' A' ' 116' ' ' THR . 24.5 t 71.35 -57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.671 HG23 HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER 57.79 11.57 1.4 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.083 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -165.5 91.58 0.51 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.358 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.65 ' OG1' HG11 ' A' ' 113' ' ' VAL . 2.1 m -138.34 172.79 12.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.319 0.581 . . . . 0.0 111.947 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.618 ' H ' HG22 ' A' ' 116' ' ' THR . 14.0 p30 -164.59 98.25 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.037 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.86 ' OD2' HD22 ' A' ' 125' ' ' LEU . 3.7 t0 -46.71 -22.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.442 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.81 -21.34 19.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.49 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.41 -2.06 8.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.816 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -153.22 171.53 18.37 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.196 0.522 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.726 ' HE2' HG12 ' A' ' 97' ' ' ILE . 7.1 tpt 63.02 37.51 11.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.929 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -50.53 -28.16 8.01 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.989 ' CD1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.552 ' N ' HD23 ' A' ' 125' ' ' LEU . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.665 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.695 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.0 mm-40 -71.31 57.01 0.24 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -170.82 164.44 5.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.76 -39.44 26.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.689 2.259 . . . . 0.0 112.544 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.45 -32.47 70.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 3.8 mt-30 53.98 24.74 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.4 68.64 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.257 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.69 57.92 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.999 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.749 0.309 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 66.31 175.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 133' ' ' GLN . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.84 HD11 HD21 ' A' ' 79' ' ' LEU . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.872 HG23 ' OG ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.748 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.872 ' OG ' HG23 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD2' HD13 ' A' ' 129' ' ' ILE . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 32' ' ' GLU . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' GLU . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' SER . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.497 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.887 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.85 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.85 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.987 ' OG1' HG11 ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 80' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.657 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.987 HG11 ' OG1' ' A' ' 51' ' ' THR . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 94' ' ' LEU . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 94' ' ' LEU . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.723 ' CD1' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.686 ' CD1' HG21 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.678 HD21 HD13 ' A' ' 6' ' ' ILE . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 79' ' ' LEU . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 98' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 103' ' ' VAL . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.751 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.614 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 99' ' ' ASP . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 HG23 ' A' ' 116' ' ' THR . 17.6 t 76.14 -62.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.582 HG22 ' NH1' ' A' ' 10' ' ' ARG . 2.5 p 63.89 6.61 2.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.9 pt-20 -154.42 56.24 0.7 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 111.309 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.587 HG23 HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -126.99 -173.06 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 111.101 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 167.92 -165.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.895 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.5 -16.21 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.3 -53.19 60.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 116' ' ' THR . 3.2 tp -47.43 -30.05 3.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.023 0.44 . . . . 0.0 110.394 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt 58.29 168.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.264 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.751 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.7 OUTLIER -179.56 88.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -46.68 -27.33 1.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.031 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.56 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.924 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 mm100 -46.43 -12.92 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 23.6 t0 89.62 39.71 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 122.881 0.472 . . . . 0.0 112.192 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 134' ' ' ASP . 75.0 Cg_endo -81.17 -32.33 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.392 2.061 . . . . 0.0 111.825 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -143.89 17.25 1.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.161 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.568 ' CB ' ' HB3' ' A' ' 140' ' ' ALA . 8.2 mt-30 52.45 36.74 20.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.606 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.41 81.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.452 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.06 60.38 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.76 130.49 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.87 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.654 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' O ' ' A' ' 114' ' ' THR . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.876 HD22 ' OH ' ' A' ' 101' ' ' TYR . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.543 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 33' ' ' ARG . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.872 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 25' ' ' LEU . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.47 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.756 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.047 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.8 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.882 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.672 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.047 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.763 ' OH ' HG12 ' A' ' 87' ' ' VAL . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.668 HG13 HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.571 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.765 HG11 HG21 ' A' ' 47' ' ' VAL . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.034 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.651 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.767 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.767 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.763 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 HD11 ' A' ' 79' ' ' LEU . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' HB2' ' A' ' 79' ' ' LEU . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 94' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.62 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.876 ' OH ' HD22 ' A' ' 19' ' ' LEU . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.733 ' NE2' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.739 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.879 HG11 HG23 ' A' ' 116' ' ' THR . 24.1 t 71.25 -62.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.672 ' O ' HD21 ' A' ' 17' ' ' LEU . 1.8 p 64.57 6.39 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.697 ' H ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.66 96.11 0.64 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.751 0.31 . . . . 0.0 111.167 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.879 HG23 HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.84 -169.55 3.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.915 0.388 . . . . 0.0 111.29 -179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.27 -165.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.882 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.84 -15.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.778 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.66 -53.31 53.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.733 HD11 ' NE2' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -56.69 -22.14 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 11.1 ttpt -46.78 108.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.009 0.433 . . . . 0.0 111.286 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.62 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -88.56 143.73 26.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.141 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -23.25 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 125' ' ' LEU . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 129' ' ' ILE . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.87 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -38.46 -31.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -72.1 166.85 37.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.803 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 9.3 Cg_endo -51.61 -25.05 18.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.53 2.153 . . . . 0.0 112.078 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.83 -59.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.631 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 69.39 6.98 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.373 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.779 0.323 . . . . 0.0 111.396 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t0 62.8 31.75 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' HB3' ' OE1' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.078 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 71.31 153.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.333 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 3' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.703 ' O ' HG21 ' A' ' 116' ' ' THR . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 8' ' ' VAL . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 6' ' ' ILE . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.762 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' CG ' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.809 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.795 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.915 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.478 HG21 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.652 ' CE1' HG22 ' A' ' 87' ' ' VAL . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HD1' HD23 ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.597 ' HG3' HD23 ' A' ' 98' ' ' LEU . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.849 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 68' ' ' VAL . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 93' ' ' LEU . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG12 ' OH ' ' A' ' 69' ' ' TYR . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.859 HD22 ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.67 ' CG2' HD12 ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CB ' ' HE3' ' A' ' 122' ' ' MET . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.938 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.899 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.411 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.899 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.588 ' C ' HG23 ' A' ' 113' ' ' VAL . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.888 HG22 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER 65.15 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.88 19.85 5.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.19 57.82 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.749 HG21 ' HA ' ' A' ' 19' ' ' LEU . 2.9 t -54.85 -170.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.883 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.638 HD22 HD23 ' A' ' 120' ' ' LEU . 48.6 p-10 -118.06 48.49 1.39 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.46 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.635 ' H ' HG23 ' A' ' 116' ' ' THR . 1.3 p30 -50.08 -22.5 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.78 30.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.638 HD23 HD22 ' A' ' 117' ' ' ASN . 15.0 tp -76.43 -40.41 50.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.676 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 0.5 OUTLIER 63.51 15.42 8.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.514 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.538 ' HB3' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER 53.48 99.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 110.937 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -48.76 -27.19 2.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.587 HD22 HD11 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.64 ' HA ' HG21 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.468 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CD2' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.997 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -42.98 -28.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 166.19 63.04 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.86 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.483 2.122 . . . . 0.0 112.192 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 m -168.2 27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 46.25 30.83 1.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.877 0.37 . . . . 0.0 110.931 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . . . 50.92 80.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.26 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.74 63.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.092 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.76 0.314 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.77 179.8 8.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.737 HG22 ' CB ' ' A' ' 133' ' ' GLN . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.823 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.685 ' CG1' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CE1' ' HB1' ' A' ' 44' ' ' ALA . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HD2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' HD2' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.882 HD21 HG13 ' A' ' 75' ' ' ILE . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 33' ' ' ARG . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 36' ' ' VAL . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.658 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.766 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.931 ' OG1' HG11 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.59 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 HG21 ' CE1' ' A' ' 67' ' ' HIS . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CE1' HG21 ' A' ' 65' ' ' ILE . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.931 HG11 ' OG1' ' A' ' 51' ' ' THR . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.823 ' CB ' HD22 ' A' ' 94' ' ' LEU . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.882 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 HG22 ' A' ' 68' ' ' VAL . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.751 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.05 HD12 HD11 ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.844 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.764 ' OH ' HG21 ' A' ' 116' ' ' THR . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.421 ' CE1' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.583 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.612 ' CE3' HG23 ' A' ' 75' ' ' ILE . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.767 ' HA ' HG22 ' A' ' 75' ' ' ILE . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 112' ' ' ASP . 1.9 t 73.59 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -87.29 24.54 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.12 76.09 0.27 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.247 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.764 HG21 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -135.43 -178.74 5.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.478 ' H ' HG22 ' A' ' 116' ' ' THR . 0.6 OUTLIER 168.62 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.638 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.66 -16.89 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.139 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.14 -31.66 55.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 120' ' ' LEU . 3.2 mm? -90.41 7.43 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.06 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -56.49 -168.45 0.0 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.604 ' HG2' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -144.89 137.22 26.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.73 -23.56 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' CE1' ' A' ' 128' ' ' TYR . 1.1 mm100 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 122' ' ' MET . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.847 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.541 ' CE1' ' NE2' ' A' ' 124' ' ' GLN . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.823 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.737 ' CB ' HG22 ' A' ' 3' ' ' ILE . 2.3 pt20 -44.97 -28.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.05 147.91 46.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.004 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.83 -26.29 15.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.534 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.66 -25.09 16.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 58.07 23.62 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.042 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.29 38.41 29.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.277 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 t70 62.13 32.36 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.067 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.885 0.374 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 64.96 158.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.212 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.858 HD11 HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.947 HD11 HD21 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 18' ' ' GLU . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.896 ' N ' HD13 ' A' ' 17' ' ' LEU . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD21 HG13 ' A' ' 75' ' ' ILE . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.579 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' ' HB2' ' A' ' 118' ' ' ASP . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 6' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' CG ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.63 ' HD2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.889 ' CG ' HD13 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.634 ' CE ' HG12 ' A' ' 36' ' ' VAL . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.824 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 1.016 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.741 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.892 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.754 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 78' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' HG12 ' A' ' 87' ' ' VAL . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' CG ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.792 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 68' ' ' VAL . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.947 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.98 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.98 ' CD1' HG21 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.657 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 79' ' ' LEU . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 94' ' ' LEU . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.675 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.922 ' HA ' HD12 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 99' ' ' ASP . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' ASP . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 75' ' ' ILE . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 115' ' ' GLU . 9.6 t -64.39 142.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -100.79 17.99 20.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.428 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.762 ' H ' HG12 ' A' ' 113' ' ' VAL . 7.5 pt-20 177.92 112.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.494 ' OG1' HG11 ' A' ' 113' ' ' VAL . 54.0 m -157.25 162.15 39.22 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' THR . 0.5 OUTLIER -156.99 136.45 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.495 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 125' ' ' LEU . 8.1 t0 -60.87 -19.12 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.4 -20.62 56.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.81 -46.44 8.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 -165.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 111.534 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.794 ' SD ' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER 82.92 33.34 0.07 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.264 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -51.81 -24.36 5.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.376 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.794 HD23 ' SD ' ' A' ' 122' ' ' MET . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.459 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -69.6 53.17 0.11 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 1.4 p30 37.86 49.16 1.6 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 54.1 Cg_endo -88.12 -39.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.462 2.108 . . . . 0.0 112.34 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.71 26.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 1.4 mt-30 53.34 29.52 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.2 49.53 12.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.745 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t0 59.32 59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -154.36 126.34 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.796 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.844 HG23 ' CB ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' CB ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 19' ' ' LEU . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' C ' HD23 ' A' ' 17' ' ' LEU . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.844 ' CB ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' ILE . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 33' ' ' ARG . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.763 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' HG12 ' A' ' 36' ' ' VAL . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.819 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.953 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.625 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.818 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.956 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.841 ' HB2' HD12 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.848 ' CD1' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' THR . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' O ' HG12 ' A' ' 8' ' ' VAL . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.88 HG22 HG22 ' A' ' 68' ' ' VAL . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.956 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.589 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.589 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.848 HD13 ' CD1' ' A' ' 69' ' ' TYR . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.798 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.567 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.616 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.628 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 115' ' ' GLU . 3.3 t -68.9 140.07 19.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.497 HG22 ' NH2' ' A' ' 10' ' ' ARG . 35.1 p -101.01 16.15 26.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.804 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.755 ' H ' HG12 ' A' ' 113' ' ' VAL . 2.0 pt-20 -163.51 86.72 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.01 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 19' ' ' LEU . 4.9 t -57.54 -160.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' N ' HG23 ' A' ' 116' ' ' THR . 16.3 p-10 178.13 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.43 ' CB ' ' HB2' ' A' ' 122' ' ' MET . 21.1 m-20 -60.62 -31.43 70.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -47.04 -42.29 18.16 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.101 0.477 . . . . 0.0 110.479 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -16.4 14.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.98 68.54 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 111.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.802 ' SD ' HD22 ' A' ' 125' ' ' LEU . 10.5 ttt -156.92 66.23 0.52 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.038 0.446 . . . . 0.0 111.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -18.37 35.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.594 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.836 ' N ' HD23 ' A' ' 125' ' ' LEU . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.859 ' CD2' HD23 ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.796 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -49.84 -9.4 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -93.19 168.5 12.04 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 110.973 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.13 -29.08 18.06 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.705 2.27 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.0 m -165.38 71.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 1.8 mp0 -42.71 -30.75 0.4 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.484 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 82.6 40.1 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.114 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t0 60.42 40.36 17.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.155 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HE2' ' CB ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.834 0.35 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 61.87 -178.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.85 HG22 ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 3' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 32' ' ' GLU . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.518 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 21' ' ' GLU . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.876 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.923 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.856 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.705 ' OG1' HG11 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 37.5 m80 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 78' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.842 ' CG ' HD22 ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 8' ' ' VAL . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 68' ' ' VAL . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD23 HD11 ' A' ' 6' ' ' ILE . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.918 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.95 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.555 ' CB ' ' HE2' ' A' ' 1' ' ' MET . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.95 ' CD1' HG21 ' A' ' 81' ' ' THR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.693 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.74 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 79' ' ' LEU . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 8' ' ' VAL . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.927 ' HA ' HD12 ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.572 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' ASP . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 115' ' ' GLU . 2.2 t -66.42 122.49 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -93.23 22.05 5.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.198 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.45 ' H ' HG12 ' A' ' 113' ' ' VAL . 7.8 pt-20 -172.59 85.93 0.07 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.686 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -132.02 -169.51 2.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.4 p30 170.8 -170.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -53.55 -21.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 111.182 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.9 -49.03 72.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 116' ' ' THR . 1.6 mp -87.28 8.12 25.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 20' ' ' SER . 3.8 ttpm? -54.38 161.2 1.45 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.86 0.362 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.754 ' SD ' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.08 135.67 54.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.982 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.81 -21.49 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.432 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD23 ' SD ' ' A' ' 122' ' ' MET . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.58 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.649 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.85 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -42.01 -30.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.471 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -76.39 169.87 18.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.486 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -53.11 -23.74 23.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 111.94 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 m -175.21 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 140' ' ' ALA . 2.5 tt0 77.83 -8.44 1.67 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.248 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 62.01 32.36 17.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.783 0.325 . . . . 0.0 111.162 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.01 42.98 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB3' ' HG2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.056 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.38 66.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 3' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.892 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 114' ' ' THR . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' H ' HD22 ' A' ' 17' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.7 HD22 ' OH ' ' A' ' 101' ' ' TYR . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 33' ' ' ARG . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.838 ' CG ' HD13 ' A' ' 25' ' ' LEU . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 4.1 tp-100 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.55 ' HE3' HG12 ' A' ' 36' ' ' VAL . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.77 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.77 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.937 ' OG1' HG11 ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.769 HE22 ' HB2' ' A' ' 50' ' ' ARG . 88.4 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.709 HG21 ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.828 ' HB2' HD12 ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.973 ' CG2' HG22 ' A' ' 78' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.65 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.973 HG22 ' CG2' ' A' ' 68' ' ' VAL . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.616 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' CD1' ' A' ' 79' ' ' LEU . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.684 HD21 HD13 ' A' ' 6' ' ' ILE . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD12 HD11 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 125' ' ' LEU . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.876 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.911 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.587 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.911 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 115' ' ' GLU . 19.7 t 77.09 -71.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 17' ' ' LEU . 3.5 p 63.41 5.19 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.917 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.761 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.0 pt-20 -160.25 58.14 0.35 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.201 0.524 . . . . 0.0 109.996 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.646 HG21 ' CA ' ' A' ' 19' ' ' LEU . 1.2 t -81.96 -161.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.82 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.642 ' N ' HG23 ' A' ' 116' ' ' THR . 10.9 p30 -140.48 65.97 1.39 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.3 p30 -49.78 -21.44 1.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.736 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -30.7 44.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.942 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.84 -38.48 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 5.4 mtpt 58.96 159.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.17 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.876 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -86.85 117.13 25.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -49.17 -28.07 4.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.892 HD11 ' CA ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.607 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.2 tm0? -66.03 57.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t0 66.6 60.12 0.96 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.915 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.33 -45.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.584 2.189 . . . . 0.0 112.024 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 m -153.08 13.49 0.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 48.17 51.66 14.46 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 52.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.778 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.63 40.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.674 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.19 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.723 0.297 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.25 169.93 21.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.904 HG22 HD13 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 20' ' ' SER . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.846 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 18' ' ' GLU . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.787 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 10' ' ' ARG . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.628 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.822 HD23 ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.822 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.869 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.794 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.936 ' OG1' HG11 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.804 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 78' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.779 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 68' ' ' VAL . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.842 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.842 ' CD1' HG21 ' A' ' 81' ' ' THR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.863 ' HG ' HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HG ' HD12 ' A' ' 79' ' ' LEU . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.418 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.637 ' CB ' HG22 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.637 HG22 ' CB ' ' A' ' 110' ' ' TRP . 9.5 t 75.52 -62.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.513 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.3 p 73.21 -11.51 0.89 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.852 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' H ' HG12 ' A' ' 113' ' ' VAL . 10.4 pt-20 -145.41 23.16 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' ASN . 6.1 t 41.82 -167.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.279 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 116' ' ' THR . 10.9 p-10 173.93 -40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.017 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD2' ' CD2' ' A' ' 101' ' ' TYR . 16.5 m-20 -76.85 -29.3 55.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.694 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.93 -51.27 61.9 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -22.34 61.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.399 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -149.81 103.72 3.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.553 ' HE1' ' HB3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -168.41 58.29 0.06 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 178.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -50.99 -23.83 3.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 HG22 ' A' ' 6' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 125' ' ' LEU . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 93' ' ' LEU . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.669 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CD2' HD23 ' A' ' 93' ' ' LEU . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.927 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.9 mt-30 -36.74 -31.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.63 167.0 40.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 0.0 111.094 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.5 -31.19 22.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m -166.67 72.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.658 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 30.0 mm-40 -44.49 -27.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 79.3 92.11 0.06 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.163 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.62 52.95 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.085 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.865 0.364 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -173.65 150.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.956 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.753 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.815 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 10' ' ' ARG . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.674 ' O ' HG21 ' A' ' 116' ' ' THR . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CZ ' ' A' ' 10' ' ' ARG . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.802 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.913 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.49 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG12 ' A' ' 36' ' ' VAL . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.78 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.912 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.801 ' OG1' HG11 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' THR . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 78' ' ' VAL . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.711 ' OH ' HG22 ' A' ' 87' ' ' VAL . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.683 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.683 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.711 HG22 ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.546 HG22 ' HE3' ' A' ' 96' ' ' LYS . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.599 HD22 HD23 ' A' ' 79' ' ' LEU . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' OH ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.848 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.508 ' HB2' ' CG ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.73 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 110' ' ' TRP . 2.3 t -92.81 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.525 ' H ' HG12 ' A' ' 113' ' ' VAL . 69.7 p -107.3 14.52 25.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.334 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -164.41 145.45 8.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.909 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.909 HG23 HD12 ' A' ' 120' ' ' LEU . 15.2 t -124.0 -179.18 4.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.0 111.767 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -175.14 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -76.86 -40.72 46.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.091 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -58.4 -49.59 76.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 116' ' ' THR . 0.6 OUTLIER -52.04 -27.5 13.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.32 48.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.019 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.553 ' HE1' ' HB3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -97.01 80.52 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -50.75 -26.32 5.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.81 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.634 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' CG ' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.956 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -41.81 -32.93 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 27.9 t70 168.64 63.0 0.01 OUTLIER Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.99 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.56 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -175.01 31.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 5.0 mt-30 47.03 28.03 0.83 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.961 0.41 . . . . 0.0 110.848 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . . . 54.64 78.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.368 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.05 54.79 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.111 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 60.86 -176.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 6' ' ' ILE . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.942 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.77 ' CZ ' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' A' ' 114' ' ' THR . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.82 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' CD2' HD23 ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.81 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.722 ' HE3' HD21 ' A' ' 25' ' ' LEU . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.817 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.847 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.767 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.926 ' OG1' HG11 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' ASN . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.98 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 68' ' ' VAL . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.052 HD11 HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.651 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.052 HD22 HD11 ' A' ' 79' ' ' LEU . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.98 HD13 ' CD1' ' A' ' 69' ' ' TYR . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 125' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.773 ' OH ' HG21 ' A' ' 116' ' ' THR . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.883 HD12 ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 106' ' ' PRO . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.557 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.701 HG11 ' OG1' ' A' ' 116' ' ' THR . 12.6 t 76.9 -51.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.77 HG23 ' CZ ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 65.82 7.73 4.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.374 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.407 ' HG3' HG12 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -166.4 81.62 0.26 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.773 HG21 ' OH ' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -143.1 178.35 7.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.379 0.609 . . . . 0.0 111.777 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.673 ' H ' HG22 ' A' ' 116' ' ' THR . 64.9 t30 -168.58 150.06 4.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.711 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' ' HA ' ' A' ' 20' ' ' SER . 14.2 p-10 -56.55 -19.47 15.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.86 61.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.978 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD13 HG23 ' A' ' 116' ' ' THR . 0.3 OUTLIER -67.92 -48.86 64.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.97 108.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.792 0.329 . . . . 0.0 111.53 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.846 ' HG3' HD22 ' A' ' 125' ' ' LEU . 6.0 tpt -175.82 31.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -24.82 5.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.976 HD12 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.946 ' N ' HD23 ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HD3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.5 pp0? -51.67 -20.59 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.68 155.04 37.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.198 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.67 -26.59 23.11 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.816 2.344 . . . . 0.0 112.262 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -21.38 26.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.228 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.572 ' CB ' ' HB3' ' A' ' 140' ' ' ALA . 6.0 mt-30 60.33 32.91 20.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 110.552 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.541 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . 59.28 73.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.177 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.07 52.34 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB3' ' CB ' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -144.51 169.06 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 3' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.878 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.833 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD11 ' C ' ' A' ' 114' ' ' THR . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.812 HD22 ' OH ' ' A' ' 101' ' ' TYR . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' HE3' ' A' ' 40' ' ' MET . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.675 ' HE3' HD11 ' A' ' 25' ' ' LEU . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB1' ' CE2' ' A' ' 9' ' ' PHE . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.966 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.871 ' OG1' HG11 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 87' ' ' VAL . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.966 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.83 ' CD1' HD22 ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CG ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.621 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB1' ' A' ' 70' ' ' ALA . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.851 HG22 ' CG2' ' A' ' 68' ' ' VAL . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.015 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.015 ' CD1' HG21 ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 67' ' ' HIS . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 94' ' ' LEU . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 HD11 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.03 HD11 HD22 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 71' ' ' ARG . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.498 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.556 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.669 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CZ2' HD23 ' A' ' 102' ' ' LEU . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.486 HG11 ' OG1' ' A' ' 116' ' ' THR . 2.0 t -73.07 130.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.502 ' C ' HD11 ' A' ' 17' ' ' LEU . 40.5 p -95.27 19.61 10.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.579 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.76 110.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.991 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 86.9 m -159.71 166.53 30.34 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.527 ' N ' HG22 ' A' ' 116' ' ' THR . 12.6 m-20 -157.57 140.33 14.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.418 ' N ' ' HA ' ' A' ' 20' ' ' SER . 10.0 p-10 -48.86 -27.3 2.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.77 -26.14 13.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.67 -57.3 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -160.16 -171.75 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.204 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.706 ' HE1' ' CG2' ' A' ' 97' ' ' ILE . 2.9 tpt 95.85 29.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.672 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -26.47 11.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.922 HD12 HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 129' ' ' ILE . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.533 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.533 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 1.036 ' HA ' HG22 ' A' ' 3' ' ' ILE . 31.4 mt-30 -36.75 -30.67 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.64 163.04 68.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.9 -29.13 88.74 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.104 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -95.94 -81.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.727 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 3.4 pt20 175.06 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.148 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 72.59 76.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.548 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t0 56.51 57.27 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.017 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' CG ' ' CB ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.973 0.416 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -157.31 153.52 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 133' ' ' GLN . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.95 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.768 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 36' ' ' VAL . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HB2' HD13 ' A' ' 25' ' ' LEU . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 40' ' ' MET . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.596 ' CE ' HD21 ' A' ' 25' ' ' LEU . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HE2' ' A' ' 5' ' ' TYR . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.5 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG11 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 78' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.674 ' CG ' HD22 ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 68' ' ' VAL . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.727 HD21 HD22 ' A' ' 93' ' ' LEU . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.417 ' CB ' ' CG ' ' A' ' 1' ' ' MET . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.616 ' HA ' HD23 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 79' ' ' LEU . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.947 HD11 HD12 ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 102' ' ' LEU . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.493 ' CD1' HD11 ' A' ' 75' ' ' ILE . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.621 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.621 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 113' ' ' VAL . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER 57.09 108.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -77.18 4.41 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.932 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -170.71 129.16 0.8 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.01 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 117' ' ' ASN . 4.1 m -133.06 169.87 16.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.175 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 116' ' ' THR . 1.8 m120 -111.59 68.46 0.67 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.836 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 p30 -45.75 -22.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.718 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 120' ' ' LEU . . . -58.41 -31.2 67.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 119' ' ' ALA . 0.3 OUTLIER -176.11 53.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.783 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.86 31.24 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.568 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -178.13 48.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.2 -31.86 1.66 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 6.8 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.95 HD11 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.69 ' N ' HD23 ' A' ' 125' ' ' LEU . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.681 HG12 HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.931 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.4 pp0? -70.7 56.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 74.0 57.65 0.3 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.157 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 131' ' ' LYS . 90.4 Cg_endo -82.57 -45.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.127 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.25 28.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 53.72 24.92 4.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 110.811 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.34 43.07 23.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.409 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.09 32.17 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.117 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.776 0.322 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.9 mmp_? 68.99 -172.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.793 HG13 HD11 ' A' ' 3' ' ' ILE . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.888 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.818 ' NH1' HG22 ' A' ' 114' ' ' THR . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 114' ' ' THR . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.603 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.906 HD13 ' HG2' ' A' ' 33' ' ' ARG . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.906 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.908 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.895 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.543 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.988 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.844 ' OG1' HG11 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 70.3 mm-40 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.592 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.74 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.988 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.704 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 68' ' ' VAL . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.991 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.652 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.013 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.013 ' CD1' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.74 HG22 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.677 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.677 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 HD11 ' A' ' 79' ' ' LEU . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 79' ' ' LEU . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 103' ' ' VAL . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' HG21 ' A' ' 116' ' ' THR . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 98' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.419 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.4 t -59.31 113.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.818 HG22 ' NH1' ' A' ' 10' ' ' ARG . 62.1 p -96.39 26.99 3.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.2 56.2 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.173 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.744 HG22 HD13 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -122.69 168.73 11.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.597 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.8 t-20 177.95 -161.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.443 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -57.46 -15.32 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.031 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.7 16.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.951 0.405 . . . . 0.0 110.86 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 116' ' ' THR . 6.4 mp -61.28 -32.12 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.729 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.38 -62.38 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.381 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE1' HG12 ' A' ' 97' ' ' ILE . 7.5 ttt 73.4 72.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.281 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -43.64 -31.17 0.71 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.69 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.716 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.79 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 pp0? -68.31 51.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 14.5 m-20 39.52 48.2 1.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 49.5 Cg_endo -88.05 -39.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.444 2.096 . . . . 0.0 112.512 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.86 22.15 0.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 1.8 tt0 56.09 31.49 18.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.0 110.342 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 47.39 46.42 17.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.465 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.81 58.44 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.977 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.772 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 18' ' ' GLU . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.759 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.772 HD22 ' OH ' ' A' ' 101' ' ' TYR . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.589 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 6' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD22 ' HA ' ' A' ' 33' ' ' ARG . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 32' ' ' GLU . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.853 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.635 ' OG1' HG11 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 71' ' ' ARG . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 51' ' ' THR . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.467 HG21 ' CE1' ' A' ' 67' ' ' HIS . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.091 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 78' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.885 ' CD1' HD22 ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.672 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 68' ' ' VAL . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.091 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.964 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.964 ' CD1' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.779 ' HA ' HG22 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.73 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.779 HG22 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 79' ' ' LEU . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 125' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.772 ' OH ' HD22 ' A' ' 19' ' ' LEU . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 99' ' ' ASP . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.514 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG21 ' OH ' ' A' ' 101' ' ' TYR . 38.0 t . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.0 HD12 HD11 ' A' ' 97' ' ' ILE . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 129' ' ' ILE . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.977 ' HA ' HG22 ' A' ' 3' ' ' ILE . 33.0 mt-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.063 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.421 ' HB3' ' HE3' ' A' ' 40' ' ' MET . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG13 ' CA ' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.752 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 9' ' ' PHE . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.964 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.748 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.146 HD12 ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 33' ' ' ARG . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.702 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.867 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.454 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.799 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.774 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.799 ' OG1' HG11 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.66 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 78' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.788 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.657 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 68' ' ' VAL . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.724 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.664 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.94 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.94 ' CD1' HG21 ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.629 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.866 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.598 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.889 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 1.146 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 98' ' ' LEU . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.74 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 101' ' ' TYR . 40.4 t . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.964 ' N ' HD23 ' A' ' 125' ' ' LEU . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.767 ' HB3' HD21 ' A' ' 93' ' ' LEU . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.785 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.866 ' CE2' HD23 ' A' ' 93' ' ' LEU . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 1.063 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 6' ' ' ILE . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 93' ' ' LEU . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.905 ' HB3' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.81 ' C ' HD23 ' A' ' 25' ' ' LEU . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.81 HD23 ' C ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HB2' ' HG3' ' A' ' 33' ' ' ARG . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.744 ' HE3' HG12 ' A' ' 36' ' ' VAL . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.858 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.783 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.061 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.783 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.832 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 51' ' ' THR . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.638 ' N ' HG12 ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.601 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.724 HD11 ' HE2' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.488 ' CE1' HG21 ' A' ' 65' ' ' ILE . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.061 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' OE1' HD13 ' A' ' 102' ' ' LEU . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.54 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.565 ' O ' HG12 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 68' ' ' VAL . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.698 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 85' ' ' TYR . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HE2' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' CG ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 6' ' ' ILE . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD23 ' CG ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.675 HG21 HD22 ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HG3' ' CB ' ' A' ' 124' ' ' GLN . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.567 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.474 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' HB3' ' HD3' ' A' ' 10' ' ' ARG . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.7 t . . . . . 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.642 HD21 ' OG ' ' A' ' 20' ' ' SER . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.662 ' HA ' HG21 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.917 0.389 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.923 HD11 HG13 ' A' ' 6' ' ' ILE . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.923 HG13 HD11 ' A' ' 3' ' ' ILE . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 75' ' ' ILE . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.83 ' OG ' HD21 ' A' ' 125' ' ' LEU . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.745 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.483 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CG ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.884 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.835 ' OG1' HG11 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 68' ' ' VAL . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.638 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.504 ' NE2' HG21 ' A' ' 65' ' ' ILE . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.96 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.765 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.021 HG13 HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 47' ' ' VAL . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.638 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.76 ' CG ' HG21 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 79' ' ' LEU . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 79' ' ' LEU . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD11 ' O ' ' A' ' 69' ' ' TYR . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 96' ' ' LYS . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.88 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.767 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.767 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 110' ' ' TRP . 43.3 t . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.83 HD21 ' OG ' ' A' ' 20' ' ' SER . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 . . . . . 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.963 0.411 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.732 HD11 HG13 ' A' ' 6' ' ' ILE . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 3' ' ' ILE . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.739 HD21 ' HE3' ' A' ' 40' ' ' MET . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.89 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.698 ' HG2' HD13 ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.739 ' HE3' HD21 ' A' ' 25' ' ' LEU . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.826 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.67 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.698 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 61' ' ' GLU . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.762 ' CE1' HG22 ' A' ' 87' ' ' VAL . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.942 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.718 ' OH ' HG12 ' A' ' 87' ' ' VAL . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 98' ' ' LEU . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.942 ' CG2' HG22 ' A' ' 68' ' ' VAL . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.835 HD11 ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.788 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.036 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.036 ' CD1' HG21 ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.762 HG22 ' CE1' ' A' ' 67' ' ' HIS . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 125' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.742 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.801 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.801 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG22 ' HB3' ' A' ' 110' ' ' TRP . 37.9 t . . . . . 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.517 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' CD2' HD12 ' A' ' 93' ' ' LEU . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.766 HD11 HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.907 HD11 HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.946 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 101' ' ' TYR . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.481 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.709 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HD2' HG21 ' A' ' 36' ' ' VAL . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.532 ' CE ' HG12 ' A' ' 36' ' ' VAL . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.823 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.879 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.686 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.725 ' OH ' HG12 ' A' ' 87' ' ' VAL . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 48' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 68' ' ' VAL . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.75 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.789 HG21 ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.789 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.725 HG12 ' OH ' ' A' ' 69' ' ' TYR . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 HD11 ' A' ' 6' ' ' ILE . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.989 HD11 ' CD1' ' A' ' 125' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.602 ' N ' HG23 ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.664 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.664 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 110' ' ' TRP . 24.5 t . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.447 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.989 ' CD1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.552 ' N ' HD23 ' A' ' 125' ' ' LEU . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.665 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.695 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.0 mm-40 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.863 0.363 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 133' ' ' GLN . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.84 HD11 HD21 ' A' ' 79' ' ' LEU . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.872 HG23 ' OG ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.748 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.872 ' OG ' HG23 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD2' HD13 ' A' ' 129' ' ' ILE . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 32' ' ' GLU . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' GLU . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' SER . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.497 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.887 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.85 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.85 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.987 ' OG1' HG11 ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 80' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.657 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.987 HG11 ' OG1' ' A' ' 51' ' ' THR . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 94' ' ' LEU . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 94' ' ' LEU . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.723 ' CD1' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.686 ' CD1' HG21 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.678 HD21 HD13 ' A' ' 6' ' ' ILE . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 79' ' ' LEU . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 98' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 103' ' ' VAL . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.614 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 99' ' ' ASP . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 110' ' ' TRP . 17.6 t . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.89 0.376 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.56 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.924 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 mm100 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.87 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.654 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.876 HD22 ' OH ' ' A' ' 101' ' ' TYR . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.543 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 33' ' ' ARG . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.872 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 25' ' ' LEU . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.47 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.756 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.047 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.8 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.882 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.672 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.047 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.763 ' OH ' HG12 ' A' ' 87' ' ' VAL . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.668 HG13 HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.571 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.765 HG11 HG21 ' A' ' 47' ' ' VAL . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.034 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.651 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.767 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.767 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.763 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 HD11 ' A' ' 79' ' ' LEU . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' HB2' ' A' ' 79' ' ' LEU . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 94' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' LYS . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.876 ' OH ' HD22 ' A' ' 19' ' ' LEU . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.532 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.739 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' TRP . 24.1 t . . . . . 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 125' ' ' LEU . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 129' ' ' ILE . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.87 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 121.029 0.442 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 3' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 8' ' ' VAL . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 6' ' ' ILE . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.762 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' CG ' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.809 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.795 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.915 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.478 HG21 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.652 ' CE1' HG22 ' A' ' 87' ' ' VAL . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HD1' HD23 ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.597 ' HG3' HD23 ' A' ' 98' ' ' LEU . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.849 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 68' ' ' VAL . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 93' ' ' LEU . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG12 ' OH ' ' A' ' 69' ' ' TYR . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.859 HD22 ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.67 ' CG2' HD12 ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 96' ' ' LYS . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.938 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.899 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.899 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.588 ' C ' HG23 ' A' ' 113' ' ' VAL . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.888 HG22 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.587 HD22 HD11 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.64 ' HA ' HG21 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.468 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CD2' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.997 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.737 HG22 ' CB ' ' A' ' 133' ' ' GLN . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.823 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.685 ' CG1' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HD2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' HD2' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.882 HD21 HG13 ' A' ' 75' ' ' ILE . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 33' ' ' ARG . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 36' ' ' VAL . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.658 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.766 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.931 ' OG1' HG11 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.59 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 HG21 ' CE1' ' A' ' 67' ' ' HIS . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CE1' HG21 ' A' ' 65' ' ' ILE . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.931 HG11 ' OG1' ' A' ' 51' ' ' THR . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.823 ' CB ' HD22 ' A' ' 94' ' ' LEU . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.882 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 HG22 ' A' ' 68' ' ' VAL . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.751 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.05 HD12 HD11 ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.844 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' CB ' ' A' ' 124' ' ' GLN . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.4 ' CE2' HG13 ' A' ' 75' ' ' ILE . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.583 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.612 ' CE3' HG23 ' A' ' 75' ' ' ILE . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.767 ' HA ' HG22 ' A' ' 75' ' ' ILE . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 112' ' ' ASP . 1.9 t . . . . . 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.845 0.355 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 4.1 mm-40 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 125' ' ' LEU . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.847 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.823 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.737 ' CB ' HG22 ' A' ' 3' ' ' ILE . 2.3 pt20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.952 0.406 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.858 HD11 HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.947 HD11 HD21 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 18' ' ' GLU . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.896 ' N ' HD13 ' A' ' 17' ' ' LEU . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD21 HG13 ' A' ' 75' ' ' ILE . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.579 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 6' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' CG ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.63 ' HD2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.889 ' CG ' HD13 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.634 ' CE ' HG12 ' A' ' 36' ' ' VAL . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.824 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 1.016 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.741 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.892 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.754 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 78' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' HG12 ' A' ' 87' ' ' VAL . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' CG ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.792 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 68' ' ' VAL . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.947 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.98 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.98 ' CD1' HG21 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.657 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 79' ' ' LEU . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 94' ' ' LEU . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 125' ' ' LEU . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.922 ' HA ' HD12 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 99' ' ' ASP . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' ASP . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 75' ' ' ILE . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 110' ' ' TRP . 9.6 t . . . . . 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 120.915 0.388 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 6' ' ' ILE . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.796 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.844 HG23 ' CB ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' CB ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 19' ' ' LEU . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' C ' HD23 ' A' ' 17' ' ' LEU . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.844 ' CB ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' ILE . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 33' ' ' ARG . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.763 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' HG12 ' A' ' 36' ' ' VAL . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.819 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.953 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.625 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.818 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.956 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.841 ' HB2' HD12 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.848 ' CD1' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' THR . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' O ' HG12 ' A' ' 8' ' ' VAL . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.88 HG22 HG22 ' A' ' 68' ' ' VAL . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.956 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.589 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.589 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.848 HD13 ' CD1' ' A' ' 69' ' ' TYR . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.798 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.616 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.628 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 110' ' ' TRP . 3.3 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.836 ' N ' HD23 ' A' ' 125' ' ' LEU . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.859 ' CD2' HD23 ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.796 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.85 HG22 ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 3' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 32' ' ' GLU . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.518 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 21' ' ' GLU . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.876 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.923 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.856 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.705 ' OG1' HG11 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.4 m-70 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 78' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.842 ' CG ' HD22 ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 8' ' ' VAL . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 68' ' ' VAL . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD23 HD11 ' A' ' 6' ' ' ILE . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.918 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.95 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.95 ' CD1' HG21 ' A' ' 81' ' ' THR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.693 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.74 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 79' ' ' LEU . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 8' ' ' VAL . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.927 ' HA ' HD12 ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.572 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' ASP . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.558 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.443 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 2.2 t . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.914 0.388 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HB3' HG13 ' A' ' 97' ' ' ILE . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.58 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.649 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.85 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 3' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.892 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' H ' HD22 ' A' ' 17' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.7 HD22 ' OH ' ' A' ' 101' ' ' TYR . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 33' ' ' ARG . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.838 ' CG ' HD13 ' A' ' 25' ' ' LEU . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 6.8 tp60 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.55 ' HE3' HG12 ' A' ' 36' ' ' VAL . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.77 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.77 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.937 ' OG1' HG11 ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 29.0 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.709 HG21 ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.828 ' HB2' HD12 ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.973 ' CG2' HG22 ' A' ' 78' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.65 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.973 HG22 ' CG2' ' A' ' 68' ' ' VAL . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.616 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' CD1' ' A' ' 79' ' ' LEU . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.684 HD21 HD13 ' A' ' 6' ' ' ILE . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD12 HD11 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 125' ' ' LEU . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.911 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.587 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.911 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' OH ' ' A' ' 101' ' ' TYR . 19.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.892 HD11 ' CA ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.607 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.2 tm0? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.904 HG22 HD13 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 20' ' ' SER . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.846 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 18' ' ' GLU . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.787 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 10' ' ' ARG . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.628 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.822 HD23 ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.822 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.869 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.794 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.936 ' OG1' HG11 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.804 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 78' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.779 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 68' ' ' VAL . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.842 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.842 ' CD1' HG21 ' A' ' 81' ' ' THR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.863 ' HG ' HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HG ' HD12 ' A' ' 79' ' ' LEU . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' LYS . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.554 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.637 ' CB ' HG22 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.637 HG22 ' CB ' ' A' ' 110' ' ' TRP . 9.5 t . . . . . 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.932 0.396 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 HG22 ' A' ' 6' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 125' ' ' LEU . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 93' ' ' LEU . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.669 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CD2' HD23 ' A' ' 93' ' ' LEU . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.927 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.9 mt-30 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.956 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.753 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.815 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 10' ' ' ARG . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CZ ' ' A' ' 10' ' ' ARG . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.802 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.913 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.49 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG12 ' A' ' 36' ' ' VAL . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.78 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.912 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.801 ' OG1' HG11 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' THR . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 78' ' ' VAL . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.711 ' OH ' HG22 ' A' ' 87' ' ' VAL . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.683 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.683 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.711 HG22 ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 88' ' ' ARG . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.546 HG22 ' HE3' ' A' ' 96' ' ' LYS . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.599 HD22 HD23 ' A' ' 79' ' ' LEU . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' OH ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.848 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.595 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.73 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 110' ' ' TRP . 2.3 t . . . . . 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.81 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.634 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' CG ' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.956 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 6' ' ' ILE . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.942 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.82 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' CD2' HD23 ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.81 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.722 ' HE3' HD21 ' A' ' 25' ' ' LEU . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.817 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.847 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.767 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.926 ' OG1' HG11 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' ASN . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.98 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 68' ' ' VAL . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.052 HD11 HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.651 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.052 HD22 HD11 ' A' ' 79' ' ' LEU . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.98 HD13 ' CD1' ' A' ' 69' ' ' TYR . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 125' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CE1' HD21 ' A' ' 19' ' ' LEU . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.883 HD12 ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 106' ' ' PRO . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.557 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 112' ' ' ASP . 12.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.976 HD12 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.946 ' N ' HD23 ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.543 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.5 pp0? . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.967 0.413 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 3' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.878 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.833 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.812 HD22 ' OH ' ' A' ' 101' ' ' TYR . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' HE3' ' A' ' 40' ' ' MET . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.675 ' HE3' HD11 ' A' ' 25' ' ' LEU . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB1' ' CE2' ' A' ' 9' ' ' PHE . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.966 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.871 ' OG1' HG11 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 87' ' ' VAL . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.966 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.83 ' CD1' HD22 ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CG ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.621 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB1' ' A' ' 70' ' ' ALA . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.851 HG22 ' CG2' ' A' ' 68' ' ' VAL . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.015 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.015 ' CD1' HG21 ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 67' ' ' HIS . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 94' ' ' LEU . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 HD11 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.03 HD11 HD22 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 71' ' ' ARG . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 96' ' ' LYS . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.556 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.669 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CZ2' HD23 ' A' ' 102' ' ' LEU . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 110' ' ' TRP . 2.0 t . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.922 HD12 HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 129' ' ' ILE . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.533 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.533 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 1.036 ' HA ' HG22 ' A' ' 3' ' ' ILE . 44.3 mt-30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 133' ' ' GLN . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.95 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.554 ' OG ' HG23 ' A' ' 8' ' ' VAL . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.768 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 36' ' ' VAL . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD22 ' A' ' 25' ' ' LEU . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 40' ' ' MET . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.596 ' CE ' HD21 ' A' ' 25' ' ' LEU . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HE2' ' A' ' 5' ' ' TYR . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.5 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG11 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 78' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.674 ' CG ' HD22 ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 68' ' ' VAL . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.727 HD21 HD22 ' A' ' 93' ' ' LEU . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.616 ' HA ' HD23 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 79' ' ' LEU . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.947 HD11 HD12 ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 102' ' ' LEU . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.493 ' CD1' HD11 ' A' ' 75' ' ' ILE . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.586 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.621 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.621 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 113' ' ' VAL . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 1.7 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.95 HD11 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.69 ' N ' HD23 ' A' ' 125' ' ' LEU . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.681 HG12 HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.931 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.4 pp0? . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.9 mmp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.915 0.388 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.793 HG13 HD11 ' A' ' 3' ' ' ILE . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.888 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 113' ' ' VAL . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.603 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.906 HD13 ' HG2' ' A' ' 33' ' ' ARG . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.906 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.908 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.895 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.543 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.988 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.844 ' OG1' HG11 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 24.7 mm100 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.592 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.74 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.988 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.704 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 68' ' ' VAL . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.991 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.652 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.013 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.013 ' CD1' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.74 HG22 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.677 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.677 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 HD11 ' A' ' 79' ' ' LEU . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 79' ' ' LEU . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 103' ' ' VAL . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' CE2' HD21 ' A' ' 19' ' ' LEU . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 98' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.57 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.419 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.368 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.69 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.716 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.79 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' CA ' ' HB2' ' A' ' 84' ' ' GLN . 24.3 ttm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -149.82 123.22 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.977 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.0 tt -64.83 153.23 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.29 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.527 ' CE1' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -123.77 -40.16 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.2 t80 -140.64 149.99 42.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.55 0.69 . . . . 0.0 112.103 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -149.24 161.92 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.793 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.772 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 160.81 -171.37 36.9 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.558 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -131.26 160.02 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.564 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 51.0 m-85 -153.84 132.34 12.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 0.0 111.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 6.4 tmm_? -94.1 110.24 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -47.56 96.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.284 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.01 42.13 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.347 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.59 -116.1 4.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.44 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.71 -21.39 57.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 111.082 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.96 150.17 45.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.381 . . . . 0.0 110.455 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -95.87 127.26 41.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 18' ' ' GLU . 1.5 tt -64.27 129.47 40.07 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.759 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 pt-20 -72.64 65.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.772 HD22 ' OH ' ' A' ' 101' ' ' TYR . 13.3 mt -46.01 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.785 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -136.18 147.27 47.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.103 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 118' ' ' ASP . 1.6 tm-20 -138.39 118.59 13.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 6' ' ' ILE . 8.2 p -120.29 138.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -114.61 157.65 22.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.752 0.787 . . . . 0.0 113.025 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -141.81 107.1 4.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.831 177.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD22 ' HA ' ' A' ' 33' ' ' ARG . 1.0 OUTLIER -128.78 82.02 2.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.129 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -78.49 -60.79 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.352 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.69 -26.43 57.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.278 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -76.81 84.02 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.24 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -59.42 -151.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.377 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.77 36.89 0.46 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.56 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.35 -40.63 0.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.217 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.5 mm-40 -101.49 -18.79 15.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.2 ttp180 -53.61 -39.13 64.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -71.61 -58.27 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 p -57.42 -55.47 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.231 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 32' ' ' GLU . 21.4 t -54.7 -46.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.1 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.95 -55.26 11.89 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.935 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -56.58 -31.43 64.24 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.5 t80 -65.5 -50.13 66.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.006 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 24.1 mmt -58.74 -59.42 5.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.718 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -59.03 -61.09 2.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.38 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -41.1 -39.04 1.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.149 0.5 . . . . 0.0 110.661 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -76.54 -43.6 38.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.129 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.853 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -59.14 -40.43 85.46 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.093 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.9 pt-20 -70.01 -40.88 74.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.506 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.4 m -60.66 -53.4 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -46.88 -61.05 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.627 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.79 -30.95 36.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 12.8 m -70.93 -34.84 71.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -78.25 -31.87 49.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.899 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.635 ' OG1' HG11 ' A' ' 68' ' ' VAL . 1.6 m -87.53 106.06 17.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.581 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.8 43.75 3.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.82 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 71' ' ' ARG . . . 59.66 153.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.17 -0.21 87.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.792 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 51' ' ' THR . 20.4 pt-20 -147.0 167.73 23.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.372 . . . . 0.0 111.171 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -119.27 159.39 24.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 3.4 mt-30 -139.22 150.64 45.76 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.376 0.608 . . . . 0.0 112.052 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.89 102.53 4.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -86.32 104.32 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.0 119.0 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.127 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.36 173.23 6.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.285 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -41.22 -29.64 0.38 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.959 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 40.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.79 0.329 . . . . 0.0 110.956 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -154.42 153.24 31.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 0.0 111.64 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.467 HG21 ' CE1' ' A' ' 67' ' ' HIS . 2.0 mt -132.41 111.0 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.091 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -92.4 80.18 1.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.034 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' LEU . 82.1 m-70 -55.2 161.21 1.86 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 78' ' ' VAL . 1.8 t -149.14 128.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.885 ' CD1' HD22 ' A' ' 94' ' ' LEU . 46.9 m-85 -130.69 113.2 13.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -88.28 149.43 23.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.482 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -75.35 -176.83 3.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.26 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.89 0.21 13.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.193 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -113.74 -69.92 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' CA ' ' NE ' ' A' ' 71' ' ' ARG . . . -164.09 -22.61 0.02 OUTLIER Glycine 0 C--N 1.343 0.939 0 C-N-CA 119.408 -1.377 . . . . 0.0 115.957 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.672 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.18 123.4 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 118.823 1.311 . . . . 0.0 111.168 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.5 m -82.85 175.41 10.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.045 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -147.85 145.85 14.88 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.262 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 68' ' ' VAL . 3.8 t -124.4 153.33 30.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.759 0.79 . . . . 0.0 113.08 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.56 149.36 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.869 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.091 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -147.69 116.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.266 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.964 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.18 -173.53 3.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.786 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 10.6 t70 -80.87 157.44 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.167 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.74 -26.96 25.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HB2' ' CA ' ' A' ' 1' ' ' MET . 31.8 mm-40 -90.83 45.17 1.23 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.964 ' CD1' HG21 ' A' ' 81' ' ' THR . 22.8 t80 -134.75 84.34 39.0 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.046 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 35.0 Cg_exo -34.71 144.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.366 2.711 . . . . 0.0 113.546 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -78.46 -27.01 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.982 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -52.01 -54.54 39.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.486 -178.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.779 ' HA ' HG22 ' A' ' 92' ' ' THR . 10.8 Cg_exo -68.98 -31.16 24.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.811 1.674 . . . . 0.0 110.733 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -26.82 68.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.73 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.4 t80 -71.2 -49.09 47.29 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.351 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.779 HG22 ' HA ' ' A' ' 89' ' ' PRO . 4.3 t -63.7 -33.22 75.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 79' ' ' LEU . 5.0 tt -65.47 -37.8 87.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -68.95 -19.96 64.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.4 -61.66 1.88 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.958 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.34 -34.43 76.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.187 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 125' ' ' LEU . 9.7 tt -67.23 -59.2 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -59.25 -33.13 70.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 110.094 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.9 t70 -76.45 -30.31 57.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 22.6 tp10 -74.55 -37.81 62.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.435 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.772 ' OH ' HD22 ' A' ' 19' ' ' LEU . 28.1 t80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.357 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HA ' ' NE1' ' A' ' 110' ' ' TRP . 4.0 pp -76.73 -26.07 54.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.395 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 99' ' ' ASP . 3.2 t -73.91 -47.84 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.7 -24.83 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 111.302 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.514 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -161.35 133.26 4.14 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.316 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' A' ' 110' ' ' TRP . 74.3 Cg_exo -27.62 149.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.199 3.266 . . . . 0.0 114.26 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.35 -62.25 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.619 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -72.32 -27.52 62.49 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -46.47 -29.24 1.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.181 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.8 ' O ' ' N ' ' A' ' 112' ' ' ASP . 7.0 p-90 -110.15 -49.84 3.03 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.008 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.67 -68.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 110.483 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.8 ' N ' ' O ' ' A' ' 110' ' ' TRP . 12.3 m-20 -127.65 -25.87 3.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.393 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.764 HG12 ' H ' ' A' ' 115' ' ' GLU . 38.0 t 70.94 -62.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.717 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.461 ' CA ' HD11 ' A' ' 17' ' ' LEU . 1.5 p 66.68 -1.59 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.072 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.764 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.5 pt-20 -164.6 109.4 0.95 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.523 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 117' ' ' ASN . 4.5 m -130.39 171.74 12.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.636 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.544 ' H ' HG22 ' A' ' 116' ' ' THR . 1.9 m120 -115.29 72.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.785 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.5 p-10 -54.23 -16.9 2.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.895 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.87 -13.45 42.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.051 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.04 27.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.44 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 117' ' ' ASN . 4.9 tptt -117.08 138.18 51.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 1.8 mtp 67.21 60.78 0.49 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.846 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.14 -27.94 16.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.116 0.484 . . . . 0.0 110.142 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.08 -61.75 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.562 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.0 HD12 HD11 ' A' ' 97' ' ' ILE . 1.1 tt -45.33 -32.9 2.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 129' ' ' ILE . 23.1 m-20 -72.43 -58.27 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 2.6 m -57.87 -28.23 63.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.2 m-30 -69.29 -55.53 10.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.58 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -58.82 -24.68 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.666 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 t -75.39 -45.79 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.831 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.88 -25.96 29.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.378 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-85 -64.82 -13.14 54.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.492 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.977 ' HA ' HG22 ' A' ' 3' ' ' ILE . 33.0 mt-30 -33.27 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 132' ' ' TYR . 7.2 m-20 -73.2 162.63 73.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.206 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.57 -26.45 36.98 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 137' ' ' GLN . 2.0 m -150.55 -55.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' SER . 0.0 OUTLIER 82.67 -17.03 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.604 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 59.16 34.81 23.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.94 31.73 20.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.094 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.91 96.49 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.13 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.063 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -64.83 146.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' HB3' ' HE3' ' A' ' 40' ' ' MET . 9.6 m-85 -120.1 -25.76 5.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 2.6 t80 -157.16 152.08 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 112.436 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 3' ' ' ILE . 2.5 mt -149.49 168.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.317 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.96 -167.11 35.86 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 119.271 -1.442 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG13 ' CA ' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -154.12 130.09 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.075 -0.562 . . . . 0.0 110.118 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.752 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -152.76 125.29 8.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.112 0.482 . . . . 0.0 110.503 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' H ' ' CB ' ' A' ' 18' ' ' GLU . 1.3 tmt_? -70.73 147.91 48.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 m -62.94 86.1 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.159 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 -131.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.26 -117.13 2.33 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -26.35 12.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.07 -175.42 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.945 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 9' ' ' PHE . . . -87.71 132.74 34.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.964 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.31 113.39 6.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.546 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.748 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.7 mt-10 159.42 -171.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 122.221 1.01 . . . . 0.0 113.259 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.146 HD12 ' CZ ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER 36.44 -123.47 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.345 -1.752 . . . . 0.0 113.733 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' VAL . 5.5 p -131.68 174.54 10.02 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -147.85 123.22 10.31 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 126' ' ' ASP . 10.6 p -120.26 152.06 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.352 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -134.11 160.5 37.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.294 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -135.41 107.07 6.95 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.043 177.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 33' ' ' ARG . 10.9 mt -126.45 79.99 1.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.843 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -107.69 -44.17 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.625 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -71.96 -22.97 61.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.406 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.702 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.3 m-85 -85.83 127.16 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ARG . . . -56.25 -165.46 0.05 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.054 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -94.71 30.68 1.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -139.22 -47.37 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.867 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.0 pt-20 -86.04 -24.28 26.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.563 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -49.25 -42.25 40.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -60.93 -48.85 79.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.423 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -44.3 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.747 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -63.48 -47.63 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.28 -47.76 34.05 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.259 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 32.0 tp60 -61.84 -33.71 74.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.87 -43.81 91.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.454 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 14.1 mmt -60.81 -58.92 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.021 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -57.18 -59.81 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 11.4 t80 -41.45 -42.9 2.44 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.18 0.514 . . . . 0.0 110.792 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.799 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.73 -40.34 69.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.199 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -63.65 -43.33 97.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 19.0 pt-20 -66.24 -35.02 79.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.737 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -64.44 -54.32 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -47.66 -61.64 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.063 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.72 -29.77 54.28 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.788 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.494 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.774 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -87.22 -29.64 21.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.799 ' OG1' HG11 ' A' ' 68' ' ' VAL . 98.1 m -76.13 107.15 8.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.03 39.22 2.03 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.777 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.98 157.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.048 0.451 . . . . 0.0 111.721 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 14.17 76.93 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.265 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.5 162.12 37.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 111.636 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 16.5 ptt180 -109.45 147.54 32.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.285 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.6 mm-40 -131.08 118.63 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 0.0 112.342 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 22.5 p -108.38 101.86 11.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.66 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.71 106.58 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.392 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 108.79 21.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -114.98 172.59 6.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.68 55.12 2.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.276 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' ND2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 t30 -173.07 -45.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.34 -178.01 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 111.757 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 4.2 mt -108.25 157.22 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.114 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.39 75.58 0.4 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.845 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' N ' ' O ' ' A' ' 79' ' ' LEU . 98.2 m-70 -57.84 148.75 24.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.903 0.382 . . . . 0.0 111.311 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 78' ' ' VAL . 2.2 t -140.92 142.78 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.925 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 91' ' ' TYR . 26.0 m-85 -148.11 110.82 4.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.552 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -96.66 149.24 22.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.121 0.486 . . . . 0.0 111.959 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -67.1 -178.54 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.429 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -49.81 7.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.398 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 179.02 109.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.309 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . 145.21 -84.69 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.788 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.43 125.66 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.455 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 32.1 p -113.56 159.4 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.892 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.657 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -114.57 151.31 18.48 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.473 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 68' ' ' VAL . 9.0 t -120.74 148.97 23.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.4 0.619 . . . . 0.0 112.315 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.724 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -135.06 120.98 19.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.688 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.664 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -123.96 117.63 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.161 0.505 . . . . 0.0 111.935 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.94 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.78 -173.75 3.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.514 ' N ' ' OG1' ' A' ' 81' ' ' THR . 43.8 t0 -75.87 163.46 27.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 111.609 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -29.43 69.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.41 39.31 0.94 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.169 0.509 . . . . 0.0 110.229 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.94 ' CD1' HG21 ' A' ' 81' ' ' THR . 16.6 t80 -132.94 79.18 63.88 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 29.5 Cg_exo -31.91 150.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.835 3.024 . . . . 0.0 113.91 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.68 -28.19 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.95 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.629 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -52.63 -53.09 57.78 Favored Pre-proline 0 N--CA 1.463 0.187 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.072 -179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 8.1 Cg_exo -70.28 -29.64 21.1 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 110.551 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -67.08 -30.81 70.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.497 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 10.1 t80 -69.88 -44.09 70.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 m -61.99 -41.27 97.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.247 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.866 HD23 ' CE2' ' A' ' 132' ' ' TYR . 3.0 tm? -62.73 -53.04 60.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.702 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.52 -8.52 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -52.43 9.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -67.93 -35.64 78.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.985 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.598 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 7.7 tt -64.67 -53.81 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.889 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.0 OUTLIER -59.19 -41.37 88.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 -27.38 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.323 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.685 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 44.1 tp10 -69.27 -49.65 54.11 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.866 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 1.146 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 42.4 t80 -63.16 -29.0 70.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 98' ' ' LEU . 6.9 mp -74.06 -38.24 64.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.414 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.9 t -71.79 -49.25 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.0 -19.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 111.403 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.24 136.16 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.341 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 105' ' ' HIS . 5.8 Cg_exo -39.22 169.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.639 2.893 . . . . 0.0 113.737 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.74 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 7.6 tmtt? -55.31 -62.68 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.313 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.33 -26.76 68.91 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 3.3 tt0 -47.94 -33.25 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.432 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.802 ' O ' ' N ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -113.89 -51.17 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.685 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' O ' HG22 ' A' ' 75' ' ' ILE . . . 46.77 -66.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.739 0.649 . . . . 0.0 110.379 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.802 ' N ' ' O ' ' A' ' 110' ' ' TRP . 14.9 m-20 -153.29 63.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.124 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 101' ' ' TYR . 40.4 t -35.7 -32.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.366 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.633 ' C ' HD11 ' A' ' 17' ' ' LEU . 11.3 p 40.74 27.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.486 ' HG2' HG12 ' A' ' 113' ' ' VAL . 7.3 pt-20 -172.02 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.439 ' HB ' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.3 164.77 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.056 0.455 . . . . 0.0 110.939 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -156.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.3 -17.36 19.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.15 -53.89 51.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 111.374 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.44 -28.29 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 168.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.924 ' HB3' HD22 ' A' ' 125' ' ' LEU . 3.4 ttt -177.32 72.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.326 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -39.47 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.028 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -65.16 -75.63 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.782 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -48.64 -31.56 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.444 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.964 ' N ' HD23 ' A' ' 125' ' ' LEU . 1.5 p30 -79.36 -54.53 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.339 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 57.7 m -62.03 -28.07 69.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 110.559 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.767 ' HB3' HD21 ' A' ' 93' ' ' LEU . 2.6 m-85 -73.13 -50.57 21.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.785 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.23 -24.97 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 120.663 0.268 . . . . 0.0 111.613 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 t -77.32 -41.74 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -83.41 -27.07 29.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.866 ' CE2' HD23 ' A' ' 93' ' ' LEU . 4.4 m-85 -68.64 -11.72 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 1.063 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -39.31 -22.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -92.13 167.98 13.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 0.0 110.764 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 28.2 Cg_endo -61.15 -34.43 89.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.444 2.096 . . . . 0.0 111.963 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -176.63 77.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.651 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 4.3 mm-40 -47.92 -23.14 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.678 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 86.48 78.59 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.057 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.26 42.37 9.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.793 0.33 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -165.95 102.47 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 6' ' ' ILE . 10.7 tt -64.86 160.54 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.221 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 8.4 m-85 -119.92 -66.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -113.93 155.01 26.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.532 0.682 . . . . 0.0 112.013 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 93' ' ' LEU . 1.4 mt -155.2 166.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.564 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . 152.23 -163.37 30.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.3 OUTLIER -130.31 162.4 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.559 0.219 . . . . 0.0 110.54 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 22.6 m-85 -152.98 121.3 6.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 113' ' ' VAL . 2.5 tmm_? -79.32 126.25 30.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.107 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.63 98.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.08 -133.33 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.297 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.12 -106.03 2.37 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.81 -26.7 67.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -136.25 -171.56 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -99.87 153.06 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 5.6 tt -91.55 137.91 31.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.36 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.58 91.49 1.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.535 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -75.05 -84.74 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.905 ' HB3' HG23 ' A' ' 8' ' ' VAL . 28.9 t -108.25 138.35 44.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -131.66 111.97 12.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.361 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.7 p -128.57 134.03 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.735 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 165.23 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.603 0.716 . . . . 0.0 112.428 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.81 ' C ' HD23 ' A' ' 25' ' ' LEU . 3.5 t70 -136.87 107.07 6.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.795 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.81 HD23 ' C ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -115.5 74.77 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.655 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.44 -27.12 9.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.89 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -94.75 -23.35 17.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.739 0.304 . . . . 0.0 111.648 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HB2' ' HG3' ' A' ' 33' ' ' ARG . 1.1 m-85 -73.69 -162.59 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.888 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 31' ' ' PHE . . . -129.99 166.71 21.97 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.489 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -69.6 37.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 29' ' ' GLY . 4.5 p90 -156.08 -44.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 109.969 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.5 pt-20 -90.77 -18.91 24.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.6 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 45.1 mtp180 -47.54 -49.79 25.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 110.716 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.4 t -59.71 -49.67 76.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.55 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -45.64 80.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.783 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.0 t -62.86 -41.19 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.17 -47.59 54.92 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.398 -0.905 . . . . 0.0 111.349 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.47 -35.07 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -66.14 -40.0 90.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.418 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.744 ' HE3' HG12 ' A' ' 36' ' ' VAL . 4.5 mtm -60.25 -59.45 5.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' ALA . 7.6 m -61.33 -56.34 21.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.269 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 24.4 t80 -42.51 -43.59 3.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.88 -33.54 66.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.168 179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.858 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.77 -34.64 69.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.583 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.6 pt-20 -71.42 -40.3 70.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.783 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.31 -54.0 51.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.061 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.26 -62.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.218 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . . . -53.17 -30.18 35.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -71.1 -36.0 72.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.783 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -75.18 -30.19 60.61 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.832 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.1 m -80.19 106.51 12.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.002 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.97 3.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.479 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.99 143.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.238 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.31 -2.82 86.48 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.597 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 51' ' ' THR . 13.3 pt-20 -135.32 175.5 9.52 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -133.65 164.15 27.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.57 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.638 ' N ' HG12 ' A' ' 68' ' ' VAL . 14.5 mm100 -140.6 165.09 28.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.522 0.677 . . . . 0.0 112.048 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 p -151.31 101.96 2.88 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -93.29 105.1 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.409 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -99.06 108.54 21.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.561 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 9.5 tt0 -134.14 103.04 5.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.47 83.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.106 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 46.53 28.83 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.786 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.7 m-85 -130.25 166.02 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.523 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.724 HD11 ' HE2' ' A' ' 83' ' ' LYS . 7.9 mm -149.0 143.85 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.662 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -133.2 76.19 0.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.759 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.488 ' CE1' HG21 ' A' ' 65' ' ' ILE . 83.9 m-70 -55.62 159.9 2.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.22 0.534 . . . . 0.0 111.516 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.061 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.17 140.78 14.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.937 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -148.16 111.43 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.263 0.554 . . . . 0.0 110.83 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.76 145.97 38.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.7 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -119.27 -178.75 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.1 t -91.95 37.52 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' OE1' HD13 ' A' ' 102' ' ' LEU . 8.9 mm-40 -97.0 -52.39 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.617 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.47 -19.83 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.883 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.54 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -137.48 112.82 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.523 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.565 ' O ' HG12 ' A' ' 8' ' ' VAL . 30.2 p -84.83 166.69 16.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.774 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -128.03 155.11 20.12 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.388 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 68' ' ' VAL . 61.6 t -125.23 146.55 30.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.44 0.638 . . . . 0.0 112.184 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.85 119.19 17.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.736 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.698 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -111.39 118.87 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.042 0.448 . . . . 0.0 111.693 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.582 HG21 ' CD2' ' A' ' 85' ' ' TYR . 2.0 t -132.53 -172.2 2.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.9 t70 -82.43 173.43 12.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HE2' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -62.51 -19.87 64.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.504 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.07 38.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -134.2 108.37 11.41 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.385 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 90.7 Cg_endo -78.15 158.47 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.136 1.891 . . . . 0.0 112.221 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -67.4 -38.15 80.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' CG ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -38.84 -60.27 1.17 Allowed Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 41.0 Cg_endo -67.27 -28.07 40.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.929 1.753 . . . . 0.0 111.569 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -30.12 69.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 3.5 t80 -69.81 -43.33 72.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -62.5 -44.82 95.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.646 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 6' ' ' ILE . 19.1 tp -62.85 -54.83 32.74 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.215 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD23 ' CG ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -64.7 -10.01 24.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.349 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -61.49 1.93 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.264 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.98 -45.89 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.441 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.675 HG21 HD22 ' A' ' 94' ' ' LEU . 5.2 tt -54.18 -50.9 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 ' CD1' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -51.59 -53.89 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.7 69.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.583 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 1.1 tm-20 -73.9 -35.25 64.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 12.8 t80 -67.22 -32.43 73.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -76.5 -33.27 58.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.41 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.19 -49.42 76.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.477 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -19.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.567 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -176.72 129.03 0.34 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.621 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.474 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 84.2 Cg_exo -33.48 154.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.218 2.612 . . . . 0.0 113.091 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 62.5 mttt -43.07 -62.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -60.94 -27.83 68.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 2.4 mm-40 -49.22 -40.67 34.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.663 0.268 . . . . 0.0 111.629 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.575 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 9.1 p-90 -96.06 -36.36 11.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.575 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 12.25 60.4 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.977 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' HB3' ' HD3' ' A' ' 10' ' ' ARG . 1.7 m-20 70.56 74.59 0.2 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.47 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.687 HG12 ' H ' ' A' ' 115' ' ' GLU . 2.7 t -65.95 133.92 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.671 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.3 t -97.81 16.48 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.687 ' H ' HG12 ' A' ' 113' ' ' VAL . 13.1 pt-20 -177.67 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 119' ' ' ALA . 4.9 t -53.64 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.76 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 177.73 -68.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.043 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.31 -33.55 59.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.384 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -60.85 -41.76 96.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.79 -23.97 33.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.501 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 32.56 5.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.583 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -77.14 81.4 3.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.413 . . . . 0.0 110.73 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -27.07 3.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.728 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -57.39 -73.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.642 HD21 ' OG ' ' A' ' 20' ' ' SER . 4.0 pp -55.31 -30.09 59.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.662 ' HA ' HG21 ' A' ' 22' ' ' VAL . 24.1 m-20 -63.65 -56.37 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 90.0 m -63.35 -29.75 71.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -68.47 -39.05 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.727 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.62 -24.84 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.571 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.5 t -72.12 -42.89 65.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -83.09 -22.35 33.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.469 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 1.1 m-85 -65.17 -14.46 60.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.89 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 59.18 0.58 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.237 0.542 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.525 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.8 OUTLIER -176.3 175.59 0.64 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -51.81 -25.63 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.115 1.877 . . . . 0.0 111.69 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.6 m -177.11 -65.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 81.06 -22.82 0.25 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.817 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 63.27 30.88 15.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.183 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.2 t0 57.97 31.61 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.156 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' CB ' ' HB2' ' A' ' 84' ' ' GLN . 1.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.815 0.34 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.91 129.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.923 HD11 HG13 ' A' ' 6' ' ' ILE . 7.4 tt -64.8 147.57 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.466 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' ASP . 60.2 m-85 -116.78 -41.05 3.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.2 t80 -149.16 153.62 37.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.613 0.721 . . . . 0.0 112.515 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.923 HG13 HD11 ' A' ' 3' ' ' ILE . 1.2 mt -146.64 165.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.252 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 160.01 -163.93 34.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.973 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -145.37 149.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.786 0.327 . . . . 0.0 111.299 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -160.35 120.56 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -87.25 138.65 31.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.325 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.6 103.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 69.1 0.56 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.739 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 57.79 -91.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.7 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -39.21 68.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.0 111.0 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -177.24 -175.31 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.644 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 9' ' ' PHE . . . -62.87 152.82 35.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -105.0 17.97 23.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.93 0.395 . . . . 0.0 111.261 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 43.25 92.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.103 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 75' ' ' ILE . 93.6 mt -74.27 -76.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.921 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 10.1 p -123.92 143.79 50.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.259 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 tt0 -126.54 113.14 16.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.5 p -123.9 134.82 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.45 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.67 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.725 0.774 . . . . 0.0 112.769 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' TYR . 29.4 t70 -144.23 107.36 4.53 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.613 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.0 mm? -112.28 75.94 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -63.31 -80.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.09 -16.48 57.96 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.819 0.342 . . . . 0.0 111.638 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.745 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -71.58 102.0 2.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.513 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -54.23 -170.19 0.05 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.954 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 42.7 p90 -61.85 -48.16 81.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.933 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 30' ' ' PHE . 55.1 p90 -66.34 -44.45 83.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.544 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -70.2 -31.63 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.481 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.483 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -58.36 -34.03 70.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.458 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -75.14 -51.04 14.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -56.29 16.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -61.05 -41.88 90.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.51 -50.49 41.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.54 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -62.86 -32.62 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -67.08 -38.92 86.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.121 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CG ' ' A' ' 5' ' ' TYR . 12.0 mmt -60.79 -59.63 5.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.06 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -61.49 -59.48 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.184 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 12.6 t80 -38.53 -47.42 1.29 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.158 0.504 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -68.11 -38.08 81.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.884 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -52.18 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.343 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 16.2 pt-20 -53.37 -39.47 64.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -60.29 -56.01 26.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.702 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.71 -62.3 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.176 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 9' ' ' PHE . . . -51.49 -30.07 18.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -69.05 -46.95 66.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.497 177.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -72.15 -26.67 62.19 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.296 179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.835 ' OG1' HG11 ' A' ' 68' ' ' VAL . 93.0 m -75.67 107.11 7.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 38.94 2.41 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.461 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.87 137.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.511 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.34 85.63 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -128.97 155.76 44.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.398 . . . . 0.0 111.169 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 68' ' ' VAL . 7.0 mtm-85 -107.78 156.61 18.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.686 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 17.1 mm-40 -140.49 141.07 35.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 111.912 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.67 102.84 6.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.76 104.71 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.014 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.26 108.85 18.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.229 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 172.92 7.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.379 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.78 -29.55 0.82 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.828 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.98 29.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -143.96 169.82 17.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.256 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 3.9 mt -138.32 146.18 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.638 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -128.42 75.58 0.42 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.769 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.504 ' NE2' HG21 ' A' ' 65' ' ' ILE . 90.2 m-70 -56.26 159.8 3.33 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.96 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.37 136.79 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.445 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.765 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -138.26 111.57 8.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.068 0.461 . . . . 0.0 110.597 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.63 154.0 21.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.446 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -178.49 3.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.718 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.9 p -94.17 30.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.97 -32.68 6.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.989 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.14 -22.44 5.36 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.591 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.021 HG13 HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -109.77 125.69 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 23.8 p -120.39 166.06 14.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.558 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -123.15 161.49 17.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.043 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 47' ' ' VAL . 23.6 t -118.89 146.84 22.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.302 0.572 . . . . 0.0 112.122 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -134.06 100.58 4.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.38 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.638 ' CG2' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -99.94 128.9 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.85 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -155.44 -176.22 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.925 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 81' ' ' THR . 13.0 t70 -69.82 169.68 12.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 65' ' ' ILE . 21.1 pttm -66.67 -17.55 64.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.188 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 1' ' ' MET . 13.9 mm100 -92.35 29.99 1.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 110.639 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.76 ' CG ' HG21 ' A' ' 81' ' ' THR . 5.6 t80 -122.52 70.05 34.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -37.99 159.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.281 2.654 . . . . 0.0 113.454 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 91' ' ' TYR . 3.5 t -73.61 -26.18 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.55 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -56.54 -56.02 36.56 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.129 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 57.0 Cg_endo -69.42 -36.22 12.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.781 1.654 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.32 -26.97 67.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 1.6 t80 -73.24 -38.39 66.04 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -66.33 -42.06 88.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.237 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 79' ' ' LEU . 4.5 tt -68.17 -45.54 73.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.632 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 79' ' ' LEU . 7.1 mt -68.96 -13.13 62.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.864 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.77 -56.26 4.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.259 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' GLU . 2.8 mptp? -62.63 -40.13 96.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.563 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 125' ' ' LEU . 15.7 tt -60.0 -58.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD11 ' O ' ' A' ' 69' ' ' TYR . 17.0 mt -58.31 -43.87 88.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.899 0.381 . . . . 0.0 110.247 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.33 -27.66 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 15.9 tp10 -78.37 -30.52 48.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.575 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.88 ' CE2' HD13 ' A' ' 19' ' ' LEU . 2.5 t80 -65.15 -31.97 73.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.767 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -76.92 -31.83 56.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.897 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 105' ' ' HIS . 16.0 t -74.71 -52.18 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.84 -21.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.146 0.498 . . . . 0.0 110.835 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -172.22 131.18 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.785 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -32.25 155.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.555 2.837 . . . . 0.0 113.854 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -48.66 -62.19 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.63 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -27.01 68.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.4 tt0 -44.14 -46.78 8.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 111.035 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.767 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -89.64 -57.18 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.253 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 41.09 50.71 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 10' ' ' ARG . 34.5 m-20 97.96 -28.01 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.408 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.835 HG12 ' H ' ' A' ' 115' ' ' GLU . 43.3 t 69.63 -64.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.903 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.553 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.2 p 74.99 -8.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.666 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.835 ' H ' HG12 ' A' ' 113' ' ' VAL . 3.9 pt-20 -158.91 103.79 1.71 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 17' ' ' LEU . 1.7 m -124.54 170.19 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 112.558 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' H ' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -120.61 86.59 2.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.526 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.921 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 4.5 m-20 -50.93 -15.69 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.313 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 120' ' ' LEU . . . -64.4 -43.91 92.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.94 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 119' ' ' ALA . 1.9 mp -153.39 47.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.357 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HG2' HG21 ' A' ' 116' ' ' THR . 0.3 OUTLIER -82.91 -19.85 36.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.167 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.625 ' HE1' ' CG1' ' A' ' 97' ' ' ILE . 1.9 mtp -162.26 78.56 0.51 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 111.795 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -24.4 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.004 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.12 -73.62 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.879 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.83 HD21 ' OG ' ' A' ' 20' ' ' SER . 2.5 pp -48.59 -36.32 15.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.885 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.4 m-20 -58.87 -43.74 90.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.5 . . . . 0.0 110.071 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 22.4 m -68.03 -28.05 67.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.783 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -58.31 4.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -57.34 -33.98 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.046 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -50.51 60.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -75.59 -25.77 57.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -58.89 -55.22 37.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.5 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.5 mt-30 13.82 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.231 0.612 . . . . 0.0 112.599 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.9 OUTLIER 169.75 171.76 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.606 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 59.7 Cg_endo -69.69 -41.39 4.4 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.483 2.122 . . . . 0.0 111.982 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m -166.37 72.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 4.6 mm-40 -47.29 -24.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.755 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 80.5 44.48 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.009 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t70 64.48 39.06 7.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.098 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 1.1 mpt_? 53.81 26.72 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.31 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.732 HD11 HG13 ' A' ' 6' ' ' ILE . 3.4 tt 166.69 126.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.85 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.9 m-30 -103.97 -37.25 7.46 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.1 t80 -154.03 161.89 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.514 0.673 . . . . 0.0 112.234 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 3' ' ' ILE . 1.4 mt -154.4 164.65 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.744 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 1.034 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.14 -172.2 35.19 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.953 -1.118 . . . . 0.0 112.823 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.7 OUTLIER -132.87 153.88 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -153.89 138.84 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 111.561 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -86.47 140.06 30.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.69 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -64.54 81.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.155 0.502 . . . . 0.0 111.056 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.16 -154.73 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.421 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.67 -81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -77.4 -23.45 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.614 0.245 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -177.34 5.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.83 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -94.25 127.22 39.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.068 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.9 tt -66.91 122.25 17.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.462 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.13 98.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.547 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 60.9 mt -82.76 -43.41 16.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 110.633 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 t -147.78 130.17 15.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.613 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -123.52 112.24 17.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.5 p -129.77 132.8 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.24 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.55 163.05 19.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.549 0.69 . . . . 0.0 112.646 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.21 107.11 7.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.3 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.739 HD21 ' HE3' ' A' ' 40' ' ' MET . 18.3 mt -124.28 79.34 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -58.34 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.16 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -84.33 -53.24 5.61 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -32.89 114.15 0.16 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.564 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.44 -173.35 0.07 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.955 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 31' ' ' PHE . 50.7 p90 -63.11 -50.6 69.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.293 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 30' ' ' PHE . 44.3 p90 -68.82 -42.08 77.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.89 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.1 tt0 -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.124 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.698 ' HG2' HD13 ' A' ' 25' ' ' LEU . 2.0 mtt180 -47.89 -36.85 12.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.796 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -72.54 -57.66 3.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -55.05 -52.55 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.6 t -57.31 -46.17 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.93 -51.23 19.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.853 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.55 -34.75 73.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -44.93 90.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.739 ' HE3' HD21 ' A' ' 25' ' ' LEU . 14.3 mtm -58.9 -53.78 54.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.697 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -61.24 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.796 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 3.2 t80 -41.47 -44.98 3.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.061 0.457 . . . . 0.0 111.323 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.826 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.32 -38.81 71.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.603 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -66.5 -37.33 84.84 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -70.71 -33.69 71.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 50' ' ' ARG . 6.0 m -65.37 -56.71 11.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.791 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.41 -61.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.098 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.93 -29.67 56.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 31.6 t -79.02 -29.23 43.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.925 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 ptm180 -90.17 -30.36 17.66 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.67 ' OG1' HG11 ' A' ' 68' ' ' VAL . 70.9 m -76.45 107.12 8.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.05 40.31 2.31 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.782 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.74 159.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 111.693 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 14.59 79.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -162.1 152.73 17.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.13 146.59 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.97 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -134.2 130.39 37.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.493 0.664 . . . . 0.0 112.413 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 22.9 p -123.9 103.56 8.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.698 HD13 HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.67 125.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.576 0.703 . . . . 0.0 111.307 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -106.85 109.6 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 42.9 tt0 -115.53 165.98 12.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.307 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 61' ' ' GLU . . . -71.86 54.71 1.35 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.218 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 10.6 m-80 -171.87 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 110.763 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 6.1 p90 -167.16 -179.07 4.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.923 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.1 mt -108.29 160.01 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -139.01 89.86 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.25 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.762 ' CE1' HG22 ' A' ' 87' ' ' VAL . 80.0 m-70 -64.44 161.71 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.2 0.524 . . . . 0.0 111.838 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.942 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.5 t -152.03 143.09 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.718 ' OH ' HG12 ' A' ' 87' ' ' VAL . 55.0 m-85 -148.59 110.84 4.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.94 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.04 155.19 23.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.34 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 98' ' ' LEU . 8.1 mtt180 -116.22 169.85 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.611 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 m -92.71 37.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 0.8 OUTLIER -109.57 -57.1 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.089 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.15 -37.04 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.823 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.93 142.89 36.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.331 0.565 . . . . 0.0 111.119 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' CB ' ' CB ' ' A' ' 70' ' ' ALA . 30.4 p -117.02 148.33 41.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.7 144.5 16.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.814 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.942 ' CG2' HG22 ' A' ' 68' ' ' VAL . 1.4 t -121.18 148.17 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.926 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.835 HD11 ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -134.88 144.08 47.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.213 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.788 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -133.47 123.99 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 0.0 111.538 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.036 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -151.51 171.87 16.88 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.46 173.12 4.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 111.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -70.95 -18.43 62.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -88.23 25.15 1.69 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.705 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.036 ' CD1' HG21 ' A' ' 81' ' ' THR . 51.9 t80 -134.25 75.77 64.44 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -34.81 155.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.86 3.04 . . . . 0.0 113.476 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.762 HG22 ' CE1' ' A' ' 67' ' ' HIS . 21.4 t -75.08 -26.74 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.728 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 7.3 mtp180 -44.99 -56.81 8.18 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.541 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.3 Cg_endo -66.43 -22.18 52.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.609 1.539 . . . . 0.0 111.065 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -70.28 -31.52 68.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 4.5 t80 -67.41 -48.47 67.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -62.81 -43.78 97.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.183 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 tt -61.25 -62.23 1.99 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -64.08 -9.05 14.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.287 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -72.83 -61.29 1.86 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.319 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -62.76 -43.82 97.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 125' ' ' LEU . 5.8 tt -53.12 -54.24 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.648 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.69 -43.86 85.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -27.89 69.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.645 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -80.22 -27.72 38.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.831 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.742 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -69.9 -30.33 67.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.119 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.801 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -76.09 -27.6 57.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.1 t -71.52 -50.18 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.35 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 118' ' ' ASP . . . -46.18 -20.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.019 0.437 . . . . 0.0 110.998 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.97 131.2 0.52 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.023 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 79.0 Cg_exo -30.29 152.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.843 3.029 . . . . 0.0 114.005 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.94 -62.46 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.52 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.82 -27.26 61.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 9.2 tt0 -41.67 -41.57 2.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.763 0.316 . . . . 0.0 111.34 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.801 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -91.35 -60.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.52 28.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 2.6 m-20 135.62 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.232 1.013 . . . . 0.0 108.851 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.745 HG12 ' H ' ' A' ' 115' ' ' GLU . 37.9 t 79.68 -63.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.175 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.4 p 69.7 -4.15 1.49 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.745 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.1 pt-20 -163.6 70.78 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.593 ' CG2' HD12 ' A' ' 120' ' ' LEU . 1.6 t -46.82 166.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.267 0.556 . . . . 0.0 111.907 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -173.96 -55.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.02 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 5.0 m-20 -76.69 -42.94 39.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.279 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . . . -62.32 -35.01 77.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.632 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.4 -25.85 67.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.94 23.86 12.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.645 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.14 83.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.5 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -47.03 -34.62 5.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.58 -65.24 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.578 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.034 HD11 ' HA2' ' A' ' 7' ' ' GLY . 1.1 tt -45.37 -35.1 3.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.517 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.6 m-20 -76.26 -41.52 48.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.071 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 56.1 m -66.26 -27.13 67.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.604 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -75.08 -60.84 2.11 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.017 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.95 -24.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.982 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -46.48 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.17 -29.51 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.448 . . . . 0.0 110.677 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' CD2' HD12 ' A' ' 93' ' ' LEU . 5.5 m-85 -68.45 -11.29 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.112 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -40.47 -18.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -93.45 167.72 13.43 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.691 0.281 . . . . 0.0 110.753 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 46.4 Cg_endo -65.96 -34.17 39.55 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m -166.42 72.4 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -44.09 -28.14 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.979 0.419 . . . . 0.0 110.566 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 77.14 33.37 0.43 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.14 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 60.49 31.4 20.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.11 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -156.87 -178.31 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.766 HD11 HG13 ' A' ' 6' ' ' ILE . 9.3 tt -65.57 140.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.141 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ASP . 19.7 m-85 -117.37 -28.29 6.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.886 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 7.4 t80 -146.04 153.71 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.678 0.752 . . . . 0.0 112.243 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.907 HD11 HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -150.66 163.69 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.854 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.946 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 164.99 -164.52 37.12 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.573 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.3 OUTLIER -149.34 149.39 14.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -151.38 130.77 12.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.671 HH11 HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -90.03 122.01 32.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.509 177.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.98 94.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.99 -83.06 0.53 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.464 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.06 -91.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.341 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -25.96 64.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.01 -177.02 5.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -96.91 131.89 43.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -63.81 142.3 58.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.411 179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 17' ' ' LEU . 48.7 mt-10 -73.54 62.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.817 0.341 . . . . 0.0 110.644 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 101' ' ' TYR . 5.7 tp -48.95 -36.85 18.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.481 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -170.87 133.45 0.93 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.828 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.9 113.22 13.19 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.5 p -121.11 137.75 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.48 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -116.74 162.5 17.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 0.0 112.746 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.4 107.17 6.6 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.652 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.709 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.8 mm? -106.21 69.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -60.7 -76.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.485 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -92.69 -19.01 22.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.373 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HD2' HG21 ' A' ' 36' ' ' VAL . 5.1 m-85 -58.41 105.98 0.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.28 -173.29 0.07 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.033 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -67.16 -32.19 73.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -86.74 -28.55 22.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -76.42 -42.34 44.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.841 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.0 ptt180 -50.64 -41.36 55.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.376 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -60.24 -58.49 8.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.1 m -61.37 -54.31 45.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.26 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.6 t -57.81 -48.84 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.62 -55.24 9.68 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.916 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -59.61 -28.89 67.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -69.52 -41.21 76.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.402 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.532 ' CE ' HG12 ' A' ' 36' ' ' VAL . 40.8 mtt -63.2 -59.5 4.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.362 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 44' ' ' ALA . 53.1 m -55.09 -59.7 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 15.0 t80 -44.17 -42.22 6.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.179 0.514 . . . . 0.0 110.683 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.823 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -72.86 -31.72 64.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.421 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.63 -37.83 62.69 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.5 pt-20 -67.64 -39.56 84.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -60.08 -54.58 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.798 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -46.66 -62.27 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.92 -30.09 22.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -40.22 71.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.4 -30.16 64.4 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.861 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.879 ' OG1' HG11 ' A' ' 68' ' ' VAL . 5.5 m -81.37 106.26 13.2 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.541 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.23 41.45 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.09 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.07 141.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.597 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 0.57 88.04 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -136.85 164.31 28.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.37 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.2 ptt-85 -119.93 158.72 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 68' ' ' VAL . 35.6 mm-40 -141.28 145.29 35.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 112.257 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 t -132.13 101.42 5.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.686 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.82 104.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.717 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -92.64 108.76 20.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.81 172.3 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.273 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.09 -5.93 36.13 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.783 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -111.33 -41.56 4.11 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.914 0.357 . . . . 0.0 111.948 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -167.48 -174.74 2.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.196 0.522 . . . . 0.0 112.353 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 mt -107.78 159.35 7.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.674 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -137.13 89.33 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.828 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 78.5 m-70 -64.5 159.05 22.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -153.38 140.75 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.176 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.725 ' OH ' HG12 ' A' ' 87' ' ' VAL . 60.4 m-85 -148.77 111.27 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.131 0.491 . . . . 0.0 110.378 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -99.54 153.46 19.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.434 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -102.39 -179.01 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -61.93 -27.42 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 -169.04 2.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 3.87 76.3 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.334 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.87 115.58 49.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.019 0.41 . . . . 0.0 110.547 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 48' ' ' ALA . 31.8 p -117.1 163.25 16.54 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.49 152.13 17.55 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.023 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 68' ' ' VAL . 73.6 t -124.57 142.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 117.288 0.544 . . . . 0.0 111.837 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.15 109.13 8.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.354 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.75 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -100.79 121.15 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.963 0.411 . . . . 0.0 111.237 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.789 HG21 ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -137.51 -172.98 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.024 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' N ' ' OG1' ' A' ' 81' ' ' THR . 7.6 t70 -83.47 168.82 16.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.382 . . . . 0.0 111.221 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.39 -19.49 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -88.24 37.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.034 0.445 . . . . 0.0 110.714 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.789 ' CD2' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -132.18 84.85 51.41 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.83 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 6.4 Cg_endo -48.78 153.61 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.725 HG12 ' OH ' ' A' ' 69' ' ' TYR . 9.1 t -67.74 -26.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.33 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -58.07 -58.27 19.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.556 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 43.0 Cg_endo -66.73 -26.97 45.1 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 121.656 1.57 . . . . 0.0 111.347 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . . . -66.94 -32.19 73.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 22.3 t80 -69.33 -44.9 70.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 25.4 m -63.04 -38.99 93.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.118 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 HD11 ' A' ' 6' ' ' ILE . 3.1 tt -62.19 -59.78 4.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -67.37 -8.71 34.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.273 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 22.1 t-20 -76.72 -57.0 4.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.486 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -64.06 -40.39 96.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.989 HD11 ' CD1' ' A' ' 125' ' ' LEU . 7.1 tt -59.65 -55.5 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.744 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.602 ' N ' HG23 ' A' ' 97' ' ' ILE . 7.1 mt -54.38 -48.46 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.225 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.5 -27.72 68.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 16.0 tp10 -77.56 -27.83 51.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 39.5 t80 -70.58 -31.91 69.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.664 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -71.61 -33.68 69.2 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.26 -48.2 89.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.19 -19.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.57 129.83 0.4 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.719 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -28.55 148.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.981 3.12 . . . . 0.0 113.95 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.549 ' O ' ' CE2' ' A' ' 110' ' ' TRP . 11.6 tttm -45.39 -50.59 12.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.405 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.0 -27.35 48.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.506 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 17.3 tt0 -48.57 -49.47 36.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.31 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.664 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 4.1 p-90 -76.58 -50.77 13.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 34.35 44.56 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.992 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 71.4 m-20 108.78 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.101 0.961 . . . . 0.0 110.771 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG11 ' OG1' ' A' ' 116' ' ' THR . 24.5 t 71.35 -57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.465 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.671 HG23 HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER 57.79 11.57 1.4 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.083 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -165.5 91.58 0.51 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.358 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.65 ' OG1' HG11 ' A' ' 113' ' ' VAL . 2.1 m -138.34 172.79 12.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.319 0.581 . . . . 0.0 111.947 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.618 ' H ' HG22 ' A' ' 116' ' ' THR . 14.0 p30 -164.59 98.25 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.037 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.86 ' OD2' HD22 ' A' ' 125' ' ' LEU . 3.7 t0 -46.71 -22.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.442 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.81 -21.34 19.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.49 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.41 -2.06 8.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.816 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -153.22 171.53 18.37 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.196 0.522 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.726 ' HE2' HG12 ' A' ' 97' ' ' ILE . 7.1 tpt 63.02 37.51 11.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.929 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -50.53 -28.16 8.01 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 1.9 mp0 -59.73 -62.07 2.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.497 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.989 ' CD1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -44.6 -36.81 3.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.06 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.552 ' N ' HD23 ' A' ' 125' ' ' LEU . 31.2 m-20 -68.88 -49.4 58.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.867 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 28.7 m -67.04 -28.31 68.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 2.1 m-85 -66.91 -55.23 15.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.665 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.13 -28.37 44.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.174 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -58.99 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.386 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -73.47 -22.24 60.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.897 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.695 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.6 m-85 -63.61 -14.08 48.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.385 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.0 mm-40 -71.31 57.01 0.24 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.093 0.473 . . . . 0.0 110.7 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -170.82 164.44 5.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.76 -39.44 26.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.689 2.259 . . . . 0.0 112.544 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.45 -32.47 70.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 2.9 mt-30 53.98 24.74 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 57.4 68.64 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.257 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.69 57.92 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.999 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.749 0.309 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 66.31 175.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 133' ' ' GLN . 5.1 tt -89.12 162.91 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 36.3 m-85 -133.14 -32.17 1.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.678 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 4.3 t80 -154.22 157.12 38.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.476 0.655 . . . . 0.0 111.849 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.84 HD11 HD21 ' A' ' 79' ' ' LEU . 1.5 mt -154.3 164.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.916 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 155.67 -169.55 33.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.057 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.872 HG23 ' OG ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -134.28 153.24 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.499 -179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.748 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -155.83 120.92 4.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -78.58 134.79 37.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.141 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 96.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . -78.65 -145.12 2.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.437 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 -83.46 1.57 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.412 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -67.67 -27.3 66.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -158.65 -176.3 5.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.73 131.12 35.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.338 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HG3' ' A' ' 10' ' ' ARG . 2.1 tt -83.03 119.92 25.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.32 104.83 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.985 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HG ' ' OH ' ' A' ' 101' ' ' TYR . 1.1 mp -82.77 -43.19 17.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.872 ' OG ' HG23 ' A' ' 8' ' ' VAL . 12.9 p -154.82 149.79 26.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.265 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -141.96 113.36 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.0 p -120.41 132.5 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.777 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 166.08 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.833 0.825 . . . . 0.0 113.141 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD2' HD13 ' A' ' 129' ' ' ILE . 3.9 m-20 -143.78 107.05 4.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.577 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -105.49 70.61 0.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.709 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -95.22 -23.5 17.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.4 OUTLIER -62.89 116.01 4.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.391 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 32' ' ' GLU . . . -83.85 -145.78 6.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.759 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.532 . . . . 0.0 112.132 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.51 -25.3 66.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.13 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.2 tt0 -73.69 -37.35 65.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 0.0 110.235 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG ' ' A' ' 25' ' ' LEU . 11.7 ttm180 -59.07 -50.99 71.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 1.1 t -62.51 -56.0 22.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.896 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.85 -56.36 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' GLU . 13.7 t -64.34 -40.13 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.992 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.31 -47.4 56.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.367 -0.921 . . . . 0.0 111.435 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' SER . 1.8 mt-30 -63.65 -39.54 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 40.1 t80 -59.85 -38.76 83.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.79 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.497 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.2 mmt -64.91 -59.2 4.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.003 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.9 m -60.41 -57.98 10.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.065 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 6.7 t80 -44.69 -43.03 8.08 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.693 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.887 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -75.68 -29.93 59.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.028 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.94 -34.34 66.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.072 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.0 pt-20 -73.12 -40.11 65.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.85 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -58.34 -53.78 54.4 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.56 -61.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.847 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.68 -29.89 19.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.13 -38.71 66.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.284 178.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.85 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -72.92 -33.31 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.6 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.987 ' OG1' HG11 ' A' ' 68' ' ' VAL . 27.4 m -81.07 106.26 12.93 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.38 41.3 2.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.343 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.02 147.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 111.395 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.84 86.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.13 -177.86 5.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 1.3 ptt85 -137.08 157.29 47.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 14.4 mm100 -133.51 164.45 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.345 0.593 . . . . 0.0 111.441 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.1 101.8 2.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 HG13 ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -91.9 104.52 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.826 -178.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 117.66 29.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.54 172.85 6.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -44.56 -28.24 1.51 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.719 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.8 t30 -161.26 35.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.605 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 48.9 m-85 -152.11 172.5 16.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.16 0.505 . . . . 0.0 111.325 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 80' ' ' ILE . 9.3 mt -144.73 155.55 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.335 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.657 ' HA2' ' CG2' ' A' ' 80' ' ' ILE . . . -140.61 72.53 0.41 Allowed Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 65' ' ' ILE . 88.7 m-70 -55.58 161.13 2.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 110.558 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.987 HG11 ' OG1' ' A' ' 51' ' ' THR . 1.8 t -152.23 141.0 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 94' ' ' LEU . 1.7 m-85 -148.2 114.64 5.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.692 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -111.44 147.32 35.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -103.37 157.71 16.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 p -58.7 -19.29 38.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 63.8 mm-40 -49.56 -78.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.449 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.1 -27.36 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.913 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -108.36 115.37 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 110.351 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 27.5 p -92.3 161.85 14.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.122 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 8' ' ' VAL . . . -126.9 152.03 18.44 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 70.9 t -116.44 145.16 22.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.749 0.785 . . . . 0.0 112.332 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 94' ' ' LEU . 1.1 tt -129.25 106.7 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.611 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.723 ' CD1' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -100.6 124.98 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.837 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 85' ' ' TYR . 15.8 p -129.77 -173.66 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.811 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -97.48 160.6 14.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HA ' HG13 ' A' ' 65' ' ' ILE . 3.1 pttp -49.01 -26.28 2.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -98.83 57.16 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.017 0.436 . . . . 0.0 110.914 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.686 ' CD1' HG21 ' A' ' 81' ' ' THR . 2.6 t80 -152.47 94.4 3.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.13 144.13 23.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.665 2.244 . . . . 0.0 112.828 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 8.9 p -77.11 -26.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.469 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 1.4 mtt85 -45.63 -55.22 12.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.384 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 50.2 Cg_endo -67.93 -26.35 37.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.588 1.525 . . . . 0.0 110.759 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 79' ' ' LEU . . . -71.58 -26.88 62.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.517 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 t80 -72.91 -38.87 66.74 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.32 -47.14 77.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.407 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.678 HD21 HD13 ' A' ' 6' ' ' ILE . 3.0 tp -66.33 -46.8 75.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.934 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 79' ' ' LEU . 12.1 mt -62.65 -17.62 60.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.947 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -77.24 -56.79 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.095 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 2.0 mttp -62.34 -43.47 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 98' ' ' LEU . 11.4 tt -56.29 -55.39 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mm? -54.13 -42.3 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.073 0.464 . . . . 0.0 110.584 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 103' ' ' VAL . 31.7 t0 -75.37 -27.48 59.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.281 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.751 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 5.6 tm-20 -78.52 -30.37 47.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.614 ' OH ' ' HG ' ' A' ' 19' ' ' LEU . 51.5 t80 -72.35 -43.04 64.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 99' ' ' ASP . 4.0 pp -71.86 -25.88 62.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.2 t -71.79 -48.55 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -43.01 -24.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.945 0.402 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -161.1 133.81 4.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.446 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 105' ' ' HIS . 91.6 Cg_exo -26.49 151.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.289 3.326 . . . . 0.0 114.313 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -48.94 -62.41 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.539 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.61 -27.47 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 3.0 tt0 -42.86 -40.02 2.75 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 111.226 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.6 p-90 -97.5 -54.52 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 38.45 35.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 62.1 m-20 118.75 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.137 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 HG23 ' A' ' 116' ' ' THR . 17.6 t 76.14 -62.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.06 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.582 HG22 ' NH1' ' A' ' 10' ' ' ARG . 2.5 p 63.89 6.61 2.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.9 pt-20 -154.42 56.24 0.7 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 111.309 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.587 HG23 HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -126.99 -173.06 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 111.101 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 167.92 -165.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.895 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.5 -16.21 3.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.3 -53.19 60.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 116' ' ' THR . 3.2 tp -47.43 -30.05 3.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.023 0.44 . . . . 0.0 110.394 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt 58.29 168.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.264 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.751 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.7 OUTLIER -179.56 88.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -46.68 -27.33 1.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.031 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -66.1 -73.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 97' ' ' ILE . 1.9 pp -53.84 -30.93 47.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.321 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.56 ' HA ' HG21 ' A' ' 22' ' ' VAL . 9.6 m-20 -76.65 -57.47 3.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.094 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 64.1 m -61.69 -28.73 69.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.734 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 93' ' ' LEU . 2.0 m-85 -69.87 -55.58 9.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.339 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -59.81 -24.57 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -73.04 -48.54 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -82.65 -24.53 33.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.252 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 93' ' ' LEU . 2.0 m-85 -67.59 -11.75 58.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.836 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.924 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 mm100 -46.43 -12.92 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 23.6 t0 89.62 39.71 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 122.881 0.472 . . . . 0.0 112.192 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 134' ' ' ASP . 75.0 Cg_endo -81.17 -32.33 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.392 2.061 . . . . 0.0 111.825 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -143.89 17.25 1.78 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.161 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.568 ' CB ' ' HB3' ' A' ' 140' ' ' ALA . 8.2 mt-30 52.45 36.74 20.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.606 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.41 81.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.452 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.06 60.38 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.76 130.49 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.6 tt -64.82 152.43 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 64' ' ' TYR . 5.3 m-30 -113.09 -50.61 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.4 t80 -145.17 161.22 40.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.521 0.677 . . . . 0.0 112.244 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.87 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.1 mt -154.47 164.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.058 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.73 -154.66 25.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.59 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -150.23 149.94 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.755 0.312 . . . . 0.0 111.502 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.654 ' HE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -158.49 122.02 3.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 112' ' ' ASP . 2.2 tmt_? -75.68 150.07 37.99 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.57 98.83 5.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.83 0.348 . . . . 0.0 110.926 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.34 112.87 1.27 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.72 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.31 -159.52 52.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.786 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.99 -14.17 61.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.577 0.227 . . . . 0.0 111.363 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -172.44 2.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 45' ' ' GLU . . . -114.69 134.07 55.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' O ' ' A' ' 114' ' ' THR . 0.1 OUTLIER -68.06 95.56 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.757 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -48.34 95.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.876 HD22 ' OH ' ' A' ' 101' ' ' TYR . 23.7 mt -71.84 -71.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.543 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -128.11 159.13 36.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -143.55 113.96 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 6' ' ' ILE . 13.0 p -120.17 132.65 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.025 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 160.79 18.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.756 0.789 . . . . 0.0 112.924 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.5 OUTLIER -134.89 107.24 7.26 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.26 177.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 33' ' ' ARG . 6.5 mt -131.77 84.18 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.85 -13.39 15.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.941 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -115.2 -25.19 8.15 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.91 129.49 34.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 0.0 110.669 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.6 -179.76 0.05 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.876 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -41.4 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 110.354 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -83.56 -25.53 30.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.664 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.872 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.87 -45.34 15.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.743 ' HB2' HD13 ' A' ' 25' ' ' LEU . 12.3 ptt180 -49.28 -37.84 25.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -62.66 -50.7 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.053 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -42.46 98.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.446 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.6 t -66.49 -38.24 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.324 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.32 -50.18 57.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.333 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.5 -35.74 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.137 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.47 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 5.2 mtt -63.04 -59.55 4.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.656 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' ALA . 33.6 m -61.19 -54.82 39.43 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.5 t80 -44.81 -42.43 7.84 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 110.387 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.756 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -73.04 -31.18 64.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.052 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.54 -38.45 65.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.42 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 7.8 pt-20 -67.08 -39.7 86.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.05 -54.19 48.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.878 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.047 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.09 -62.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.204 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -52.43 -30.09 27.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.6 t -71.07 -38.51 72.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.8 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -72.87 -30.23 63.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.864 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.882 ' OG1' HG11 ' A' ' 68' ' ' VAL . 4.9 m -80.51 106.33 12.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.824 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.47 39.11 3.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.692 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.64 145.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.362 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.19 87.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.615 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.46 166.92 23.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.955 0.407 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -120.74 164.33 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.698 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 5.2 mm-40 -137.17 163.76 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.363 0.601 . . . . 0.0 111.589 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.5 t -149.93 102.01 3.09 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.672 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -90.81 104.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.238 -178.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -97.58 108.57 21.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.14 172.39 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 54.65 2.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.194 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.07 -45.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 7.8 p90 -167.23 -178.93 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.401 0.62 . . . . 0.0 111.861 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 7.8 mt -108.2 159.87 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.38 75.19 0.38 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.821 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.8 m-70 -56.58 161.57 2.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.047 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.27 145.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.763 ' OH ' HG12 ' A' ' 87' ' ' VAL . 32.5 m-85 -148.88 114.13 5.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 0.0 110.928 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -106.29 154.93 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.67 -178.67 3.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -96.53 34.37 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -118.29 -46.34 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.035 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 -18.13 1.77 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.668 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.668 HG13 HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -108.79 123.38 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 21.5 p -119.42 159.38 24.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.541 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.571 ' CA ' HG13 ' A' ' 8' ' ' VAL . . . -119.35 163.39 13.48 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.764 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.765 HG11 HG21 ' A' ' 47' ' ' VAL . 42.9 t -124.93 148.94 29.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 117.432 0.616 . . . . 0.0 112.457 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.034 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -134.33 107.52 7.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.27 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.651 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -107.7 117.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.767 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -143.52 177.06 8.73 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.391 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.9 t70 -67.73 166.47 15.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 111.853 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -18.46 62.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -88.65 27.87 1.23 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.075 0.464 . . . . 0.0 110.504 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.767 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.4 t80 -128.84 77.28 77.97 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 73.9 Cg_exo -41.26 163.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.026 2.484 . . . . 0.0 113.322 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.763 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.8 t -78.51 -26.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.796 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -55.5 -53.61 60.43 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.159 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 14.5 Cg_exo -67.13 -36.1 22.85 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.945 1.763 . . . . 0.0 110.666 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.35 -27.41 69.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -44.43 77.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.936 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 HD11 ' A' ' 79' ' ' LEU . 6.5 tt -62.32 -47.07 85.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.305 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.034 HD21 ' HB2' ' A' ' 79' ' ' LEU . 3.9 mm? -68.37 -12.6 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.209 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.52 -49.92 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.726 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 100' ' ' GLU . 14.7 mmtp -70.25 -43.47 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.538 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 94' ' ' LEU . 7.1 tt -56.81 -55.35 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 111.382 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 3.4 mm? -55.58 -51.3 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.86 0.362 . . . . 0.0 110.399 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -27.4 68.49 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.39 0.614 . . . . 0.0 109.492 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.62 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 47.3 tp10 -73.35 -34.27 65.54 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.91 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.876 ' OH ' HD22 ' A' ' 19' ' ' LEU . 2.3 t80 -68.13 -32.63 73.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -76.73 -33.73 58.14 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.109 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 14.3 t -71.28 -51.05 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.894 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.8 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.072 0.463 . . . . 0.0 111.004 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.932 ' CE1' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -173.08 128.82 0.53 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.099 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 88.3 Cg_exo -36.26 168.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.353 2.702 . . . . 0.0 114.083 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.739 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.7 OUTLIER -50.03 -63.15 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 22.2 mt-10 -66.84 -27.74 67.79 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.5 mm-40 -45.62 -41.04 9.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 1.1 p-90 -100.77 -52.06 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.021 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 34.6 53.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.447 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 6.9 m-20 93.82 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.532 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.879 HG11 HG23 ' A' ' 116' ' ' THR . 24.1 t 71.25 -62.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.663 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.672 ' O ' HD21 ' A' ' 17' ' ' LEU . 1.8 p 64.57 6.39 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.697 ' H ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.66 96.11 0.64 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.751 0.31 . . . . 0.0 111.167 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.879 HG23 HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.84 -169.55 3.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.915 0.388 . . . . 0.0 111.29 -179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.27 -165.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.882 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.84 -15.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.778 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.66 -53.31 53.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.932 HD11 ' CE1' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -56.69 -22.14 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 11.1 ttpt -46.78 108.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.009 0.433 . . . . 0.0 111.286 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.62 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -88.56 143.73 26.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.141 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -23.25 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -68.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 125' ' ' LEU . 1.3 pp -52.31 -30.01 26.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.172 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 129' ' ' ILE . 45.7 m-20 -77.43 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.1 m -57.4 -27.99 62.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.552 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.13 -55.03 7.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.625 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.87 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -25.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 t -80.79 -44.38 18.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.834 0.349 . . . . 0.0 111.068 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 3.6 mptt -84.47 -20.86 31.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.161 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-85 -80.07 -13.44 59.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -38.46 -31.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -72.1 166.85 37.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.803 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 9.3 Cg_endo -51.61 -25.05 18.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.53 2.153 . . . . 0.0 112.078 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.83 -59.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.631 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 69.39 6.98 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.373 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.779 0.323 . . . . 0.0 111.396 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t0 62.8 31.75 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' HB3' ' OE1' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.078 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 71.31 153.13 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.333 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 133' ' ' GLN . 13.1 tt -68.78 153.39 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.797 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.513 ' CE2' ' CZ ' ' A' ' 64' ' ' TYR . 27.1 m-85 -121.08 -50.48 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.771 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.9 t80 -129.81 155.87 45.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.738 0.78 . . . . 0.0 112.286 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 3' ' ' ILE . 2.0 mt -156.88 164.51 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.541 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 158.61 -157.14 28.12 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.501 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' C ' ' CD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -148.22 149.66 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.782 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -153.94 135.71 14.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 1.7 tmm_? -86.33 130.09 34.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 94.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.33 -127.29 0.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.95 -76.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.401 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -82.19 -24.34 34.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.51 -173.83 4.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -97.03 119.06 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.254 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -62.0 90.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.317 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.703 ' O ' HG21 ' A' ' 116' ' ' THR . 1.0 OUTLIER -39.2 113.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.645 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mt -92.17 -34.47 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 8' ' ' VAL . 1.2 p -174.18 113.85 0.19 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.274 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -108.45 124.99 51.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 6' ' ' ILE . 11.0 p -120.85 135.86 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.448 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mttp -120.33 163.85 17.21 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 112.699 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -137.21 107.15 6.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.811 177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.5 mm? -106.11 70.37 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.904 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 t -64.86 -79.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.675 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -83.84 -17.35 41.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.921 0.391 . . . . 0.0 111.373 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.762 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.8 m-85 -63.66 109.77 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.81 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.91 -153.46 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.049 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -80.62 -47.86 13.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -75.43 -18.99 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.529 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 tt0 -84.69 -43.8 14.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 25' ' ' LEU . 4.1 ptm180 -52.71 -35.99 56.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.89 0.376 . . . . 0.0 110.994 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -66.37 -56.82 9.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -52.6 61.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.353 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.3 t -57.46 -46.76 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.749 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' CG ' ' A' ' 40' ' ' MET . . . -51.44 -45.55 53.24 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.005 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -61.4 -30.86 70.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 17.8 t80 -71.81 -48.4 46.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.888 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' TYR . 12.9 ptp -63.69 -46.26 86.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.689 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -60.75 3.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.583 0.23 . . . . 0.0 110.984 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.9 t80 -46.37 -40.24 11.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.809 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.75 -38.65 67.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -67.29 -39.62 86.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 111.198 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 18.7 pt-20 -68.78 -34.83 76.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.375 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ARG . 3.0 m -64.33 -55.62 19.98 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.32 -61.73 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -55.23 -29.37 57.87 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.737 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 9.9 t -79.68 -28.87 40.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.906 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.795 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 3.4 ptm85 -88.55 -37.63 15.55 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.982 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.915 ' OG1' HG11 ' A' ' 68' ' ' VAL . 86.5 m -68.61 106.88 2.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.33 39.97 1.93 Allowed Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.99 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . . . 57.07 158.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.815 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.25 76.85 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.49 157.86 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.105 0.479 . . . . 0.0 111.681 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HD3' ' CE2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -105.24 144.58 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 mm-40 -124.97 130.06 51.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 0.0 112.163 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 m -118.99 101.83 8.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -87.3 105.37 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.541 -178.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 65' ' ' ILE . 4.3 mt-10 -98.83 112.18 24.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 25.8 tt0 -142.21 103.71 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.08 85.99 0.02 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.281 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.84 28.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 4' ' ' TYR . 3.9 m-85 -139.2 129.03 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.478 HG21 ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -119.75 147.01 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.704 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.45 92.51 0.3 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.194 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.652 ' CE1' HG22 ' A' ' 87' ' ' VAL . 68.0 m-70 -65.6 151.52 46.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.738 0.304 . . . . 0.0 110.908 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -149.64 140.87 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.947 0.403 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HD1' HD23 ' A' ' 94' ' ' LEU . 72.4 m-85 -148.76 111.72 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.88 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -108.79 141.58 40.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.597 ' HG3' HD23 ' A' ' 98' ' ' LEU . 1.1 mtt-85 -97.8 176.41 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.21 28.57 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -98.46 -50.33 4.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.22 -23.56 0.52 Allowed Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.917 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.849 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.57 130.1 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.1 p -110.49 159.77 17.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.859 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -113.12 149.38 18.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.709 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 68' ' ' VAL . 1.2 t -125.69 146.95 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.265 0.555 . . . . 0.0 112.084 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 93' ' ' LEU . 1.9 mp -134.92 144.41 47.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.087 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -141.72 117.18 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.137 0.494 . . . . 0.0 111.343 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -136.31 -174.37 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' N ' ' OG1' ' A' ' 81' ' ' THR . 5.0 t70 -84.95 165.18 17.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.762 0.315 . . . . 0.0 110.52 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -56.03 -21.78 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.084 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 39.93 0.95 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.167 0.508 . . . . 0.0 110.721 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -147.83 84.29 7.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.325 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -42.28 154.13 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.918 2.412 . . . . 0.0 113.058 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG12 ' OH ' ' A' ' 69' ' ' TYR . 20.0 t -76.14 -26.87 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.172 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -48.16 -56.41 14.12 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.01 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 37.5 Cg_endo -64.33 -25.41 64.11 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.705 1.603 . . . . 0.0 110.747 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' VAL . . . -69.11 -28.63 66.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -47.88 66.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 9.2 m -63.23 -42.76 99.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 79' ' ' LEU . 5.2 tt -66.64 -50.0 64.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.521 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.859 HD22 ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -68.64 -11.18 59.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.876 178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' THR . 22.2 t-20 -77.27 -63.46 1.36 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -57.22 -40.24 77.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.67 ' CG2' HD12 ' A' ' 94' ' ' LEU . 14.2 tt -59.98 -54.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -58.39 -47.45 83.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.192 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.89 -27.91 69.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CB ' ' HE3' ' A' ' 122' ' ' MET . 19.0 tp10 -77.79 -29.98 51.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.645 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.938 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 12.6 t80 -68.71 -29.91 68.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.899 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 1.1 mt -74.47 -27.58 60.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 105' ' ' HIS . 10.0 t -71.61 -50.76 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.421 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.18 -21.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.52 130.96 0.64 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 71.0 Cg_exo -30.68 154.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.777 2.985 . . . . 0.0 114.173 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.76 -62.08 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.615 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.45 -27.29 61.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.2 tt0 -42.88 -44.38 4.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.796 0.331 . . . . 0.0 111.323 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.899 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -88.64 -58.69 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.071 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.92 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.834 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.588 ' C ' HG23 ' A' ' 113' ' ' VAL . 2.3 p30 143.43 -33.82 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 109.031 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.888 HG22 ' HB2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER 65.15 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.729 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.88 19.85 5.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.19 57.82 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.749 HG21 ' HA ' ' A' ' 19' ' ' LEU . 2.9 t -54.85 -170.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.883 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.638 HD22 HD23 ' A' ' 120' ' ' LEU . 48.6 p-10 -118.06 48.49 1.39 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.46 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.635 ' H ' HG23 ' A' ' 116' ' ' THR . 1.3 p30 -50.08 -22.5 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.78 30.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.638 HD23 HD22 ' A' ' 117' ' ' ASN . 15.0 tp -76.43 -40.41 50.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.676 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 0.5 OUTLIER 63.51 15.42 8.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.514 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.538 ' HB3' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER 53.48 99.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 110.937 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -48.76 -27.19 2.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -75.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.213 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.587 HD22 HD11 ' A' ' 97' ' ' ILE . 3.3 pp -47.77 -34.56 8.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.383 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.64 ' HA ' HG21 ' A' ' 22' ' ' VAL . 49.2 m-20 -58.78 -58.31 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.061 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.468 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 54.1 m -60.25 -28.7 68.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 2.1 m-85 -69.83 -58.68 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -56.67 -24.56 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.154 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 t -70.7 -56.76 5.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -77.14 -27.72 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CD2' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -62.2 -13.45 27.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.997 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -42.98 -28.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.631 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 166.19 63.04 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.86 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.483 2.122 . . . . 0.0 112.192 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 m -168.2 27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 46.25 30.83 1.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.877 0.37 . . . . 0.0 110.931 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . . . 50.92 80.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.26 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.74 63.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.092 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.76 0.314 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.77 179.8 8.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.737 HG22 ' CB ' ' A' ' 133' ' ' GLN . 4.6 tt -80.6 154.08 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.783 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ASP . 22.1 m-85 -128.92 -38.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 9.7 t80 -145.93 153.97 41.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 0.0 112.36 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.823 HD12 ' CB ' ' A' ' 129' ' ' ILE . 3.3 mt -155.72 166.2 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.671 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 156.89 -155.68 26.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.712 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.685 ' CG1' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.56 162.53 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.688 0.28 . . . . 0.0 110.647 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CE1' ' HB1' ' A' ' 44' ' ' ALA . 88.8 m-85 -156.42 126.36 6.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HD2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -79.39 121.98 25.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 98.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.93 -137.73 4.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.493 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.54 -95.54 2.38 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.17 -26.62 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.307 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -177.04 5.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -88.22 140.37 29.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.274 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' HD2' ' A' ' 10' ' ' ARG . 10.1 tt -85.26 124.16 31.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.65 106.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.135 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.882 HD21 HG13 ' A' ' 75' ' ' ILE . 8.6 tp -88.39 -66.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.88 155.43 44.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.0 mt-10 -140.28 113.21 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HA ' ' A' ' 126' ' ' ASP . 11.1 p -121.45 133.82 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.127 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -122.37 169.28 11.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.824 0.821 . . . . 0.0 113.081 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 4' ' ' TYR . 9.0 t0 -146.69 107.28 4.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.621 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 33' ' ' ARG . 15.8 mt -114.86 76.96 1.03 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.649 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.4 p -113.14 -21.23 11.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -98.52 -23.91 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.27 . . . . 0.0 111.7 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.6 m-85 -78.16 153.91 31.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.339 . . . . 0.0 111.061 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.56 -167.47 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.901 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -97.63 31.23 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -154.84 -48.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.126 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 36' ' ' VAL . 34.0 tt0 -73.07 -26.11 61.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.345 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.658 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -48.04 -32.45 6.69 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -73.75 -49.4 25.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -37.3 73.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 32' ' ' GLU . 1.9 t -66.58 -46.19 86.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.21 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.12 -47.35 33.29 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.259 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -64.15 -34.22 77.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -66.47 -36.73 83.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.186 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.471 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 14.0 mmt -62.94 -51.03 68.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -58.15 -60.35 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.0 t80 -45.35 -40.71 8.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.122 0.487 . . . . 0.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -74.63 -36.43 62.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.036 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.86 -37.87 82.38 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -72.33 -35.51 68.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.427 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.766 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -63.0 -52.92 61.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.342 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.47 -61.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -51.97 -30.05 23.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.821 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.62 -35.54 65.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.766 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.9 OUTLIER -73.08 -49.62 27.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.696 178.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.931 ' OG1' HG11 ' A' ' 68' ' ' VAL . 19.4 m -67.47 106.34 2.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 41.27 2.44 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.139 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 61.11 143.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.64 2.06 84.48 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.377 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -136.19 166.8 22.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 111.273 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.55 147.34 38.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.59 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 83.3 mm-40 -136.35 114.21 11.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.138 0.494 . . . . 0.0 112.265 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . 13.5 t -107.77 101.99 11.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -85.91 109.39 18.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.266 -178.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.87 108.51 20.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.708 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 4.4 mm-40 -104.9 172.29 6.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.395 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.76 53.91 3.71 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.245 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.64 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -179.25 7.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.344 0.592 . . . . 0.0 112.199 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 HG21 ' CE1' ' A' ' 67' ' ' HIS . 4.1 mt -117.96 154.89 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.996 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -130.73 86.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CE1' HG21 ' A' ' 65' ' ' ILE . 81.5 m-70 -70.53 142.27 51.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.633 0.254 . . . . 0.0 110.981 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.931 HG11 ' OG1' ' A' ' 51' ' ' THR . 2.5 t -132.94 143.5 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.82 0.343 . . . . 0.0 110.566 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.823 ' CB ' HD22 ' A' ' 94' ' ' LEU . 1.1 m-85 -147.48 111.48 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.3 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -92.77 145.18 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.61 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -178.37 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 t -45.0 -50.51 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 179.47 90.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.46 -98.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.88 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.882 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -108.32 120.82 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.191 0.52 . . . . 0.0 110.728 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.15 147.69 24.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.331 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -107.11 143.24 15.82 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 HG22 ' A' ' 68' ' ' VAL . 9.6 t -113.85 150.78 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 117.755 0.778 . . . . 0.0 112.756 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.97 140.5 45.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.622 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.751 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -146.91 117.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -149.58 164.0 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.01 161.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 111.809 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -20.92 63.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.119 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.18 15.15 2.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.796 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -124.38 77.62 61.75 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -43.2 172.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.528 2.818 . . . . 0.0 113.691 -178.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 67' ' ' HIS . 2.7 t -78.32 -27.07 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.039 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.29 -53.32 60.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.364 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 7.1 Cg_exo -71.27 -29.93 16.46 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.987 1.792 . . . . 0.0 110.644 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -30.02 69.25 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 69' ' ' TYR . 5.5 t80 -70.7 -43.73 68.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -62.98 -42.08 99.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.246 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.05 HD12 HD11 ' A' ' 79' ' ' LEU . 3.2 tm? -62.71 -54.92 31.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -67.35 -8.48 32.86 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.33 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -76.34 -52.38 10.05 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -70.12 -35.22 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.9 tt -63.04 -55.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.49 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.844 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -60.19 -41.22 92.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.018 0.437 . . . . 0.0 110.155 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -27.44 65.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 37.9 tp10 -76.19 -39.18 55.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.768 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.764 ' OH ' HG21 ' A' ' 116' ' ' THR . 13.2 t80 -64.42 -29.39 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.0 mp -66.13 -36.52 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 105' ' ' HIS . 9.5 t -70.16 -49.62 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.81 -20.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.836 0.351 . . . . 0.0 111.459 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.1 131.02 0.59 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.31 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -32.48 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.569 2.846 . . . . 0.0 113.613 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.583 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 1.5 mttp -46.43 -61.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.31 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -27.27 63.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 105' ' ' HIS . 12.9 tt0 -45.87 -49.74 15.12 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.579 0.228 . . . . 0.0 111.452 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.612 ' CE3' HG23 ' A' ' 75' ' ' ILE . 1.6 p-90 -79.19 -54.04 6.37 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.462 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 37.92 31.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.612 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.767 ' HA ' HG22 ' A' ' 75' ' ' ILE . 24.4 m-20 122.46 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.177 0.991 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 112' ' ' ASP . 1.9 t 73.59 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.748 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -87.29 24.54 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.12 76.09 0.27 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.247 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.764 HG21 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -135.43 -178.74 5.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.478 ' H ' HG22 ' A' ' 116' ' ' THR . 0.6 OUTLIER 168.62 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.638 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.66 -16.89 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.139 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.14 -31.66 55.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 120' ' ' LEU . 3.2 mm? -90.41 7.43 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.06 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -56.49 -168.45 0.0 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.604 ' HG2' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -144.89 137.22 26.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.73 -23.56 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.773 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 4.1 mm-40 -63.51 -67.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.005 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 122' ' ' MET . 1.3 pp -55.3 -29.64 58.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.337 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.847 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.1 m-20 -77.03 -58.58 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.144 0.497 . . . . 0.0 111.142 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 60.4 m -58.24 -27.53 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.766 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.4 m-85 -73.68 -57.34 4.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.991 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.823 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -53.66 -28.61 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.747 0.308 . . . . 0.0 111.454 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -75.41 -47.9 25.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.468 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -84.15 -17.88 38.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.97 -14.49 59.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.737 ' CB ' HG22 ' A' ' 3' ' ' ILE . 2.3 pt20 -44.97 -28.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 111.658 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.05 147.91 46.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.004 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.83 -26.29 15.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.534 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.66 -25.09 16.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 58.07 23.62 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.042 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 54.29 38.41 29.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.277 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 t70 62.13 32.36 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.067 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.885 0.374 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 64.96 158.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.212 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.858 HD11 HG13 ' A' ' 6' ' ' ILE . 6.0 tt -64.67 150.65 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.368 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.5 p90 -128.22 -19.31 3.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 11.0 t80 -157.09 151.74 25.56 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.749 0.785 . . . . 0.0 112.045 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.947 HD11 HD21 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -153.03 165.08 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.993 178.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.509 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -169.33 31.96 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.983 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -130.33 156.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 0.0 110.781 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.3 m-85 -154.53 116.85 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.666 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 17' ' ' LEU . 2.4 ppt_? -72.62 134.32 45.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m -60.67 93.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.55 -148.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.91 -81.5 1.48 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.6 -26.71 58.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.898 0.38 . . . . 0.0 110.94 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -166.88 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -98.41 151.56 20.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.302 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 18' ' ' GLU . 3.2 tm? -85.99 144.62 27.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.522 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.896 ' N ' HD13 ' A' ' 17' ' ' LEU . 13.1 mt-10 -78.24 63.29 3.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.754 0.311 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD21 HG13 ' A' ' 75' ' ' ILE . 1.2 tp -47.93 -80.46 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.579 ' OG ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -122.84 130.16 52.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' N ' ' HB2' ' A' ' 118' ' ' ASP . 12.6 mt-10 -123.8 112.51 17.39 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 6' ' ' ILE . 14.8 p -124.76 140.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.948 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 5' ' ' TYR . 19.1 mttt -130.39 156.51 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.51 107.32 10.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' CG ' ' A' ' 33' ' ' ARG . 5.4 mt -126.81 79.93 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.776 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -73.87 -19.5 60.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.63 ' HD2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -75.02 94.79 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.944 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' ARG . . . -112.55 -135.2 6.38 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.667 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -63.38 -6.98 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -121.12 14.78 11.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.643 0.258 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.7 mm-40 -161.57 -41.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.771 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.889 ' CG ' HD13 ' A' ' 25' ' ' LEU . 15.3 ttp180 -47.89 -35.94 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.946 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -72.52 -58.31 3.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -61.96 -55.18 32.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.406 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.4 t -57.89 -46.33 87.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.183 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.27 -50.34 34.9 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.607 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.32 -31.95 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 16.4 t80 -66.49 -40.63 89.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.129 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.634 ' CE ' HG12 ' A' ' 36' ' ' VAL . 11.4 mtt -61.09 -59.57 5.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.865 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -60.62 3.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.451 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -42.71 -43.94 4.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.824 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.71 -38.38 67.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.275 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 1.016 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -66.05 -38.87 89.46 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.592 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.1 pt-20 -70.82 -35.44 72.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.684 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 50' ' ' ARG . 2.5 m -62.71 -55.28 28.18 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.58 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -47.58 -61.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.053 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -54.26 -29.01 45.38 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.72 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 1.4 t -76.57 -36.87 57.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.316 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.741 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 ptm180 -82.8 -24.01 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.642 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.892 ' OG1' HG11 ' A' ' 68' ' ' VAL . 95.1 m -82.82 107.1 15.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.4 40.15 2.55 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.024 -0.607 . . . . 0.0 114.018 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.99 151.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 111.679 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.04 10.08 77.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.283 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -150.22 155.37 39.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.025 0.441 . . . . 0.0 111.31 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 9.2 mtm180 -106.52 145.44 31.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.94 137.23 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.38 0.609 . . . . 0.0 111.78 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.98 102.73 7.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.754 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -92.9 107.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.522 -178.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -98.25 115.61 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.529 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 tp10 -139.12 103.68 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.881 0.372 . . . . 0.0 111.994 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.5 81.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.428 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 50.53 20.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.9 m-85 -130.52 143.43 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.7 mt -125.88 156.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -138.14 75.91 0.37 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.992 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.7 m-70 -55.56 158.34 3.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 78' ' ' VAL . 2.1 t -152.19 136.37 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' HG12 ' A' ' 87' ' ' VAL . 45.1 m-85 -141.2 111.28 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -94.27 155.16 17.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' CG ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.48 -179.48 5.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.615 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 t -53.65 -46.32 70.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.72 86.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.213 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.22 -101.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.581 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.792 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -111.01 116.3 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.087 0.47 . . . . 0.0 110.472 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' PHE . 10.2 p -89.48 157.97 17.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.156 0.503 . . . . 0.0 111.814 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -116.49 152.47 17.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.978 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.045 HG22 HG22 ' A' ' 68' ' ' VAL . 2.7 t -120.11 146.08 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.442 0.639 . . . . 0.0 112.043 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.947 HD21 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.33 105.79 6.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.109 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.27 120.07 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.98 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -143.95 -174.44 4.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' N ' ' OG1' ' A' ' 81' ' ' THR . 4.7 t70 -87.07 166.86 14.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.966 0.412 . . . . 0.0 111.603 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -25.06 54.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -87.74 42.18 1.03 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.214 0.53 . . . . 0.0 110.179 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.98 ' CD1' HG21 ' A' ' 81' ' ' THR . 20.3 t80 -140.47 84.34 14.23 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.314 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 49.3 Cg_exo -37.81 145.48 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.128 2.552 . . . . 0.0 113.255 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.657 HG12 ' OH ' ' A' ' 69' ' ' TYR . 2.1 t -77.22 -27.0 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.4 mmt85 -56.51 -57.48 23.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.098 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 19.8 Cg_endo -57.91 -30.17 88.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.635 1.557 . . . . 0.0 110.468 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -66.13 -31.09 71.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.51 -42.37 87.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -60.21 -43.53 95.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.254 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 79' ' ' LEU . 1.6 tt -62.86 -45.19 93.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.709 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.91 -23.81 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.182 178.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 94' ' ' LEU . 32.4 t-20 -76.39 -67.11 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 3.0 mmtm -57.6 -37.49 73.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.675 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 8.9 tt -65.66 -56.0 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 3.1 mm? -55.47 -49.81 71.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.825 0.345 . . . . 0.0 110.385 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.922 ' HA ' HD12 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -62.55 -26.07 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.419 0.628 . . . . 0.0 109.985 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 97' ' ' ILE . 35.9 tp10 -75.05 -50.57 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.21 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CZ ' ' HG ' ' A' ' 19' ' ' LEU . 28.6 t80 -58.65 -31.53 68.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.517 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 99' ' ' ASP . 1.2 mt -76.61 -32.75 58.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.489 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' ASP . 5.2 t -67.24 -48.56 77.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 111.486 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.29 -20.09 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.16 130.11 0.49 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.56 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 99.6 Cg_exo -34.63 158.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.236 2.624 . . . . 0.0 113.146 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 22.9 mmtm -45.69 -62.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.43 -27.79 67.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.8 mm-40 -48.44 -49.04 36.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.668 0.27 . . . . 0.0 111.594 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 4.9 p-90 -82.74 -44.13 15.98 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.349 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 21.46 50.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.831 0.707 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 75' ' ' ILE . 3.0 m-20 76.06 76.06 0.09 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.498 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 115' ' ' GLU . 9.6 t -64.39 142.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.255 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -100.79 17.99 20.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.428 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.762 ' H ' HG12 ' A' ' 113' ' ' VAL . 7.5 pt-20 177.92 112.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.494 ' OG1' HG11 ' A' ' 113' ' ' VAL . 54.0 m -157.25 162.15 39.22 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' THR . 0.5 OUTLIER -156.99 136.45 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.495 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 125' ' ' LEU . 8.1 t0 -60.87 -19.12 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.4 -20.62 56.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.81 -46.44 8.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 -165.44 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 111.534 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.794 ' SD ' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER 82.92 33.34 0.07 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.264 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -51.81 -24.36 5.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.376 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 4.9 tp60 -53.64 -70.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.96 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.794 HD23 ' SD ' ' A' ' 122' ' ' MET . 2.8 pp -52.96 -36.42 60.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.442 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -60.92 -58.64 7.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.774 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.8 m -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.673 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 1.7 m-85 -72.63 -49.58 30.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.064 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -61.51 -33.19 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.572 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.7 t -74.61 -38.85 62.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.165 0.507 . . . . 0.0 110.391 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.459 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 6.8 mptt -84.37 -16.89 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.391 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.5 m-85 -81.24 -12.63 59.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -69.6 53.17 0.11 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 1.4 p30 37.86 49.16 1.6 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 54.1 Cg_endo -88.12 -39.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.462 2.108 . . . . 0.0 112.34 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.71 26.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 1.4 mt-30 53.34 29.52 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 46.2 49.53 12.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.745 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t0 59.32 59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -154.36 126.34 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.976 0.417 . . . . 0.0 111.136 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.796 HG22 ' HA ' ' A' ' 133' ' ' GLN . 4.8 tt -72.57 153.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.674 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 44.2 m-85 -120.01 -43.56 2.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 12.3 t80 -133.93 156.46 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.502 0.668 . . . . 0.0 111.944 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -156.83 161.37 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.446 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 158.26 -169.7 34.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.513 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.844 HG23 ' CB ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -128.64 162.71 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 56.0 m-85 -150.84 116.85 5.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' CB ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -77.46 114.19 16.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -52.43 104.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.969 0.414 . . . . 0.0 111.172 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -146.9 11.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.437 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.62 -68.65 0.91 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -27.85 61.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.996 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -163.11 -171.55 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.564 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -80.46 149.66 30.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.914 0.388 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 19' ' ' LEU . 6.9 tt -91.49 144.0 26.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' C ' HD23 ' A' ' 17' ' ' LEU . 3.1 pt-20 -72.62 70.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.115 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 2.9 tp -60.47 -75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.6 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.844 ' CB ' HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.69 141.74 51.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -137.49 111.99 8.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 112.29 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' ILE . 12.1 p -127.39 132.62 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.412 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -115.49 167.23 11.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.753 0.787 . . . . 0.0 112.692 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' ILE . 1.1 t0 -142.11 107.18 4.94 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.296 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -103.67 70.73 1.04 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.05 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t -57.63 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -88.0 -23.63 23.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 1.1 m-85 -60.29 170.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 33' ' ' ARG . . . -175.41 -145.81 5.58 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.763 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -43.94 -46.71 8.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -110.6 14.28 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.763 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.0 mt-10 -128.35 -38.89 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.279 . . . . 0.0 110.676 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.1 ttt-85 -59.56 -35.95 75.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 109.847 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -67.56 -58.11 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.603 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -63.03 -55.96 21.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.333 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -60.12 -50.87 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.602 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.73 -55.47 9.61 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -32.58 69.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -45.11 95.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.017 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' HG12 ' A' ' 36' ' ' VAL . 19.2 mtt -61.5 -60.37 3.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.636 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -54.12 -60.06 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.324 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -43.25 -42.76 4.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.819 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.6 m-85 -73.25 -35.56 66.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.555 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.88 -34.7 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.475 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.8 pt-20 -72.55 -37.43 68.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -61.57 -55.23 33.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.953 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.17 -62.33 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.13 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.625 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -52.95 -29.41 28.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -74.67 -39.76 61.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.891 178.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -86.27 -1.89 57.89 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.285 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.818 ' OG1' HG11 ' A' ' 68' ' ' VAL . 36.7 m -90.93 107.52 19.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.53 38.04 2.92 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.986 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 60.41 133.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.98 0.419 . . . . 0.0 111.777 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.08 80.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.351 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 mm-40 -128.98 122.87 31.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 69' ' ' TYR . 8.4 mtm180 -83.59 148.28 27.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.35 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 46.6 mm-40 -124.47 161.01 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.712 0.768 . . . . 0.0 111.896 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -153.14 102.73 2.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.907 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.97 103.62 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.233 -178.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.18 108.64 13.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -103.8 173.34 6.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.275 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -40.79 -29.59 0.29 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.901 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -163.52 41.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.712 0.292 . . . . 0.0 111.112 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -152.47 176.88 11.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.184 0.516 . . . . 0.0 111.547 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -153.25 111.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.907 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.956 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -89.77 83.52 1.39 Allowed Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.205 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.841 ' HB2' HD12 ' A' ' 79' ' ' LEU . 78.5 m-70 -60.58 155.12 19.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.1 t -152.72 140.46 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.848 ' CD1' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -142.37 111.64 6.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.261 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' THR . . . -89.73 150.26 22.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -93.84 -178.19 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.018 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 t -48.73 -52.57 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.326 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 3.2 tt0 -177.41 100.09 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' HA3' ' CZ3' ' A' ' 110' ' ' TRP . . . 167.33 -94.15 0.11 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.278 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG13 HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.67 121.0 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.907 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' O ' HG12 ' A' ' 8' ' ' VAL . 28.1 t -89.71 157.99 17.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.602 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -118.1 147.02 18.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.432 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.88 HG22 HG22 ' A' ' 68' ' ' VAL . 48.4 t -128.37 136.32 60.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.192 0.52 . . . . 0.0 112.396 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -136.63 122.66 20.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.649 178.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.956 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -107.33 126.81 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 111.759 -179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.589 HG21 ' CD1' ' A' ' 85' ' ' TYR . 2.8 t -139.66 -173.69 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.524 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 81' ' ' THR . 27.1 t70 -74.85 161.77 29.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.105 0.479 . . . . 0.0 111.939 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -58.94 -21.67 58.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -89.51 33.81 0.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.096 0.475 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.589 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -128.21 81.38 70.6 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.441 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 Cg_endo -46.78 172.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.616 2.211 . . . . 0.0 112.712 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t -78.23 -26.48 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.972 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -54.48 -53.27 61.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.173 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.3 Cg_exo -69.66 -33.95 15.91 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.071 1.847 . . . . 0.0 110.809 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.42 -28.66 68.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 8.1 t80 -70.4 -39.6 74.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 m -63.49 -44.03 95.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.225 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -63.32 -51.86 64.29 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.848 HD13 ' CD1' ' A' ' 69' ' ' TYR . 8.1 mt -63.69 -13.38 42.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.072 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.05 -65.45 0.95 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.756 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.9 mptt -57.83 -41.15 81.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.962 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 9.7 tt -59.7 -54.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.579 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.798 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -64.03 -36.96 85.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.89 -27.6 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.567 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -74.04 -57.38 4.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.27 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 t80 -56.29 -28.45 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.965 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.5 mp -69.93 -39.48 76.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.454 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 105' ' ' HIS . 7.5 t -71.02 -48.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.49 -21.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 111.494 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.616 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -172.37 132.11 0.7 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.316 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -32.47 155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 113.67 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 3.7 mtmp? -46.38 -62.15 1.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.437 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -26.83 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 11.6 tt0 -45.46 -49.6 13.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.628 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -73.89 -50.72 18.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.194 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 110' ' ' TRP . . . 29.22 47.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.973 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 3.5 m-20 80.98 77.3 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.069 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 115' ' ' GLU . 3.3 t -68.9 140.07 19.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.883 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.497 HG22 ' NH2' ' A' ' 10' ' ' ARG . 35.1 p -101.01 16.15 26.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.804 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.755 ' H ' HG12 ' A' ' 113' ' ' VAL . 2.0 pt-20 -163.51 86.72 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.01 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 19' ' ' LEU . 4.9 t -57.54 -160.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' N ' HG23 ' A' ' 116' ' ' THR . 16.3 p-10 178.13 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.43 ' CB ' ' HB2' ' A' ' 122' ' ' MET . 21.1 m-20 -60.62 -31.43 70.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.42 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -47.04 -42.29 18.16 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.101 0.477 . . . . 0.0 110.479 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -16.4 14.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.98 68.54 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 111.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.802 ' SD ' HD22 ' A' ' 125' ' ' LEU . 10.5 ttt -156.92 66.23 0.52 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.038 0.446 . . . . 0.0 111.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -18.37 35.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.594 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.03 -72.1 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.355 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 126' ' ' ASP . 0.5 OUTLIER -65.36 -31.07 71.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.836 ' N ' HD23 ' A' ' 125' ' ' LEU . 3.7 t70 -70.6 -48.44 55.14 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -65.27 -28.49 69.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.972 0.415 . . . . 0.0 109.919 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.7 m-85 -72.78 -45.51 58.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.417 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.695 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -64.51 -33.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 t -66.18 -45.54 80.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.723 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -20.35 37.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.859 ' CD2' HD23 ' A' ' 93' ' ' LEU . 1.9 m-85 -70.22 -12.85 61.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.548 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.796 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -49.84 -9.4 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -93.19 168.5 12.04 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 110.973 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.13 -29.08 18.06 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.705 2.27 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.0 m -165.38 71.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 1.8 mp0 -42.71 -30.75 0.4 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.484 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 82.6 40.1 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.114 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t0 60.42 40.36 17.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.155 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HE2' ' CB ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.834 0.35 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 61.87 -178.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.85 HG22 ' HA ' ' A' ' 133' ' ' GLN . 17.0 tt -72.6 160.62 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 28' ' ' PHE . 57.6 m-85 -142.49 -26.13 0.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.1 t80 -152.05 150.37 29.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.43 0.633 . . . . 0.0 112.152 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 3' ' ' ILE . 2.1 mt -156.22 167.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.5 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 159.39 -158.14 29.26 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.902 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.25 162.09 21.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.285 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 42.2 m-85 -156.12 127.13 6.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.06 119.75 24.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.216 178.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.4 99.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.02 -150.34 17.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.408 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.62 -78.78 1.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -28.97 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -160.91 -167.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -92.0 120.11 32.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.8 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.561 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.9 tp -80.51 -64.02 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -161.28 110.6 1.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.769 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' HG23 ' A' ' 41' ' ' THR . 2.5 mp0 -106.84 132.68 52.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 126' ' ' ASP . 7.1 p -120.61 134.84 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.045 177.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.01 160.75 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.557 0.694 . . . . 0.0 112.756 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.4 OUTLIER -136.67 106.99 6.41 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.626 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.2 mm? -104.5 68.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.08 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -74.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.31 -21.89 28.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -74.48 131.77 41.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.211 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.5 -19.58 0.06 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.823 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 39.8 p90 -84.05 37.62 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.497 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 4.5 m-85 87.76 17.4 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.726 0.41 . . . . 0.0 110.794 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.5 pt-20 -113.76 -29.38 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 32.8 ptt85 -51.02 -35.68 35.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 t -62.04 -53.54 54.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.147 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -39.75 95.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.623 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 32' ' ' GLU . 4.5 t -63.65 -49.71 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.63 -47.11 46.37 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.134 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -60.71 -32.08 71.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 2.7 t80 -65.35 -48.84 71.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.703 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.518 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -64.07 -57.08 10.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.041 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 21' ' ' GLU . 1.7 m -53.8 -60.29 3.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -45.56 -41.0 9.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.012 0.434 . . . . 0.0 110.703 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.876 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -74.52 -32.32 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.569 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.923 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.28 -34.2 63.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.32 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -71.51 -41.66 68.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.692 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -59.01 -52.56 65.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.656 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.22 -62.22 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.98 -29.79 13.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -73.9 -36.99 64.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.541 178.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.856 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -75.22 -49.88 17.95 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.349 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.705 ' OG1' HG11 ' A' ' 68' ' ' VAL . 21.1 m -64.56 106.63 1.19 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.42 40.79 2.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.129 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.1 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 111.333 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.66 80.4 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -171.7 -175.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 163.77 27.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 36.9 mm-40 -133.92 173.38 11.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.362 0.601 . . . . 0.0 111.186 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -153.67 102.39 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -85.2 103.83 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.229 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -87.16 117.99 26.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.94 172.97 7.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.376 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.66 -29.09 0.71 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.734 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -164.87 46.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 62.3 m-85 -160.19 148.6 16.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.038 0.447 . . . . 0.0 111.547 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 1.1 mt -134.38 116.65 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.85 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -94.94 87.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.524 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 79' ' ' LEU . 87.4 m-70 -66.17 112.98 4.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 78' ' ' VAL . 2.0 t -103.87 142.64 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.8 0.333 . . . . 0.0 110.508 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.842 ' CG ' HD22 ' A' ' 94' ' ' LEU . 41.1 m-85 -144.8 111.74 5.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -111.62 152.27 27.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.364 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.4 tpm_? -121.83 163.16 19.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.26 40.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HB3' ' CH2' ' A' ' 110' ' ' TRP . 0.6 OUTLIER -103.59 -51.79 3.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.5 -21.61 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.166 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -136.13 114.8 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 8' ' ' VAL . 31.8 p -86.15 174.54 9.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -134.39 164.79 24.55 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.704 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.034 HG22 HG22 ' A' ' 68' ' ' VAL . 37.8 t -137.27 153.02 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.516 0.674 . . . . 0.0 112.477 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD23 HD11 ' A' ' 6' ' ' ILE . 5.9 mp -135.34 153.38 51.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.933 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.918 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -148.79 117.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.894 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.95 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -140.69 -173.79 3.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' N ' ' OG1' ' A' ' 81' ' ' THR . 16.0 t70 -82.05 156.68 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 111.066 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -26.31 14.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.529 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.555 ' CB ' ' HE2' ' A' ' 1' ' ' MET . 0.5 OUTLIER -89.89 44.62 1.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.219 0.533 . . . . 0.0 110.187 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.95 ' CD1' HG21 ' A' ' 81' ' ' THR . 5.9 t80 -141.94 91.04 8.24 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 61.3 Cg_exo -40.11 143.45 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.956 2.437 . . . . 0.0 113.554 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.3 p -78.45 -29.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.693 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 4.4 mmp_? -53.57 -53.85 52.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.321 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 23.8 Cg_exo -61.36 -33.13 89.58 Favored 'Trans proline' 0 CA--C 1.515 -0.439 0 C-N-CA 121.699 1.599 . . . . 0.0 110.394 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.35 -30.02 70.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.74 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.7 t80 -65.96 -41.49 91.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 m -59.31 -42.14 90.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.147 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 79' ' ' LEU . 3.5 tt -63.64 -42.65 98.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.66 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -63.54 -18.8 64.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.634 178.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -76.64 -67.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.084 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 19.2 mmtm -55.24 -43.41 74.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.703 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 8' ' ' VAL . 14.6 tt -57.48 -56.27 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.98 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.629 ' N ' HG23 ' A' ' 97' ' ' ILE . 3.0 mm? -54.08 -53.48 52.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.445 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.927 ' HA ' HD12 ' A' ' 102' ' ' LEU . 2.8 m-20 -62.63 -25.92 68.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 124' ' ' GLN . 11.8 tp10 -77.5 -46.37 22.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.617 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.572 ' CZ ' HD21 ' A' ' 19' ' ' LEU . 38.7 t80 -58.4 -32.59 68.77 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -76.43 -32.05 58.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.373 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' ASP . 6.8 t -68.54 -49.39 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.575 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.93 -20.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 111.245 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.558 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -174.18 129.8 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.542 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 79.1 Cg_exo -34.32 158.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.281 2.654 . . . . 0.0 113.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 25.2 mttp -45.51 -62.84 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 pt-20 -60.32 -28.03 67.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 3.9 mm-40 -48.46 -42.19 31.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.658 0.266 . . . . 0.0 111.434 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CE3' ' N ' ' A' ' 111' ' ' ALA . 8.8 p-90 -95.54 -36.71 11.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.321 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 16.03 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.197 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.1 m-20 69.89 75.58 0.22 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.359 0.6 . . . . 0.0 109.763 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 115' ' ' GLU . 2.2 t -66.42 122.49 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -93.23 22.05 5.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.198 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.45 ' H ' HG12 ' A' ' 113' ' ' VAL . 7.8 pt-20 -172.59 85.93 0.07 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.686 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -132.02 -169.51 2.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.4 p30 170.8 -170.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -53.55 -21.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 111.182 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.9 -49.03 72.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 116' ' ' THR . 1.6 mp -87.28 8.12 25.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 20' ' ' SER . 3.8 ttpm? -54.38 161.2 1.45 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.86 0.362 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.754 ' SD ' HD23 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.08 135.67 54.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.982 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.81 -21.49 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.432 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -59.58 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.016 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD23 ' SD ' ' A' ' 122' ' ' MET . 3.2 pp -50.69 -39.99 52.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.507 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.9 t70 -66.5 -58.21 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.021 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' CD ' ' A' ' 131' ' ' LYS . 79.2 m -60.74 -29.29 69.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.968 0.413 . . . . 0.0 110.313 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.58 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 10.3 m-85 -68.99 -60.13 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.982 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.649 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.57 -27.41 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.474 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.3 t -69.62 -59.69 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.803 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -83.7 -17.76 40.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 3.9 m-85 -67.44 -14.27 62.78 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.492 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.85 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -42.01 -30.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.471 ' CB ' ' HD2' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -76.39 169.87 18.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.486 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 134' ' ' ASP . 11.2 Cg_endo -53.11 -23.74 23.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 111.94 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 m -175.21 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 140' ' ' ALA . 2.5 tt0 77.83 -8.44 1.67 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.248 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 62.01 32.36 17.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.783 0.325 . . . . 0.0 111.162 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.01 42.98 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB3' ' HG2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.056 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.38 66.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 6' ' ' ILE . 3.8 tt -64.86 143.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 64' ' ' TYR . 20.8 m-85 -119.51 -32.01 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.6 t80 -149.6 152.07 34.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 112.196 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 3' ' ' ILE . 1.9 mt -151.72 165.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.441 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.892 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.79 -160.61 33.03 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.134 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -150.34 148.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.459 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -150.96 135.19 16.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.847 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -76.4 138.54 40.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.79 89.34 0.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.9 -160.65 29.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.68 -107.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.316 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -85.02 -16.66 40.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 0.0 110.945 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 132.63 47.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.144 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -64.4 168.57 5.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 114' ' ' THR . 0.3 OUTLIER -84.1 -145.68 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.203 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' H ' HD22 ' A' ' 17' ' ' LEU . 10.8 mt-10 -154.14 39.03 0.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.289 . . . . 0.0 110.243 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.7 HD22 ' OH ' ' A' ' 101' ' ' TYR . 62.8 mt -25.09 -55.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.808 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 5.7 p -171.93 116.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -108.22 130.42 55.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 6' ' ' ILE . 9.2 p -120.12 132.89 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.216 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 151.03 37.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 25.1 t70 -128.98 107.18 9.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 33' ' ' ARG . 2.1 mt -128.98 84.3 2.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.293 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -87.17 -61.54 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.291 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -74.3 -18.07 60.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -80.03 114.11 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.684 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.55 -168.57 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.109 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -67.43 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.42 -31.88 66.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.6 tt0 -73.83 -38.48 64.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.838 ' CG ' HD13 ' A' ' 25' ' ' LEU . 36.5 ttt180 -54.96 -38.06 67.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.869 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 t -71.54 -48.32 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -62.64 -55.38 27.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 32' ' ' GLU . 3.1 t -56.63 -39.23 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.626 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 40' ' ' MET . . . -55.83 -48.48 72.09 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.276 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 6.8 tp60 -58.15 -31.68 67.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 62.3 t80 -69.18 -55.73 9.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.521 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.55 ' HE3' HG12 ' A' ' 36' ' ' VAL . 9.3 ptp -59.81 -53.55 56.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.963 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -58.99 -60.9 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 111.452 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 7.2 t80 -45.53 -35.25 3.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.129 0.49 . . . . 0.0 110.644 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -76.21 -38.67 56.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.299 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.79 -35.51 78.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.8 pt-20 -71.42 -38.68 71.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.77 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.2 m -60.03 -55.09 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.74 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.08 -61.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -50.2 -29.75 10.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -73.58 -40.37 63.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.942 178.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.77 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.3 -32.39 60.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 109.979 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.937 ' OG1' HG11 ' A' ' 68' ' ' VAL . 92.0 m -73.3 106.5 5.15 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.91 38.41 2.53 Favored Glycine 0 N--CA 1.454 -0.134 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.575 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 60.26 147.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 111.639 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.01 84.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.37 164.73 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 111.342 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' CD ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -120.0 144.86 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 29.0 mt-30 -123.05 159.01 29.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 111.655 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.61 102.57 3.7 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.709 HG21 ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -95.66 104.24 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.632 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 116.09 31.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 63' ' ' ASN . 9.4 tt0 -127.96 102.93 6.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.86 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.39 -62.06 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.528 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 61' ' ' GLU . 2.3 p30 -160.1 25.34 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.896 0.379 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 6.9 m-85 -131.66 123.6 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.662 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 2.1 mt -108.71 137.53 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.551 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 80' ' ' ILE . . . -117.12 82.72 0.33 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.177 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.828 ' HB2' HD12 ' A' ' 79' ' ' LEU . 84.8 m-70 -57.26 153.39 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.973 ' CG2' HG22 ' A' ' 78' ' ' VAL . 2.0 t -153.17 137.59 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.071 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HD13 ' A' ' 94' ' ' LEU . 12.7 m-85 -149.52 112.46 4.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.089 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -91.4 137.4 32.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.302 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.65 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -61.11 -178.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -47.72 -46.25 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 72' ' ' SER . 5.4 tt0 177.68 95.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.049 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.81 -96.61 0.12 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -112.4 119.81 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' PHE . 21.2 p -92.84 167.14 12.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -126.89 159.24 21.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.649 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.973 HG22 ' CG2' ' A' ' 68' ' ' VAL . 6.4 t -137.04 142.72 36.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 117.294 0.547 . . . . 0.0 112.104 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.55 121.35 19.72 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.537 178.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -108.7 119.78 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.0 0.429 . . . . 0.0 111.647 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.616 HG21 ' CG ' ' A' ' 85' ' ' TYR . 1.5 t -142.63 178.99 7.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . 1.4 t70 -61.67 173.13 1.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 111.899 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -23.07 59.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -87.56 25.23 1.5 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -123.58 73.96 52.89 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -35.47 153.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' ' CE1' ' A' ' 67' ' ' HIS . 9.4 p -74.31 -26.77 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.537 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -46.51 -57.0 9.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.424 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 39.1 Cg_endo -65.49 -25.53 55.51 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.697 1.598 . . . . 0.0 111.029 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' CD1' ' A' ' 79' ' ' LEU . . . -69.78 -30.69 68.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 69' ' ' TYR . 11.9 t80 -70.2 -40.26 74.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 18.7 m -66.94 -41.44 86.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.63 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.684 HD21 HD13 ' A' ' 6' ' ' ILE . 8.9 tp -65.49 -56.63 11.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.152 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD12 HD11 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -60.94 -16.95 48.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 91' ' ' TYR . 19.5 t30 -77.86 -43.47 30.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 110.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -76.51 -37.18 57.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.496 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 125' ' ' LEU . 83.9 mt -61.93 -61.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.645 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 2.7 mp -50.18 -46.76 54.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.366 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.06 -27.7 68.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.876 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 17.9 tp10 -78.21 -27.78 47.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.537 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 25.9 t80 -74.09 -29.85 62.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.826 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.911 HD22 ' CZ2' ' A' ' 110' ' ' TRP . 5.1 mt -66.77 -32.27 73.45 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.674 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 105' ' ' HIS . 6.7 t -68.26 -48.74 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.333 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.24 -19.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.99 0.424 . . . . 0.0 111.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.587 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.66 131.46 0.42 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -28.89 150.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.995 3.13 . . . . 0.0 113.98 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.8 -53.83 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.406 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.36 -27.3 46.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 18.1 tt0 -46.02 -50.13 15.35 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.911 ' CZ2' HD22 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -72.47 -63.3 1.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.49 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.566 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 42.35 28.44 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.154 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 15.3 m-20 129.28 -32.07 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.194 0.998 . . . . 0.0 109.96 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 115' ' ' GLU . 19.7 t 77.09 -71.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.411 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 17' ' ' LEU . 3.5 p 63.41 5.19 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.917 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.761 ' H ' HG12 ' A' ' 113' ' ' VAL . 5.0 pt-20 -160.25 58.14 0.35 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.201 0.524 . . . . 0.0 109.996 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.646 HG21 ' CA ' ' A' ' 19' ' ' LEU . 1.2 t -81.96 -161.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.82 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.642 ' N ' HG23 ' A' ' 116' ' ' THR . 10.9 p30 -140.48 65.97 1.39 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.3 p30 -49.78 -21.44 1.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.736 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.92 -30.7 44.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.942 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.84 -38.48 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' SER . 5.4 mtpt 58.96 159.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.17 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.876 ' HE3' ' HB3' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -86.85 117.13 25.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -49.17 -28.07 4.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.099 0.476 . . . . 0.0 110.559 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -70.31 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.892 HD11 ' CA ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -45.38 -30.92 1.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 129' ' ' ILE . 5.8 t70 -76.78 -56.34 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.508 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m -57.27 -28.42 62.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.453 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 8.8 m-85 -75.31 -42.46 54.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -73.13 -26.92 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.167 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -76.83 -39.23 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 110.665 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -83.06 -28.72 29.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.74 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.607 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -64.51 -12.24 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.813 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.2 tm0? -66.03 57.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.127 0.489 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t0 66.6 60.12 0.96 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.915 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.33 -45.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.584 2.189 . . . . 0.0 112.024 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 m -153.08 13.49 0.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 48.17 51.66 14.46 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 52.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.778 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.63 40.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.674 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.19 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.723 0.297 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.25 169.93 21.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 111.123 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.5 tt -70.7 147.75 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 64' ' ' TYR . 54.4 m-85 -122.34 -33.05 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 6.5 t80 -147.33 151.7 36.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 112.336 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.904 HG22 HD13 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -148.93 164.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.947 178.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.74 -171.08 32.49 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.977 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 20' ' ' SER . 1.0 OUTLIER -134.03 155.47 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 110.757 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 2.9 m-85 -152.78 136.54 16.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.271 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.846 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.73 127.74 38.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -56.28 89.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.114 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ARG . . . -68.77 -145.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.469 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.87 -85.58 0.54 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -90.61 -13.49 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.637 0.256 . . . . 0.0 111.288 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 -176.79 4.98 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.723 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -96.67 153.48 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 18' ' ' GLU . 4.4 tt -94.49 154.05 17.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.468 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.787 ' N ' HD23 ' A' ' 17' ' ' LEU . 2.4 mp0 -85.53 82.22 8.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.456 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 10' ' ' ARG . 42.0 mt -77.52 -30.14 52.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.088 0.471 . . . . 0.0 110.654 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -165.95 132.96 2.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.018 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.19 111.9 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.163 0.506 . . . . 0.0 111.898 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.628 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.3 p -120.86 132.61 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.141 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -110.21 154.24 23.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.767 0.794 . . . . 0.0 113.14 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -134.0 107.21 7.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.594 177.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.822 HD23 ' CD1' ' A' ' 28' ' ' PHE . 1.2 mt -134.82 88.33 2.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.207 0.527 . . . . 0.0 111.413 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.9 -37.65 8.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.938 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -88.44 -22.88 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.822 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -82.51 114.4 20.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.539 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.87 171.04 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -64.41 -12.94 48.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -91.24 -51.48 5.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.143 0.497 . . . . 0.0 109.841 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.869 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt0 -73.58 -34.49 65.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.512 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.794 ' HA ' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -47.5 -29.59 2.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.461 . . . . 0.0 110.538 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -75.56 -49.18 19.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.659 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -41.76 94.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.252 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -68.12 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 110.074 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.93 -44.83 82.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.85 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.15 -34.77 78.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 43.0 t80 -64.61 -41.22 96.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.215 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 12.1 mmt -58.84 -59.06 6.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.93 -60.61 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.481 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 42.2 t80 -42.48 -42.45 3.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.106 0.479 . . . . 0.0 110.794 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.92 -39.98 69.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.246 179.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -64.63 -40.69 95.91 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.341 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 10.5 pt-20 -69.66 -34.03 73.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.644 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.3 m -65.24 -54.12 34.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.786 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.98 -61.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.746 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 9' ' ' PHE . . . -53.47 -30.64 41.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' THR . 1.3 t -72.44 -33.89 67.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.826 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -76.81 -44.51 32.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.708 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.936 ' OG1' HG11 ' A' ' 68' ' ' VAL . 25.1 m -71.76 106.48 4.14 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.399 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.39 40.72 2.21 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.919 -0.657 . . . . 0.0 113.465 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.76 146.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.483 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.75 4.07 84.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.422 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -141.39 173.83 11.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HG2' ' CG ' ' A' ' 69' ' ' TYR . 26.1 mtm180 -120.09 154.29 34.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.7 mt-30 -140.93 127.54 20.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.319 0.58 . . . . 0.0 112.463 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -118.81 101.89 8.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.804 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.03 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -89.52 125.84 35.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.526 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -116.42 172.78 6.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.38 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.0 -27.54 2.51 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.675 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 14.9 p-10 -165.93 34.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CE2' ' CE2' ' A' ' 4' ' ' TYR . 69.6 m-85 -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.8 mt -108.34 153.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.03 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.71 75.33 0.41 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.182 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.6 m-70 -56.28 154.82 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.792 0.33 . . . . 0.0 110.832 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 78' ' ' VAL . 2.5 t -147.61 139.7 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.779 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.9 m-85 -143.04 111.06 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.218 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -94.66 153.28 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 -178.39 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.753 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t -45.89 -47.8 16.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.354 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -179.83 100.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.51 -93.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.577 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -111.93 133.21 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 110.492 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 9' ' ' PHE . 29.9 p -108.07 138.11 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 111.994 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -91.53 136.77 13.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.526 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.018 HG22 HG22 ' A' ' 68' ' ' VAL . 2.3 t -106.68 144.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.353 0.597 . . . . 0.0 111.686 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -134.27 110.05 9.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.708 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -112.04 120.28 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.967 0.413 . . . . 0.0 111.896 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.842 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.8 -174.27 4.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.511 ' N ' ' OG1' ' A' ' 81' ' ' THR . 19.8 t70 -81.7 163.32 22.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.926 0.393 . . . . 0.0 111.589 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -25.47 51.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.925 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.22 39.68 0.91 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.842 ' CD1' HG21 ' A' ' 81' ' ' THR . 7.8 t80 -137.95 81.24 28.08 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.54 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.2 162.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.847 2.364 . . . . 0.0 112.879 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 67' ' ' HIS . 20.1 t -76.1 -34.41 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.464 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HG2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -39.76 -60.65 1.29 Allowed Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 88' ' ' ARG . 39.7 Cg_endo -66.8 -26.89 44.65 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.981 1.787 . . . . 0.0 110.981 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.72 -27.43 66.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -70.89 -47.92 56.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 7.1 m -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.869 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.863 ' HG ' HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -63.42 -58.82 5.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.84 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HG ' HD12 ' A' ' 79' ' ' LEU . 5.6 mt -63.27 -10.27 15.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.731 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' THR . 46.1 t30 -77.3 -60.98 2.14 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 120.924 0.392 . . . . 0.0 110.58 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -58.7 -39.52 81.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 125' ' ' LEU . 14.5 tt -61.15 -57.06 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.746 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' N ' HG23 ' A' ' 97' ' ' ILE . 1.9 mp -59.64 -42.19 92.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.752 0.311 . . . . 0.0 110.173 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.36 -27.92 66.67 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 35.5 tp10 -76.25 -28.6 57.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.004 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.7 t80 -75.12 -30.0 60.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.497 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 1.1 mt -72.09 -31.83 66.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.487 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' N ' ' A' ' 105' ' ' HIS . 15.1 t -70.94 -51.17 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.07 -20.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.011 0.434 . . . . 0.0 111.224 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.554 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -175.04 132.3 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.098 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 105' ' ' HIS . 83.1 Cg_exo -31.27 155.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.722 2.948 . . . . 0.0 113.917 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 10.3 mttp -50.52 -62.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.519 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -27.44 63.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -43.48 -49.33 7.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 111.333 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.637 ' CB ' HG22 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -80.19 -60.57 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.919 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 112' ' ' ASP . . . 44.76 21.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.628 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 3.6 p30 143.48 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.076 0.95 . . . . 0.0 108.861 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.637 HG22 ' CB ' ' A' ' 110' ' ' TRP . 9.5 t 75.52 -62.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.847 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.513 HG23 ' C ' ' A' ' 113' ' ' VAL . 1.3 p 73.21 -11.51 0.89 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.852 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' H ' HG12 ' A' ' 113' ' ' VAL . 10.4 pt-20 -145.41 23.16 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' ASN . 6.1 t 41.82 -167.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.279 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.47 ' ND2' ' CE1' ' A' ' 105' ' ' HIS . 0.7 OUTLIER 173.93 -40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.017 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD2' ' CD2' ' A' ' 101' ' ' TYR . 16.5 m-20 -76.85 -29.3 55.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.694 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 19' ' ' LEU . . . -52.93 -51.27 61.9 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -22.34 61.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.399 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -149.81 103.72 3.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.553 ' HE1' ' HB3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -168.41 58.29 0.06 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 178.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -50.99 -23.83 3.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 128' ' ' TYR . 2.1 tp60 -50.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 HG22 ' A' ' 6' ' ' ILE . 2.7 pp -62.65 -34.41 77.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.373 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 125' ' ' LEU . 58.5 m-20 -60.24 -59.39 5.48 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.084 0.468 . . . . 0.0 111.031 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 22.2 m -61.45 -28.6 69.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 93' ' ' LEU . 5.1 m-85 -71.62 -48.46 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.669 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -63.42 -24.87 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.479 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.5 t -77.24 -45.3 26.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.048 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -83.91 -30.01 26.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.732 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CD2' HD23 ' A' ' 93' ' ' LEU . 5.2 m-85 -63.85 -12.4 35.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.639 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.927 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.9 mt-30 -36.74 -31.58 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.63 167.0 40.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 0.0 111.094 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.5 -31.19 22.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m -166.67 72.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.658 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 30.0 mm-40 -44.49 -27.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 79.3 92.11 0.06 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.163 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.62 52.95 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.085 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.865 0.364 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -173.65 150.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.956 HG22 ' HA ' ' A' ' 133' ' ' GLN . 8.3 tt -64.91 149.67 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' ASP . 13.6 m-85 -117.68 -55.54 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 10.2 t80 -126.41 156.62 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.075 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.753 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.1 mt -157.07 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.858 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . 153.01 -163.47 30.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.729 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -130.86 163.31 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 69.9 m-85 -151.49 116.74 5.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.815 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -91.12 107.3 19.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 178.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 p -48.91 113.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.308 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.46 94.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.579 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.67 -164.57 12.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.651 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.23 -26.79 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -165.61 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.237 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -81.11 149.93 28.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.884 0.373 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 10' ' ' ARG . 2.0 tt -88.04 148.58 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.674 ' O ' HG21 ' A' ' 116' ' ' THR . 2.0 tt0 -74.27 74.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.401 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CZ ' ' A' ' 10' ' ' ARG . 3.5 tp -59.6 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.313 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.802 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.0 t -115.04 132.7 56.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -124.6 112.27 16.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 126' ' ' ASP . 14.5 p -131.7 142.96 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.996 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -139.02 166.25 24.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.537 0.684 . . . . 0.0 112.495 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' TYR . 5.9 t0 -129.43 107.01 9.17 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.401 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.9 mm? -103.86 69.0 0.94 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.941 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -74.0 -75.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -82.26 -15.98 51.13 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HD2' HG21 ' A' ' 36' ' ' VAL . 4.5 m-85 -66.94 113.99 5.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.928 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.13 -177.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.147 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -44.53 90.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -83.18 -29.51 28.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.913 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -77.46 -42.44 35.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.49 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -52.44 -31.78 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -74.72 -53.12 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.68 -47.69 79.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.7 t -62.52 -41.6 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.579 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.93 -47.57 47.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.524 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -64.97 -33.68 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.11 -36.17 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.375 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG12 ' A' ' 36' ' ' VAL . 8.2 mtt -62.55 -59.27 5.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -58.81 -51.01 71.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.675 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 12.3 t80 -45.31 -43.12 10.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.143 0.497 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.78 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -73.61 -31.29 63.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.535 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.912 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.88 -34.6 62.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.1 pt-20 -71.31 -38.4 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.77 79.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.576 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -52.08 -62.33 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -51.83 -29.54 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.105 0.479 . . . . 0.0 109.81 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -74.05 -41.34 61.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.144 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.75 -33.45 52.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.956 0.407 . . . . 0.0 110.401 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.801 ' OG1' HG11 ' A' ' 68' ' ' VAL . 35.9 m -69.1 106.79 2.93 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.54 37.66 1.85 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.165 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 59.51 142.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.041 0.448 . . . . 0.0 111.74 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.46 5.06 81.74 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' THR . 9.3 mm-40 -138.92 144.94 39.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 111.243 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 31.5 mtm180 -94.2 149.06 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.45 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.2 mp0 -131.76 131.51 43.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.0 111.787 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -123.02 102.19 7.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -88.57 106.64 16.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.354 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -96.98 109.04 21.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.728 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -114.99 172.5 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.3 55.52 1.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.246 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -173.56 -45.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.344 . . . . 0.0 110.601 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -167.39 -177.31 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.347 0.594 . . . . 0.0 111.728 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.9 mt -107.61 159.23 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.86 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.38 82.1 0.29 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' LEU . 88.2 m-70 -59.94 158.31 11.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.929 0.395 . . . . 0.0 111.388 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 78' ' ' VAL . 1.6 t -152.06 144.33 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.711 ' OH ' HG22 ' A' ' 87' ' ' VAL . 95.7 m-85 -145.25 112.03 5.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.4 142.4 37.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.379 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.26 166.82 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 p -70.03 -22.6 63.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -55.26 -71.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.44 -20.81 0.2 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.26 109.0 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 29.9 p -98.57 169.37 9.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.327 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -124.95 150.97 17.26 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.577 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -123.92 147.31 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.367 0.583 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -134.95 123.13 22.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.833 178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -117.03 117.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.548 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.683 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.3 t -137.41 175.21 9.81 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -72.71 167.35 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.22 -18.51 61.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.024 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -88.41 29.53 0.97 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.135 0.493 . . . . 0.0 110.489 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.683 ' CD1' HG21 ' A' ' 81' ' ' THR . 1.1 t80 -137.21 84.47 24.28 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.05 151.36 1.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.914 2.41 . . . . 0.0 112.923 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.711 HG22 ' OH ' ' A' ' 69' ' ' TYR . 7.5 p -66.58 -26.45 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HB2' ' CD ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.35 -61.48 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.53 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.594 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 18.1 Cg_endo -59.37 -27.41 84.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.601 1.534 . . . . 0.0 110.734 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.78 66.71 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -45.46 68.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.546 HG22 ' HE3' ' A' ' 96' ' ' LYS . 6.2 m -61.56 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.804 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.599 HD22 HD23 ' A' ' 79' ' ' LEU . 5.8 tt -62.36 -53.24 57.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -67.47 -8.31 32.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.152 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -50.92 12.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.133 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.83 -36.0 75.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.957 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 94' ' ' LEU . 6.6 tt -64.05 -53.4 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.688 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -60.65 -40.57 92.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -27.05 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 23.7 tp10 -78.09 -31.67 50.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.586 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' OH ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -70.83 -29.06 65.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.848 HD13 ' O ' ' A' ' 98' ' ' LEU . 7.6 mp -76.01 -40.55 53.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 105' ' ' HIS . 12.2 t -72.63 -49.94 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.69 -20.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.595 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.4 131.25 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.907 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -31.96 151.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.573 2.849 . . . . 0.0 113.754 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -49.47 -42.83 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.339 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 4.5 mm-40 -78.28 -26.92 47.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.508 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 2.1 tt0 -45.25 -41.66 8.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.055 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.73 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -101.34 -47.83 4.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.443 179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 28.21 44.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.469 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 111' ' ' ALA . 9.3 t0 76.42 82.04 0.09 Allowed 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 110' ' ' TRP . 2.3 t -92.81 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.946 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.525 ' H ' HG12 ' A' ' 113' ' ' VAL . 69.7 p -107.3 14.52 25.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.334 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -164.41 145.45 8.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.909 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.909 HG23 HD12 ' A' ' 120' ' ' LEU . 15.2 t -124.0 -179.18 4.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.0 111.767 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -175.14 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -76.86 -40.72 46.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.091 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -58.4 -49.59 76.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 116' ' ' THR . 0.6 OUTLIER -52.04 -27.5 13.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.32 48.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.019 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.553 ' HE1' ' HB3' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -97.01 80.52 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -50.75 -26.32 5.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.22 -72.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 97' ' ' ILE . 2.9 pp -56.4 -31.8 64.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.81 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.3 m-20 -58.68 -58.41 8.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.4 m -59.86 -27.61 66.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 5.0 m-85 -71.14 -54.08 12.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.634 HG13 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -60.4 -26.24 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.759 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -40.68 38.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -83.69 -29.82 27.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.371 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' CG ' HD12 ' A' ' 93' ' ' LEU . 2.7 m-85 -68.78 -13.37 62.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.805 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.956 ' HA ' HG22 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -41.81 -32.93 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.73 0.3 . . . . 0.0 111.502 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' GLN . 27.9 t70 168.64 63.0 0.01 OUTLIER Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.99 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.56 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -175.01 31.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.057 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 5.0 mt-30 47.03 28.03 0.83 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.961 0.41 . . . . 0.0 110.848 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . . . 54.64 78.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.368 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.05 54.79 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.111 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.322 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 60.86 -176.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 6' ' ' ILE . 7.0 tt -64.78 143.23 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 40' ' ' MET . 1.1 p90 -126.55 -26.33 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 15.0 t80 -150.09 150.71 32.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.683 0.754 . . . . 0.0 112.192 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -152.15 162.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.538 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.942 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 156.09 -169.13 33.63 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.907 -1.139 . . . . 0.0 112.816 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -132.06 162.18 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' CZ ' ' HB1' ' A' ' 44' ' ' ALA . 29.9 m-85 -153.71 171.01 19.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.291 0.567 . . . . 0.0 112.059 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.77 ' CZ ' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -133.89 105.63 6.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.411 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.44 101.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.617 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 10' ' ' ARG . . . -96.96 27.48 18.02 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.549 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.03 -104.17 3.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.719 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.29 -29.64 61.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 111.185 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 162.63 39.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -78.79 158.85 28.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' A' ' 114' ' ' THR . 3.1 tt -96.76 151.41 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.738 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.36 71.21 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 8' ' ' VAL . 1.5 tp -64.32 -40.39 95.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -167.5 131.98 1.87 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.406 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.32 114.09 12.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 6' ' ' ILE . 10.9 p -119.99 132.67 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.329 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 166.63 10.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.774 0.797 . . . . 0.0 112.806 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.82 ' HB2' HD11 ' A' ' 129' ' ' ILE . 0.9 OUTLIER -148.36 107.37 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.428 177.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 28' ' ' PHE . 2.5 mt -131.98 84.93 2.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -110.67 -14.07 14.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -21.97 9.72 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' CD2' HD23 ' A' ' 25' ' ' LEU . 1.9 m-85 -76.03 124.55 27.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -167.35 0.05 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.501 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -75.98 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.211 -0.495 . . . . 0.0 111.679 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.87 -26.73 67.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.671 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.7 tt0 -65.52 -43.73 89.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.81 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -49.53 -47.89 48.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -61.69 -48.55 80.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.113 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -61.38 -44.36 97.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.309 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -68.31 -36.57 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.86 -52.99 45.08 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.316 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -61.53 -33.95 74.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.8 t80 -64.43 -38.21 90.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.01 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.722 ' HE3' HD21 ' A' ' 25' ' ' LEU . 18.0 mtt -61.75 -59.49 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.624 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.24 -61.05 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.605 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 2.6 t80 -44.93 -43.04 8.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.817 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -72.11 -36.89 69.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.616 179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.915 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -69.37 -39.54 77.98 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.268 0.556 . . . . 0.0 111.523 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.7 pt-20 -67.83 -37.58 82.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.859 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.8 m -63.27 -53.86 46.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.235 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.847 HG13 ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -47.56 -61.37 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 120.878 0.371 . . . . 0.0 111.112 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -55.53 -29.25 58.56 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.134 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 p -80.13 -29.67 38.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.767 ' HG2' ' HA ' ' A' ' 47' ' ' VAL . 7.4 ptp180 -86.88 -30.55 21.33 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.926 ' OG1' HG11 ' A' ' 68' ' ' VAL . 91.4 m -77.33 106.87 9.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.54 40.53 2.6 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.854 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 57.61 156.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 111.656 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.16 75.88 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.329 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -159.04 165.4 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.86 144.62 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 24.2 mm-40 -124.49 136.15 53.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.748 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -126.37 102.35 7.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.11 107.93 19.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.657 -178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 1.5 mt-10 -96.02 117.85 31.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.36 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' ASN . 1.1 mm-40 -117.35 103.1 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.44 -63.42 0.06 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.891 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.5 t-20 -152.04 18.54 0.67 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 5.2 m-85 -118.12 -179.64 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.213 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 81' ' ' THR . 1.7 mt -153.71 149.43 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.069 0.461 . . . . 0.0 110.972 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -134.31 84.73 0.27 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.195 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 79' ' ' LEU . 79.0 m-70 -61.04 154.98 21.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 78' ' ' VAL . 2.3 t -152.43 137.92 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.949 0.404 . . . . 0.0 111.448 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.98 ' CD1' HD13 ' A' ' 94' ' ' LEU . 3.8 m-85 -141.29 111.54 6.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.463 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -110.49 155.33 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.923 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.79 170.02 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.476 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.8 m -80.22 -1.46 40.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.64 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG3' ' CH2' ' A' ' 110' ' ' TRP . 39.8 mm-40 -74.3 -74.45 0.19 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.549 0.214 . . . . 0.0 111.345 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.62 -30.65 0.05 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.464 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.524 ' CG2' ' CE3' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -108.54 135.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.324 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 70' ' ' ALA . 26.9 p -118.53 156.73 28.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.982 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 8' ' ' VAL . . . -102.21 138.04 13.69 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.983 HG22 HG22 ' A' ' 68' ' ' VAL . 1.6 t -113.22 144.59 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.487 0.661 . . . . 0.0 112.328 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.052 HD11 HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -134.46 132.85 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.932 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -134.66 119.52 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.12 0.486 . . . . 0.0 111.825 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.651 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -141.7 -177.41 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.736 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.7 t70 -78.51 164.49 24.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -21.91 42.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.964 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -86.84 33.51 0.66 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.089 0.471 . . . . 0.0 110.502 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CG ' HG21 ' A' ' 81' ' ' THR . 1.6 t80 -139.03 80.07 24.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.222 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 71.6 Cg_exo -40.63 162.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.045 2.497 . . . . 0.0 113.339 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 91' ' ' TYR . 7.0 t -79.0 -26.43 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.683 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -54.73 -52.35 70.98 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.239 -179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 10.9 Cg_exo -69.74 -36.37 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.99 1.793 . . . . 0.0 110.93 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -66.43 -28.33 68.52 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 3.0 t80 -70.67 -37.64 73.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -64.6 -44.59 90.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.052 HD22 HD11 ' A' ' 79' ' ' LEU . 5.1 tt -68.0 -38.13 82.26 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.503 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.98 HD13 ' CD1' ' A' ' 69' ' ' TYR . 6.7 mt -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.389 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -64.56 1.11 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.592 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -54.89 -46.77 74.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 125' ' ' LEU . 11.9 tt -53.55 -53.42 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.641 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.1 mm? -55.39 -58.52 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.637 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -26.13 67.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.481 0.658 . . . . 0.0 110.32 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 122' ' ' MET . 46.6 tp10 -68.69 -58.24 4.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.412 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.773 ' OH ' HG21 ' A' ' 116' ' ' THR . 34.4 t80 -59.72 -28.73 67.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.883 HD12 ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -66.8 -36.39 82.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.503 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.07 -46.98 64.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.44 -21.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 111.522 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -169.74 132.67 1.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 99.2 Cg_exo -30.86 150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.639 2.892 . . . . 0.0 113.524 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 14.7 pttt -45.19 -54.75 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.365 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.42 -27.55 46.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 106' ' ' PRO . 14.0 tt0 -44.75 -48.51 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 111.246 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.557 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 2.7 p-90 -82.09 -53.16 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.822 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . 34.0 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.395 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 111' ' ' ALA . 31.5 m-20 122.7 -49.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.177 0.991 . . . . 0.0 109.988 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.701 HG11 ' OG1' ' A' ' 116' ' ' THR . 12.6 t 76.9 -51.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.812 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.77 HG23 ' CZ ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 65.82 7.73 4.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.374 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.407 ' HG3' HG12 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -166.4 81.62 0.26 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.773 HG21 ' OH ' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -143.1 178.35 7.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.379 0.609 . . . . 0.0 111.777 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.673 ' H ' HG22 ' A' ' 116' ' ' THR . 64.9 t30 -168.58 150.06 4.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.711 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' ' HA ' ' A' ' 20' ' ' SER . 14.2 p-10 -56.55 -19.47 15.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.86 61.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.978 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD13 HG23 ' A' ' 116' ' ' THR . 0.3 OUTLIER -67.92 -48.86 64.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.97 108.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.792 0.329 . . . . 0.0 111.53 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.846 ' HG3' HD22 ' A' ' 125' ' ' LEU . 6.0 tpt -175.82 31.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -24.82 5.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.982 0.42 . . . . 0.0 110.594 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -62.62 -73.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.976 HD12 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -50.53 -28.31 8.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.516 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.946 ' N ' HD23 ' A' ' 125' ' ' LEU . 60.5 m-20 -69.6 -58.25 4.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.271 0.558 . . . . 0.0 109.948 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 m -56.8 -27.59 60.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.576 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 3.9 m-85 -73.0 -60.09 2.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.19 -28.55 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.205 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -75.18 -50.68 15.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.548 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HD3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.97 -17.81 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.543 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -79.56 -14.62 58.72 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.5 pp0? -51.67 -20.59 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.68 155.04 37.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.198 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.67 -26.59 23.11 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.816 2.344 . . . . 0.0 112.262 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -21.38 26.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.228 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.572 ' CB ' ' HB3' ' A' ' 140' ' ' ALA . 31.9 mt-30 60.33 32.91 20.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 110.552 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.541 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . 59.28 73.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.177 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.07 52.34 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB3' ' CB ' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -144.51 169.06 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 133' ' ' GLN . 16.6 tt -66.77 145.69 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.714 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' ASP . 16.0 m-85 -120.45 -39.57 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.4 t80 -139.35 149.05 43.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.08 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 3' ' ' ILE . 1.7 mt -149.6 165.92 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.475 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.878 ' CA ' HD11 ' A' ' 125' ' ' LEU . . . 162.8 -157.85 29.96 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.713 -1.232 . . . . 0.0 113.412 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.49 141.86 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.583 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.833 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 4.5 m-85 -145.29 129.88 17.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.907 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -75.46 116.52 16.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.973 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.57 96.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 111.367 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.76 -147.98 3.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.431 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 -81.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.401 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.16 -26.11 62.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -173.73 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.512 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . . . -85.54 -175.7 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 111.208 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD11 ' C ' ' A' ' 114' ' ' THR . 0.3 OUTLIER -107.03 -154.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -141.44 45.89 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.49 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.812 HD22 ' OH ' ' A' ' 101' ' ' TYR . 55.0 mt -40.43 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -135.48 102.92 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -103.74 124.11 48.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.7 p -120.53 139.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.863 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 162.4 23.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.462 0.649 . . . . 0.0 112.257 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t70 -132.55 107.1 8.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.923 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD11 ' HE3' ' A' ' 40' ' ' MET . 2.2 mm? -109.49 69.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.926 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -65.28 -86.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -74.34 -16.64 60.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 111.045 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' HD2' HG21 ' A' ' 36' ' ' VAL . 1.2 m-85 -72.27 125.79 28.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.482 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.02 -16.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.354 -0.926 . . . . 0.0 113.576 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 31' ' ' PHE . 45.1 p90 -83.18 38.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.21 0.505 . . . . 0.0 111.398 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m-85 90.4 10.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.885 0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.5 pt-20 -111.98 -27.82 8.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -47.8 -45.74 29.9 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.135 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -58.24 -50.98 71.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -62.44 -43.75 98.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.15 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.2 t -62.97 -49.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.729 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -48.55 -53.5 16.48 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.432 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -58.4 -30.47 66.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -68.23 -45.03 74.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.327 178.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.675 ' HE3' HD11 ' A' ' 25' ' ' LEU . 12.3 mtt -63.09 -56.36 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.151 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -58.19 -60.23 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 13.6 t80 -42.78 -42.88 3.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.231 0.539 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -72.43 -39.26 68.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.901 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB1' ' CE2' ' A' ' 9' ' ' PHE . . . -63.42 -41.17 98.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.288 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 8.6 pt-20 -69.94 -33.38 72.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.604 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -65.5 -52.02 55.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.888 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.966 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.38 -61.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.109 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -54.88 -29.69 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.334 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -71.32 -42.65 68.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.556 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.2 -6.34 58.75 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.318 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.871 ' OG1' HG11 ' A' ' 68' ' ' VAL . 99.9 m -95.11 107.46 19.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -80.16 35.25 2.16 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.234 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 58.88 143.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 111.653 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.41 3.74 83.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.221 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.23 175.78 9.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -128.88 151.31 49.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.297 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 26.4 mm100 -131.47 164.87 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.453 0.644 . . . . 0.0 111.899 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.03 101.95 2.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -94.52 106.79 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.236 -178.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -91.43 108.85 20.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.724 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -107.43 172.28 6.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.85 55.09 3.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.193 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 6.5 t-20 -178.95 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.662 0.268 . . . . 0.0 110.751 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -167.19 -177.01 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.258 0.552 . . . . 0.0 111.819 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 3.1 mt -107.73 162.43 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.773 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -135.89 74.73 0.42 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.232 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 87' ' ' VAL . 88.9 m-70 -57.3 160.8 3.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.966 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -152.22 145.57 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.246 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.83 ' CD1' HD22 ' A' ' 94' ' ' LEU . 56.3 m-85 -145.22 115.62 7.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.019 0.438 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -107.65 144.85 34.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CG ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -99.21 172.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.728 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -94.1 39.88 1.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.598 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -116.55 -58.63 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.6 -26.2 0.19 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.618 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.621 ' O ' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -116.04 119.92 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB1' ' A' ' 70' ' ' ALA . 3.2 m -98.03 163.93 12.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.061 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.46 162.57 19.69 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.07 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.851 HG22 ' CG2' ' A' ' 68' ' ' VAL . 3.8 t -122.55 147.83 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.288 0.566 . . . . 0.0 112.443 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.01 101.14 4.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.327 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.4 118.43 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 111.738 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.015 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.0 OUTLIER -139.98 -172.46 3.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 81' ' ' THR . 14.8 t70 -84.9 163.95 18.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.09 66.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.73 48.86 1.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.159 0.504 . . . . 0.0 110.535 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.015 ' CD1' HG21 ' A' ' 81' ' ' THR . 27.8 t80 -139.17 87.07 14.15 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.265 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 54.7 Cg_exo -38.58 146.48 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.082 2.521 . . . . 0.0 113.478 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 67' ' ' HIS . 3.7 t -78.79 -30.15 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.015 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -47.89 -52.93 35.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.647 -178.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 11.8 Cg_exo -68.56 -29.63 30.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.744 1.629 . . . . 0.0 110.602 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.53 72.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.855 ' HA ' HD23 ' A' ' 94' ' ' LEU . 5.5 m-85 -67.1 -44.08 80.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 m -58.22 -40.17 80.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.596 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 HD11 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -58.54 -56.73 18.36 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.4 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -54.99 -21.69 12.77 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 5.5 t-20 -76.26 -42.01 47.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.443 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -80.52 -44.96 18.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.963 0.411 . . . . 0.0 110.207 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.03 HD11 HD22 ' A' ' 93' ' ' LEU . 60.9 mt -59.36 -61.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.682 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 71' ' ' ARG . 14.4 mt -57.62 -42.95 84.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 102' ' ' LEU . 35.3 t70 -64.73 -27.14 68.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.498 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 4.7 tp10 -81.97 -30.42 31.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.11 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 19' ' ' LEU . 5.6 t80 -67.79 -34.18 76.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.056 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -77.53 -35.01 53.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.173 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' C ' ' N ' ' A' ' 105' ' ' HIS . 13.8 t -71.19 -50.98 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.847 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.48 -19.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -175.64 128.35 0.38 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.022 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.556 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 73.9 Cg_exo -35.03 157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.127 2.552 . . . . 0.0 113.378 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.669 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -45.52 -60.59 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -63.18 -27.28 69.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' PRO . 1.4 mm-40 -46.76 -35.08 5.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.402 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CZ2' HD23 ' A' ' 102' ' ' LEU . 1.9 p-90 -110.03 -41.59 4.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.25 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . . . 23.07 60.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.835 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 75' ' ' ILE . 1.8 m-20 71.04 75.8 0.18 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.486 HG11 ' OG1' ' A' ' 116' ' ' THR . 2.0 t -73.07 130.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.311 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.502 ' C ' HD11 ' A' ' 17' ' ' LEU . 40.5 p -95.27 19.61 10.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.579 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.76 110.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.991 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 19' ' ' LEU . 86.9 m -159.71 166.53 30.34 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.527 ' N ' HG22 ' A' ' 116' ' ' THR . 12.6 m-20 -157.57 140.33 14.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.418 ' N ' ' HA ' ' A' ' 20' ' ' SER . 10.0 p-10 -48.86 -27.3 2.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.77 -26.14 13.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.67 -57.3 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -160.16 -171.75 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.204 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.706 ' HE1' ' CG2' ' A' ' 97' ' ' ILE . 2.9 tpt 95.85 29.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.672 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -26.47 11.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.992 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -60.23 -68.01 0.34 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.824 179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.922 HD12 HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -47.38 -32.43 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.704 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 129' ' ' ILE . 8.8 m-20 -70.06 -58.68 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -59.83 -28.34 67.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.533 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.7 m-85 -67.9 -57.75 5.71 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.62 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -55.34 -28.41 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -64.95 -59.39 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.699 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -83.31 -20.02 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.533 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 m-85 -64.25 -13.24 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.514 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 1.036 ' HA ' HG22 ' A' ' 3' ' ' ILE . 44.3 mt-30 -36.75 -30.67 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.64 163.04 68.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.9 -29.13 88.74 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.104 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -95.94 -81.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.727 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 3.4 pt20 175.06 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.148 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 137' ' ' GLN . . . 72.59 76.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.548 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t0 56.51 57.27 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.017 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' CG ' ' CB ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.973 0.416 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -157.31 153.52 27.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 133' ' ' GLN . 15.8 tt -65.3 158.76 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.15 -39.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.911 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.7 t80 -143.7 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.468 0.652 . . . . 0.0 112.029 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -154.45 168.9 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.436 178.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.95 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.01 -165.89 36.67 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.098 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -145.68 144.65 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.561 -0.319 . . . . 0.0 110.383 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -152.95 133.94 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 111.671 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HG3' ' CA ' ' A' ' 112' ' ' ASP . 0.5 OUTLIER -91.13 137.83 32.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.042 178.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 99.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 110.934 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.59 -124.15 2.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.72 -92.11 2.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -25.39 68.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.08 -174.56 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.615 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -86.27 129.89 34.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.379 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 4.7 tt -62.83 107.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.262 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.38 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.676 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 1.2 tp -66.04 -72.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 118' ' ' ASP . 2.7 p -149.22 116.32 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.189 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' CB ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -109.81 129.24 55.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' CG1' HG21 ' A' ' 129' ' ' ILE . 7.2 p -120.18 140.45 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.209 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.0 149.75 43.04 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -129.59 107.05 9.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.141 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.768 HD23 ' CD2' ' A' ' 28' ' ' PHE . 4.6 mt -126.4 82.89 2.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.03 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.3 m -102.43 -25.61 13.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.834 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -100.19 -22.65 15.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.768 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -88.38 124.24 33.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 110.46 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.69 169.16 0.03 OUTLIER Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.119 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -65.35 -23.14 66.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -92.79 -36.18 13.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 36' ' ' VAL . 27.9 tt0 -79.2 -40.26 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.656 ' HB2' HD13 ' A' ' 25' ' ' LEU . 4.8 ptm180 -47.99 -36.31 12.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -61.39 -55.0 36.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.125 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -61.05 -42.75 99.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.569 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 32' ' ' GLU . 2.1 t -61.33 -48.16 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.432 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' ' HE3' ' A' ' 40' ' ' MET . . . -48.68 -51.21 23.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.58 -32.02 68.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.61 -46.6 72.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.387 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.596 ' CE ' HD21 ' A' ' 25' ' ' LEU . 15.0 mtm -63.74 -49.35 73.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HE2' ' A' ' 5' ' ' TYR . 10.5 m -62.46 -59.6 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.5 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.8 t80 -44.52 -39.58 4.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -71.61 -32.7 68.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.53 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.5 -40.68 56.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.213 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 42' ' ' PHE . 9.3 pt-20 -64.31 -37.41 87.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.2 m -62.62 -55.28 28.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.058 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.82 -62.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.353 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 78' ' ' VAL . . . -53.58 -29.59 38.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -73.75 -40.33 63.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -84.92 -13.83 49.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.919 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.534 ' OG1' HG11 ' A' ' 68' ' ' VAL . 54.5 m -86.94 107.3 18.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' ALA . . . -81.93 40.14 2.63 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.297 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . . . 56.33 156.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.109 0.455 . . . . 0.0 111.8 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.28 15.2 72.28 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 168.94 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.055 0.455 . . . . 0.0 111.232 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.36 155.27 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.08 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 22.2 mm-40 -137.7 142.79 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.444 0.64 . . . . 0.0 112.245 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -130.44 102.31 6.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -83.51 104.27 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.469 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 108.88 20.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.105 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 172.08 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.4 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.8 -12.02 52.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.767 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.4 m-80 -104.01 -43.37 5.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.848 0.324 . . . . 0.0 111.787 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 81' ' ' THR . 2.2 p90 -167.3 -172.35 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 0.0 112.435 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 2.2 mt -106.94 154.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -128.58 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.932 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' LEU . 82.7 m-70 -65.82 159.57 25.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.055 0.455 . . . . 0.0 111.366 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 78' ' ' VAL . 1.4 t -152.23 140.11 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.288 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.674 ' CG ' HD22 ' A' ' 94' ' ' LEU . 48.4 m-85 -146.26 111.02 5.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 53' ' ' ALA . . . -108.15 145.93 33.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.696 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -100.44 172.18 7.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.689 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -80.45 -13.69 58.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -62.82 -63.62 1.16 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.12 -22.95 0.38 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.833 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -108.71 109.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 109.963 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 p -99.47 171.0 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.773 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.62 155.55 20.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.3 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.009 HG22 HG22 ' A' ' 68' ' ' VAL . 40.8 t -128.24 148.35 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.511 0.655 . . . . 0.0 112.22 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.727 HD21 HD22 ' A' ' 93' ' ' LEU . 1.4 mp -135.15 148.63 49.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.548 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.678 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -139.93 117.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.0 110.797 179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -138.32 -176.81 4.58 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.496 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' N ' ' OG1' ' A' ' 81' ' ' THR . 6.8 t70 -76.77 167.65 21.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -62.44 -19.45 63.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.417 ' CB ' ' CG ' ' A' ' 1' ' ' MET . 2.0 mp0 -90.02 33.78 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.401 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.668 ' CG ' HG21 ' A' ' 81' ' ' THR . 2.5 t80 -134.42 77.18 60.34 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.088 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.76 149.49 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.174 2.583 . . . . 0.0 112.895 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 ' OH ' ' A' ' 69' ' ' TYR . 7.2 p -70.91 -26.8 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.344 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 2.8 mtt180 -53.48 -57.59 16.44 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.187 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 38.2 Cg_endo -65.03 -32.9 52.77 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.762 1.641 . . . . 0.0 110.772 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.614 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . . . -64.74 -30.06 71.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.616 ' HA ' HD23 ' A' ' 94' ' ' LEU . 23.0 t80 -67.15 -43.5 82.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -57.37 -40.66 78.61 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 79' ' ' LEU . 4.7 tt -63.94 -40.09 95.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.321 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -61.11 -22.63 64.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.387 178.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.74 -60.64 2.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.668 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -61.18 -39.73 91.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.801 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.947 HD11 HD12 ' A' ' 125' ' ' LEU . 6.5 tt -62.69 -58.99 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.792 ' O ' HD13 ' A' ' 102' ' ' LEU . 17.7 mt -60.4 -29.84 69.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.046 0.45 . . . . 0.0 110.392 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.57 -27.1 55.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' CE ' ' A' ' 122' ' ' MET . 0.0 OUTLIER -75.6 -50.96 13.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.046 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.493 ' CD1' HD11 ' A' ' 75' ' ' ILE . 37.8 t80 -60.21 -29.76 68.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 98' ' ' LEU . 4.3 mp -72.1 -29.45 64.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.342 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.05 -50.2 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.584 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.17 -22.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.211 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -167.55 130.71 1.4 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' HIS . 67.7 Cg_exo -35.42 161.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.621 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -47.24 -62.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.586 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.88 -27.31 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 105' ' ' HIS . 12.7 tt0 -47.87 -49.26 30.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.621 ' CZ2' ' HA ' ' A' ' 107' ' ' LYS . 3.6 p-90 -81.02 -47.31 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 109.942 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 32.29 50.59 0.19 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.54 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 113' ' ' VAL . 3.5 m-20 94.52 -34.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.202 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER 57.09 108.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.484 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -77.18 4.41 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.932 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -170.71 129.16 0.8 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.01 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 117' ' ' ASN . 4.1 m -133.06 169.87 16.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.175 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.466 ' H ' HG22 ' A' ' 116' ' ' THR . 1.8 m120 -111.59 68.46 0.67 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.836 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 p30 -45.75 -22.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.718 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 120' ' ' LEU . . . -58.41 -31.2 67.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 119' ' ' ALA . 0.3 OUTLIER -176.11 53.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.783 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.86 31.24 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.568 ' CE ' ' HB3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -178.13 48.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.2 -31.86 1.66 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.968 0.413 . . . . 0.0 110.802 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 1.7 mp0 -61.35 -61.43 2.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.95 HD11 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -49.4 -29.9 7.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.544 179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.69 ' N ' HD23 ' A' ' 125' ' ' LEU . 4.4 m-20 -70.52 -48.8 53.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.78 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -65.26 -28.19 69.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.46 -51.77 39.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.681 HG12 HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -63.75 -29.7 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.09 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 46.5 t -67.05 -44.77 79.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -83.66 -30.12 27.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 93' ' ' LEU . 1.9 m-85 -61.72 -12.98 19.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.931 ' HA ' HG22 ' A' ' 3' ' ' ILE . 2.4 pp0? -70.7 56.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.7 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 74.0 57.65 0.3 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.157 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 131' ' ' LYS . 90.4 Cg_endo -82.57 -45.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.127 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.25 28.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 53.72 24.92 4.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 110.811 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 49.34 43.07 23.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.409 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.09 32.17 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.117 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.776 0.322 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.9 mmp_? 68.99 -172.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 6' ' ' ILE . 10.1 tt -64.54 144.35 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -118.48 -39.65 2.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.933 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 5.7 t80 -147.08 154.44 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.693 0.758 . . . . 0.0 112.772 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.793 HG13 HD11 ' A' ' 3' ' ' ILE . 3.9 mt -149.31 165.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.884 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.888 ' HA2' HD11 ' A' ' 125' ' ' LEU . . . 163.52 -160.29 32.98 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.611 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -147.57 154.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.464 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 8' ' ' VAL . 1.9 m-85 -148.74 125.45 11.13 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.818 ' NH1' HG22 ' A' ' 114' ' ' THR . 0.9 OUTLIER -79.76 120.01 23.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 178.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.15 100.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.377 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.91 -135.75 2.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.418 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.45 -81.73 1.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.35 -19.43 39.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -146.75 -179.86 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.696 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 45' ' ' GLU . . . -90.41 134.22 34.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 114' ' ' THR . 4.9 tt -80.13 133.68 36.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.464 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -63.5 102.97 0.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.291 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 3.7 tp -77.26 -71.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.603 ' OG ' HG23 ' A' ' 8' ' ' VAL . 5.1 p -142.92 119.08 10.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -104.66 118.58 36.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 126' ' ' ASP . 12.5 p -120.61 134.18 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -123.25 160.63 26.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -139.92 107.46 5.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.633 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.906 HD13 ' HG2' ' A' ' 33' ' ' ARG . 1.3 mt -126.94 83.93 2.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.185 0.516 . . . . 0.0 111.328 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 -66.46 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.025 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -17.19 62.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.21 109.13 16.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.846 0.355 . . . . 0.0 110.532 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.38 -161.84 0.02 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.044 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.98 -66.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.983 0.421 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -56.44 -29.31 61.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.5 mp0 -80.65 -36.85 31.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.906 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -57.21 -37.85 72.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.626 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 t -75.11 -47.79 26.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.6 p -62.5 -56.21 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.954 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 32' ' ' GLU . 6.6 t -57.59 -48.39 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.92 -48.6 24.49 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.672 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.69 -33.01 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.99 -42.32 85.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 5' ' ' TYR . 19.0 mmt -61.89 -59.37 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.513 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.17 -58.58 7.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 10.3 t80 -44.25 -41.03 5.59 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.094 0.474 . . . . 0.0 110.722 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.908 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -75.23 -35.73 61.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.311 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.895 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.49 -32.53 70.08 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 20.7 pt-20 -74.08 -39.87 63.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.543 HG22 ' HD2' ' A' ' 50' ' ' ARG . 1.1 m -59.52 -53.02 62.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.988 ' HB ' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.07 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' CB ' ' A' ' 16' ' ' ALA . . . -50.16 -30.24 10.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.18 -42.66 72.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -67.56 -32.59 73.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.367 178.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.844 ' OG1' HG11 ' A' ' 68' ' ' VAL . 17.1 m -77.97 106.03 9.56 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.783 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.98 38.1 3.16 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.602 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . . . 62.83 144.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.21 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.33 -0.27 87.96 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -138.58 175.08 9.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.04 0.448 . . . . 0.0 111.445 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 67.9 mtm180 -128.0 162.34 27.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 24.7 mm100 -140.03 155.2 47.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 112.077 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.29 102.09 4.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.592 ' CD1' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.29 104.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -178.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.43 108.62 21.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.692 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -116.63 172.53 7.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.707 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.08 55.08 2.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.18 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.5 t-20 -172.02 -47.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . 1.6 p90 -167.39 -177.34 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.756 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 66' ' ' GLY . 5.3 mt -107.75 159.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.993 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 80' ' ' ILE . . . -136.96 77.54 0.34 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.901 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.74 ' CE1' HG22 ' A' ' 87' ' ' VAL . 86.8 m-70 -55.86 161.36 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.988 HG21 ' HB ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.32 142.89 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.491 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 94' ' ' LEU . 16.6 m-85 -146.78 111.52 5.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 110.476 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 53' ' ' ALA . . . -91.93 150.09 21.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.212 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -178.84 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.5 m -48.66 -48.34 39.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.9 87.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.17 -98.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.833 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.704 HG23 ' CE3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -113.63 116.13 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.461 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' PHE . 22.3 p -93.47 162.34 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.389 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -125.52 159.48 20.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.952 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 68' ' ' VAL . 70.3 t -125.16 150.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.057 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.991 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.3 tt -134.29 104.72 6.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.663 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.652 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -102.57 121.78 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.907 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.013 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -144.47 -174.36 4.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' OG1' ' A' ' 81' ' ' THR . 3.8 t70 -83.46 166.74 18.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -58.98 -24.38 62.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -88.9 40.48 0.98 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.199 0.523 . . . . 0.0 110.343 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.013 ' CD1' HG21 ' A' ' 81' ' ' THR . 25.0 t80 -136.47 77.99 45.38 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.456 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_exo -36.61 152.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.382 2.721 . . . . 0.0 113.364 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.74 HG22 ' CE1' ' A' ' 67' ' ' HIS . 26.2 t -78.52 -26.96 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.677 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -53.77 -54.21 49.02 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.115 -179.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.677 ' HD3' ' HB2' ' A' ' 88' ' ' ARG . 13.0 Cg_exo -67.32 -27.94 40.11 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.927 1.751 . . . . 0.0 110.483 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -68.4 -29.1 67.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -43.45 73.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 m -62.94 -45.78 90.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.706 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 HD11 ' A' ' 79' ' ' LEU . 7.0 tt -62.65 -50.04 72.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.178 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 79' ' ' LEU . 4.2 mm? -64.76 -14.42 58.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.28 -48.92 18.43 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.119 0.485 . . . . 0.0 110.034 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 100' ' ' GLU . 9.9 mmtt -73.94 -32.29 63.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 125' ' ' LEU . 7.5 tt -65.07 -57.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 120.722 0.296 . . . . 0.0 111.087 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -61.59 -37.77 85.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 103' ' ' VAL . 24.4 m-20 -70.62 -27.46 64.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 32.2 tp10 -73.52 -57.56 3.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.018 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' HG21 ' A' ' 116' ' ' THR . 41.8 t80 -52.72 -29.82 28.99 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.245 0.545 . . . . 0.0 109.535 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 98' ' ' LEU . 5.0 mp -75.87 -34.98 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.421 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 99' ' ' ASP . 4.9 t -67.54 -48.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.553 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.56 -20.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 111.38 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.57 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -173.19 129.61 0.54 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.631 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' CD ' ' HG3' ' A' ' 109' ' ' GLU . 62.2 Cg_exo -34.51 159.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.382 2.721 . . . . 0.0 113.599 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -42.93 -62.6 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.68 -30.79 71.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG3' ' CD ' ' A' ' 106' ' ' PRO . 5.0 mm-40 -49.43 -31.67 10.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.308 . . . . 0.0 111.335 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' O ' ' N ' ' A' ' 112' ' ' ASP . 11.2 p-90 -108.39 -28.04 9.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.052 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' N ' ' CE3' ' A' ' 110' ' ' TRP . . . 26.86 -65.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.077 0.861 . . . . 0.0 112.131 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.871 ' N ' ' O ' ' A' ' 110' ' ' TRP . 20.1 m-20 -158.82 70.42 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.111 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.419 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.4 t -59.31 113.73 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.623 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.818 HG22 ' NH1' ' A' ' 10' ' ' ARG . 62.1 p -96.39 26.99 3.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.2 56.2 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.173 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.744 HG22 HD13 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -122.69 168.73 11.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.597 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.8 t-20 177.95 -161.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.443 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -57.46 -15.32 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.031 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.7 16.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.951 0.405 . . . . 0.0 110.86 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.744 HD13 HG22 ' A' ' 116' ' ' THR . 6.4 mp -61.28 -32.12 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.729 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.38 -62.38 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.381 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE1' HG12 ' A' ' 97' ' ' ILE . 7.5 ttt 73.4 72.04 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.281 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -43.64 -31.17 0.71 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -69.81 -66.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.715 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -50.97 -31.96 19.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.631 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.69 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.6 m-20 -77.2 -56.3 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -56.94 -27.04 60.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.876 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 132' ' ' TYR . 4.9 m-85 -75.8 -56.75 4.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.267 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.716 ' CB ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.03 -24.81 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -82.12 -41.77 20.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.009 0.433 . . . . 0.0 110.641 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -84.21 -17.51 39.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.627 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 128' ' ' TYR . 2.1 m-85 -81.44 -12.76 58.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.79 ' HA ' HG22 ' A' ' 3' ' ' ILE . 1.7 pp0? -68.31 51.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.809 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 14.5 m-20 39.52 48.2 1.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 49.5 Cg_endo -88.05 -39.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.444 2.096 . . . . 0.0 112.512 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.86 22.15 0.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 140' ' ' ALA . 1.8 tt0 56.09 31.49 18.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.444 . . . . 0.0 110.342 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 47.39 46.42 17.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.465 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.81 58.44 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 137' ' ' GLN . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 stop_ save_